
<html lang="en"     class="pb-page"  data-request-id="88a54f4a-8833-4fa2-9018-6c23a9f6f953"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c00451;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials" /></meta><meta name="dc.Creator" content="Amit  Mahindra" /></meta><meta name="dc.Creator" content="Omar  Janha" /></meta><meta name="dc.Creator" content="Kopano  Mapesa" /></meta><meta name="dc.Creator" content="Ana  Sanchez-Azqueta" /></meta><meta name="dc.Creator" content="Mahmood M.  Alam" /></meta><meta name="dc.Creator" content="Alfred  Amambua-Ngwa" /></meta><meta name="dc.Creator" content="Davis C.  Nwakanma" /></meta><meta name="dc.Creator" content="Andrew B.  Tobin" /></meta><meta name="dc.Creator" content="Andrew G.  Jamieson" /></meta><meta name="dc.Description" content="The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfC..." /></meta><meta name="Description" content="The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfC..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 28, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00451" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00451" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00451" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00451" /></link>
        
    
    

<title>Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00451" /></meta><meta property="og:title" content="Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0012.jpeg" /></meta><meta property="og:description" content="The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfCLK3 as a drug target in malaria that offers prophylactic, transmission blocking, and curative potential. Herein, we describe the synthesis of our initial hit TCMDC-135051 (1) and efforts to establish a structure–activity relationship with a 7-azaindole-based series. A total of 14 analogues were assessed in a time-resolved fluorescence energy transfer assay against the full-length recombinant protein kinase PfCLK3, and 11 analogues were further assessed in asexual 3D7 (chloroquine-sensitive) strains of P. falciparum parasites. SAR relating to rings A and B was established. These data together with analysis of activity against parasites collected from patients in the field suggest that TCMDC-135051 (1) is a promising lead compound for the development of new antimalarials with a novel mechanism of action targeting PfCLK3." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00451"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00451">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00451&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00451&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00451&amp;href=/doi/10.1021/acs.jmedchem.0c00451" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9300-9315</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00433" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00500" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Potent <i>Pf</i>CLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Amit Mahindra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit Mahindra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit++Mahindra">Amit Mahindra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Omar Janha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Omar Janha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Omar++Janha">Omar Janha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kopano Mapesa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kopano Mapesa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kopano++Mapesa">Kopano Mapesa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Sanchez-Azqueta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Sanchez-Azqueta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Sanchez-Azqueta">Ana Sanchez-Azqueta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mahmood M. Alam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mahmood M. Alam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wellcome Centre for Integrative Parasitology and Centre for Translational Pharmacology, Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mahmood+M.++Alam">Mahmood M. Alam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alfred Amambua-Ngwa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alfred Amambua-Ngwa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Unit The Gambia at LSHTM, Atlantic Boulevard, Fajara, P. O. Box 273, Banjul, The Gambia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alfred++Amambua-Ngwa">Alfred Amambua-Ngwa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Davis C. Nwakanma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Davis C. Nwakanma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MRC Unit The Gambia at LSHTM, Atlantic Boulevard, Fajara, P. O. Box 273, Banjul, The Gambia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Davis+C.++Nwakanma">Davis C. Nwakanma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew B. Tobin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew B. Tobin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#d392bdb7a1b6a4fd87bcb1babd93b4bfb2a0b4bca4fdb2b0fda6b8"><span class="__cf_email__" data-cfemail="3c7d52584e594b1268535e55527c5b505d4f5b534b125d5f124957">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+B.++Tobin">Andrew B. Tobin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1807-3123" title="Orcid link">http://orcid.org/0000-0002-1807-3123</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Andrew G. Jamieson</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew G. Jamieson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#05646b617760722b6f64686c60766a6b2b374562696476626a722b64662b706e"><span class="__cf_email__" data-cfemail="74151a100611035a1e15191d11071b1a5a463413181507131b035a15175a011f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+G.++Jamieson">Andrew G. Jamieson</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1726-7353" title="Orcid link">http://orcid.org/0000-0003-1726-7353</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00451&amp;href=/doi/10.1021%2Facs.jmedchem.0c00451" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9300–9315</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 March 2020</li><li><span class="item_label"><b>Published</b> online</span>28 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00451</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00451"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3131</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00451" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;Mahindra&quot;},{&quot;first_name&quot;:&quot;Omar&quot;,&quot;last_name&quot;:&quot;Janha&quot;},{&quot;first_name&quot;:&quot;Kopano&quot;,&quot;last_name&quot;:&quot;Mapesa&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Sanchez-Azqueta&quot;},{&quot;first_name&quot;:&quot;Mahmood&quot;,&quot;last_name&quot;:&quot;M. Alam&quot;},{&quot;first_name&quot;:&quot;Alfred&quot;,&quot;last_name&quot;:&quot;Amambua-Ngwa&quot;},{&quot;first_name&quot;:&quot;Davis&quot;,&quot;last_name&quot;:&quot;C. Nwakanma&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;B. Tobin&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;G. Jamieson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9300-9315&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00451&quot;},&quot;abstract&quot;:&quot;The protein kinase PfCLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage Plasmodium falciparum. We recently validated PfCLK3 as a drug target in malaria that offers prophylactic, transmission blocking, and curative potential. Herein, we describe the synthesis of our initial hit TCMDC-135051 (1) and efforts to establish a structure–activity relationship with a 7-azaindole-based series. A total of 14 analogues were assessed in a time-resolved fluorescence energy transfer assay against the full-length recombinant protein kinase PfCLK3, and 11 analogues were further assessed in asexual 3D7 (chloroquine-sensitive) strains of P. falciparum parasites. SAR relating to rings A and B was established. These data together with analysis of activity against parasites collected from patients in the field suggest that TCMDC-135051 (1) is a promising lead compound for the development of new antimalarials with a novel mechanism of action targeting PfCL&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00451&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00451" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00451&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00451" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00451&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00451" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00451&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00451&amp;href=/doi/10.1021/acs.jmedchem.0c00451" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00451" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00451" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00451%26sid%3Dliteratum%253Aachs%26pmid%3D32787140%26genre%3Darticle%26aulast%3DMahindra%26date%3D2020%26atitle%3DDevelopment%2Bof%2BPotent%2BPfCLK3%2BInhibitors%2BBased%2Bon%2BTCMDC-135051%2Bas%2Ba%2BNew%2BClass%2Bof%2BAntimalarials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9300%26epage%3D9315%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The protein kinase <i>Pf</i>CLK3 plays a critical role in the regulation of malarial parasite RNA splicing and is essential for the survival of blood stage <i>Plasmodium falciparum</i>. We recently validated <i>Pf</i>CLK3 as a drug target in malaria that offers prophylactic, transmission blocking, and curative potential. Herein, we describe the synthesis of our initial hit TCMDC-135051 <b>(1)</b> and efforts to establish a structure–activity relationship with a 7-azaindole-based series. A total of 14 analogues were assessed in a time-resolved fluorescence energy transfer assay against the full-length recombinant protein kinase <i>Pf</i>CLK3, and 11 analogues were further assessed in asexual 3D7 (chloroquine-sensitive) strains of <i>P. falciparum</i> parasites. SAR relating to rings A and B was established. These data together with analysis of activity against parasites collected from patients in the field suggest that TCMDC-135051 <b>(1)</b> is a promising lead compound for the development of new antimalarials with a novel mechanism of action targeting <i>Pf</i>CLK3.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the global fight against malaria, the distribution of over 0.5 billion insecticide impregnated bed nets since 2015, together with artemisinin-based combination therapies, has contributed to 20 million fewer cases of malaria being reported in 2017 compared to 2010.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite this success, the rate of reduction in malaria has stalled with no significant reduction seen over the last 3 years.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This, together with evidence of the emergence of resistance to both artemisinin<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> and partner drugs including piperaquine and mefloquine,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> means that there is a danger that the progress made in the reduction of malaria will be reversed unless new medicines with novel mechanisms of action are discovered. To address this, we have been testing the notion that targeting malaria parasite protein kinases, known to be essential for the survival of the parasite, might offer a novel strategy for the development of next-generation antimalarials.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a></div><div class="NLM_p">In 2011, we determined that 36 of the 65 eukaryotic protein kinases are essential for the survival of the blood stage of the most virulent species of human malaria, <i>Plasmodium falciparum</i>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Among these protein kinases was <i>Pf</i>CLK3 (<i>PF</i>3D7_1114700), one of the four members of the cyclin-dependent like protein kinase family (<i>Pf</i>CLK1-4). The plasmodium CLK-family are closely related to the mammalian CLK family and the serine–arginine-rich protein kinase (SRPK) family,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> both of which are crucial mediators of multiple phosphorylation events on splicing factors necessary for the correct assembly and catalytic activity of spliceosomes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><i>In vitro</i> studies showed that <i>Pf</i>CLK3 can phosphorylate parasite SR proteins,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> indicating that <i>Pf</i>CLK3, together with other members of the <i>Pf</i>CLK family,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> plays a role in the processing of parasite RNA.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We reasoned therefore that inhibitors of PfCLK3 might have parasiticidal activity at any stage of the parasite life cycle where RNA splicing played an essential role.</div><div class="NLM_p">Screening of ∼25,000 compounds, including all 13,533 compounds of the Tres cantos antimalarial set, resulted in the discovery of TCMDC-135051 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a compound with nanomolar (nM) activity against <i>Pf</i>CLK3 <i>in vitro</i> kinase assays and submicromolar (μM) parasiticidal activity in asexual blood stage <i>P. falciparum</i> parasites (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Subsequent studies revealed that TCMDC-135051 rapidly killed <i>P. falciparum</i> at the trophozoite to schizont stages as well as preventing the development of stage V gametocytes and inhibiting the development of liver stage parasites. TCMDC-135051 also showed equivalent <i>in vitro</i> kinase activity at CLK3 from <i>P. falciparum</i>, <i>Plasmodium berghei</i> (mouse malaria), <i>Plasmodium vivax</i> (human malaria), and <i>Plasmodium knowlesi</i> (monkey and human malaria).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Our recent studies have therefore validated <i>Pf</i>CLK3 as a target with the potential to deliver a curative treatment, be transmission blocking, and act as a prophylactic target.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and biological profile of hit PfCLK3 inhibitor TCMDC-135051, <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Key structural features of <b>1</b> include a core 7-azaindole scaffold with aromatic rings in the 2- and 4-positions (ring A and B, respectively). These aromatic rings are further substituted with various functional groups, including a tertiary amine (ring A) and carboxylic acid (ring B), resulting in a zwitterionic compound at physiological pH.</div><div class="NLM_p">7-Azaindoles are a widely studied pharmacophore incorporated into several therapeutic agents.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Kinases are the predominate target with the 7-azaindole moiety generally interacting at the ATP binding site within the kinase hinge region.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> An interaction occurs between the kinase hinge region peptide backbone and the azaindole <i>via</i> two H-bonds; the first involving the pyridine nitrogen lone pair and peptide backbone NH, and the second between the pyrrole NH and peptide backbone carbonyl. The resulting H-bond acceptor and donor bidentate 7-azaindole interaction with the hinge region of the kinase can occur in the more common “normal” orientation or the “flipped” orientation with the 2-position of the 7-azaindole projected out of the hinge region into the solvent-exposed space.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a></div><div class="NLM_p">A number of small molecule kinase 7-azaindole inhibitors have progressed to different stages of clinical trials.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A potential drug candidate GSK1070916 is being developed as an aurora kinase (Ser/Thr protein kinases family) inhibitor and has reached human clinical trials (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The core scaffold is a 7-azaindole with aromatic substituents in the 2- and 4-positions. An X-ray crystal structure of the molecule:aurora kinase complex revealed a flipped hinge region binding mechanism, with 2-aryl projecting out of the hinge region into solvent and 4-aryl bound within the ribose pocket.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Aurora kinase inhibitor GSK1070916, (B) 1-<i>p</i>-chlorobenzyl-7-azaindole-3-α-piperidylmethanol has in vivo activity against <i>P. berghei</i>, (C) PfHsp90 inhibitor IND31119, and (D) drug candidates incorporating a core 7-azaindole scaffold, vemurafenib, PLX3397, and AZD5363.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substructure analysis using Scifinder revealed several 7-azaindole analogues described as antimalarials. In 1972, Verbiscar reported the first example of a 7-azaindole with antimalarial activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 1-<i>p</i>-Chlorobenzyl-7-azaindole-3-α-piperidylmethanol displayed antimalarial activity in mice against <i>P. berghei</i>(<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). More recently, Picard et al. reported 7-azaindole compounds that were identified from an <i>in silico</i> structure-based drug screen (1,013,483 compounds, Chembridge library).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compound IND31119 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C) binds to the recombinant N-terminal domain of <i>Pf</i>Hsp90 and shows selectivity over human Hsp90 and <i>Pf</i>Hsp90 mutants.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">In addition to antimalarial activity, the 7-azaindole scaffold has been identified as having a wide variety of biological applications, including antitumor activity, and acts as an HIV-1 inhibitor in infected patients.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> The 7-azaindole motif can be regarded as a privileged scaffold in medicinal chemistry as it is found in three clinical candidates (vemurafenib, PLX3397, and AZD5363) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D), which suggests its usefulness for developing novel pharmaceuticals.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a></div><div class="NLM_p">To investigate the structure–activity relationship (SAR) of hit compound <b>1</b>, a series of analogues were prepared through varying different substituents on ring A and ring B (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The <i>N</i>-diethyl amine group (ring A) was initially replaced with different amine substituents to investigate lipophilicity and solubility (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, SAR1). Next, we replaced the methoxy moiety (ring A) with hydroxyl or hydrogen to modify polarity and to explore the role of the methoxy group on activity (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, SAR2). The isopropyl substituent (ring B) was replaced with other small hydrophobic substituents to probe noncoplanar conformations that could potentially lower the energy of crystal packing and consequently improve aqueous solubility and log <i>P</i> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, SAR3). Finally, we exchanged the carboxylic acid group (ring B) with other substituents to investigate its role in binding, to potentially improve metabolic stability, and to explore the effect of increased lipophilic character (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, SAR4).</div><div class="NLM_p">TCMDC-135051 is a promising hit compound for a medicinal chemistry program to develop as a preclinical lead that meets many of the criteria set by the Medicines for Malaria Venture (capable of rapidly clearing the parasite, has multistage potency, and killing multiple parasite species with action as a transmission blocker).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Here, we describe the synthetic route to TCMDC-135051 and determine a SAR that will be key for lead development.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">To investigate the effect of the <i>N</i>-diethyl group of ring A on antimalarial activity, analogues of 4-(2-(5-((diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic acid (TCMDC-135051) <b>1</b>, <b>8a–c</b> were prepared, as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Protection of 4-bromo-7-azaindole <b>2</b> was achieved using <i>p</i>-toluenesulfonyl chloride under basic conditions to provide <i>N</i>-tosyl-7-azaindole <b>3</b>. Regioselective iodination of <b>3</b> using lithium diisopropylamide (LDA) and iodine in tetrahydrofuran (THF) at −78 °C provided 2-iodoazaindole <b>4</b>, which was subsequently subjected to Suzuki coupling with (5-formyl-2-methoxyphenyl)boronic acid to give 2-aryl substituted azaindole <b>5</b>. Reductive amination of the aldehyde functionality of <b>5</b> was performed with various amines in the presence of sodium triacetoxyborohydride to give amines <b>6a–d</b> in excellent yields. Next, the <i>N</i>-tosyl protecting group was removed under basic conditions at reflux for 18 h to yield <b>7a–d</b>. Finally, the desired analogues <b>1</b> and <b>8a–c</b> were obtained by Suzuki cross-coupling with 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf" class="ext-link">Supporting Information</a> for boronate ester synthesis).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of TCMDC-135051 <b>1</b> and Analogues <b>8a–c</b> & <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TsCl, NaH, THF, 0 °C, 2 h; (ii) LDA, I<sub>2</sub>, THF, −78 °C, 3 h; (iii) (5-formyl-2-methoxyphenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 12 h; (iv) amine, NaBH(AcO)<sub>3</sub>, 1,4-dioxane, 20 °C, 12 h; (v) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 55 °C, 18 h; (vi) 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 0.5 h, MW; and (vii) SOCl<sub>2</sub>, CH<sub>3</sub>CH<sub>2</sub>OH, reflux, 18 h.</p></p></figure><div class="NLM_p">Compound <b>9</b> was prepared, as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The carboxylic acid of <b>1</b> was converted to its corresponding ethyl ester by refluxing in thionyl chloride and ethanol for 18 h.</div><div class="NLM_p">The synthetic route outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was modified to prepare primary amine <b>12</b>. The first step of this synthetic route involved coupling 2-iodo-azaindole <b>4</b> with the appropriate boronate ester under Suzuki conditions to yield nitrile <b>10</b> in 87% yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Tosyl deprotection was then achieved using K<sub>2</sub>CO<sub>3</sub>, followed by a Suzuki coupling at the 4-bromo-azaindole scaffold with the appropriate pinacol boronate ester. The crude material was reduced <i>in situ</i> using cobalt(II) chloride hexahydrate and sodium borohydride to provide the corresponding amine <b>12</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-(2-(5-(Aminomethyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 18 h; (ii) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 55 °C, 18 h; (iii) 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, Pd(dppf)Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 0.5 h, MW; and (iv) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, CH<sub>3</sub>OH.</p></p></figure><div class="NLM_p">Similarly, analogue <b>15</b> was synthesized <i>via</i> Suzuki coupling of <b>4</b> with 2-methoxyphenyl boronic acid, followed by tosyl deprotection and Suzuki coupling (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Isopropyl-4-(2-(2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzoic Acid <b>15</b>, 4-(2-(5-((Diethylamino)methyl)-2-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid <b>19</b>, 4-(2-(3-((Diethylamino)methyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid <b>23</b> and [4-(2-(3-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid] <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (2-methoxyphenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 12 h; (ii) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 55 °C, 18 h; (iii) 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 0.5 h, MW; (iv) 4-(methoxymethoxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde or 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 18 h; (v) Et<sub>2</sub>NH, NaBH(AcO)<sub>3</sub>, 1,4-dioxane, rt, 18 h; and (vi) HCl, MeCN/H<sub>2</sub>O 3:1.</p></p></figure><div class="NLM_p">To investigate the precise role of the methoxy group of ring A on activity, we prepared analogues <b>19</b> and <b>23</b> in which the OMe is replaced by a hydroxy group (<b>19</b>) and OMe is removed (<b>23</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The synthetic route toward <b>19</b> starts with Suzuki coupling of <b>4</b> with methoxymethyl ether (MOM)-protected boronate ester (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf" class="ext-link">Supporting Information</a> for boronate ester synthesis) to yield <b>16</b>. Reductive amination of <b>16</b> followed by removal of the tosyl group gave <b>18</b>. Finally, <b>18</b> was coupled with boronate ester under Suzuki conditions, and the MOM protecting group was removed under acidic conditions to provide the desired analogue <b>19</b> in excellent yields. Analogue <b>23</b> was synthesized in four steps using the same methods.</div><div class="NLM_p">To investigate whether the substitution pattern on ring A is important for antimalarial activity, we produced analogue <b>27</b> in which the methoxy group is moved from para to the ortho position relative to the methylene N-diethyl functionality (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><div class="NLM_p">To investigate the effect of the isopropyl substituent (ring B) on efficacy, we prepared analogues <b>28–29</b>, as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. 4-Bromo-7-azaindole <b>7a</b> was coupled with various boronate esters under Suzuki conditions to yield the desired 4-aryl-7-azaindole analogues <b>28</b>–<b>29</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-Aryl-7-azaindole Analogues, <b>28</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) boronate esters, Pd(dppf)Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1-4-dioxane, 110 °C, 0.5 h, MW.</p></p></figure><div class="NLM_p">To investigate the role of the carboxylic acid substituent of ring B on antimalarial activity, several analogues <b>30</b>–<b>32</b> were synthesized, as depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Synthesis of analogues <b>30</b>–<b>32</b> was achieved by Suzuki coupling <b>7a</b> with various boronate esters (<i>R</i><sup>2</sup> = 1<i>H</i>-tetrazole or H) to yield target compounds <b>30–31</b> in good yields.</div><div class="NLM_p last">An isomer, in which the isopropyl and carboxylic acids were switched, <b>32</b> was synthesized to investigate the role of these functional groups on antimalarial activity (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this work, we have maintained the core 7-azaindole molecular scaffold of TCMDC-135051 and focused on the SARs of the substitutes on ring A and -B to assess the requirement for this functionality. All synthesized analogues were assessed in a time-resolved fluorescence energy transfer (TR-FRET) <i>Pf</i>CLK3 <i>in vitro</i> kinase assay against the full recombinant protein kinase (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Analogues which gave low nanomolar activity were then further assessed in live parasite viability (parasiticidal) assays using laboratory strain 3D7 (chloroquine-sensitive) <i>P. falciparum</i> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The synthesized analogues were evaluated for log <i>D</i><sub>7.4</sub> (distribution co-efficient) and metabolic stability, and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physicochemical Properties and Activity Data of TCMDC-135051 Ring A Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0010.gif" alt="" id="GRAPHIC-d7e1123-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>Pf</i>CLK3</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">3D7</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">c<sub>lint</sub> (mL/min/g liver)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="left">7.4 (±0.221)</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="left">6.7 (±0.126)</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="char" char=".">1.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="left">7.5 (±0.224)</td><td class="colsep0 rowsep0" align="char" char=".">457</td><td class="colsep0 rowsep0" align="left">6.3 (±0.129)</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">2.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">N-pyrrolidinyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left">7.4 (±0.113)</td><td class="colsep0 rowsep0" align="char" char=".">382</td><td class="colsep0 rowsep0" align="left">6.4 (±0.081)</td><td class="colsep0 rowsep0" align="char" char=".">2.43</td><td class="colsep0 rowsep0" align="char" char=".">1.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">N-morpholinyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left">8.0 (±0.191)</td><td class="colsep0 rowsep0" align="char" char=".">1339</td><td class="colsep0 rowsep0" align="left">5.9 (±0.118)</td><td class="colsep0 rowsep0" align="char" char=".">1.20</td><td class="colsep0 rowsep0" align="char" char=".">1.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="left">7.1 (±0.142)</td><td class="colsep0 rowsep0" align="char" char=".">2801</td><td class="colsep0 rowsep0" align="left">5.6 (±0.104)</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">2.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="left">7.1 (±0.132)</td><td class="colsep0 rowsep0" align="char" char=".">1456</td><td class="colsep0 rowsep0" align="left">5.8 (±0.152)</td><td class="colsep0 rowsep0" align="char" char=".">2.45</td><td class="colsep0 rowsep0" align="char" char=".">2.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="left">7.7 (±0.115)</td><td class="colsep0 rowsep0" align="char" char=".">3529</td><td class="colsep0 rowsep0" align="left">5.5 (±0.133)</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td><td class="colsep0 rowsep0" align="char" char=".">1.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="left">7.6 (±0.089)</td><td class="colsep0 rowsep0" align="char" char=".">309</td><td class="colsep0 rowsep0" align="left">6.5 (±0.114)</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left">7.7 (±0.116)</td><td class="colsep0 rowsep0" align="char" char=".">3167</td><td class="colsep0 rowsep0" align="left">5.6 (±0.109)</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="char" char=".">1.65</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> (the concentration of an inhibitor where the response is reduced by half).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> (the concentration of a drug that gives half-maximal response). IC<sub>50</sub> and EC<sub>50</sub> values are means ± SEM of three independent experiments run in triplicates (<i>n</i> = 3).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">log <i>D</i><sub>7.4</sub> (distribution co-efficient) was estimated using HPLC chromatography.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><i>In vitro</i> intrinsic clearance in mouse liver microsomes.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Physicochemical Properties and Activity Data of TCMDC-135051 Ring B Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0011.gif" alt="" id="GRAPHIC-d7e1464-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>Pf</i>CLK3</th><th class="rowsep1 colsep0" colspan="2" align="center">3D7</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">analogue</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">log <i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> (mL/min/g liver)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left">7.6 (±0.10)</td><td class="colsep0 rowsep0" align="left">1185</td><td class="colsep0 rowsep0" align="left">5.6 (±0.097)</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">1.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">7.5 (±0.089)</td><td class="colsep0 rowsep0" align="left">3272</td><td class="colsep0 rowsep0" align="left">5.5 (±0.124)</td><td class="colsep0 rowsep0" align="left">0.65</td><td class="colsep0 rowsep0" align="left">11.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1<i>H</i>-tetrazole</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left">7.7 (±0.089)</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">6.6 (±0.158)</td><td class="colsep0 rowsep0" align="left">0.93</td><td class="colsep0 rowsep0" align="left">2.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1300</td><td class="colsep0 rowsep0" align="left">6.0 (±0.091)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">4.45</td><td class="colsep0 rowsep0" align="left">9.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">390</td><td class="colsep0 rowsep0" align="left">6.4 (±0.087)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">2.45</td><td class="colsep0 rowsep0" align="left">16.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1385</td><td class="colsep0 rowsep0" align="left">4.9 (±0.093)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> (the concentration of an inhibitor where the response is reduced by half).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> (the concentration of a drug that gives half-maximal response). IC<sub>50</sub> and EC<sub>50</sub> values are means ± SEM of three independent experiments run in triplicates (<i>n</i> = 3).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">log <i>D</i><sub>7.4</sub> (distribution co-efficient) was estimated using HPLC chromatography.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last"><i>In vitro</i> intrinsic clearance in mouse liver microsomes.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">SAR1 corresponding to analogues <b>8a–c</b>, <b>12</b>, and <b>15</b> were designed to examine the effect of the N-diethyl group of ring A on antimalarial activity. In analogue <b>8a</b>, the N-diethyl group was replaced with an N-dimethyl group to investigate the effect of alkyl group size and molecular lipophilicity (log <i>D</i><sub>7.4</sub> = 0.85). For <i>in vitro</i> kinase activity of <b>8a</b>, the half maximal inhibitory activity (IC<sub>50</sub>) IC<sub>50</sub> = 29 nM (pIC<sub>50</sub> = 7.5 ± 0.224) remains the same in recombinant <i>Pf</i>CLK3 kinase, whereas a 2-fold decrease in the half maximal parasite growth inhibition effect (EC<sub>50</sub>) EC<sub>50</sub> = 457 nM (pEC<sub>50</sub> = 6.3 ± 0.129) was observed (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). To further investigate the steric requirements of this functionality and polarity, pyrrolidine (<b>8b</b>) and morpholino groups (<b>8c</b>) were introduced. Analogue <b>8b</b> shows comparable <i>in vitro</i> kinase activity, IC<sub>50</sub> = 38 nM (pIC<sub>50</sub> = 7.4 ± 0.113), and a 2-fold decrease in parasite growth inhibition <b>8b</b>, EC<sub>50</sub> = 382 nM (pEC<sub>50</sub> = 6.4 ± 0.081), was observed. However, the more polar <b>8c</b> shows a slight improvement <i>in vitro</i> kinase activity of IC<sub>50</sub> = 9 nM (pIC<sub>50</sub> = 8.0 ± 0.191), a 7-fold decrease in parasite growth inhibition was observed <b>8c</b>, EC<sub>50</sub> = 1339 nM (pEC<sub>50</sub> = 5.9 ± 0.118) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). To further investigate the polarity of this moiety, we replaced the N-diethyl functionality with a more polar primary amine (log <i>D</i><sub>7.4</sub> = 0.61). Analogue <b>12</b> incorporating a primary amine gave an IC<sub>50</sub> = 76 nM (pIC<sub>50</sub> = 7.1 ± 0.142), thus was 2-fold less potent <i>in vitro</i> and showed a dramatic loss of efficacy, EC<sub>50</sub> = 2801 nM (pEC<sub>50</sub> = 5.6 ± 0.104), in parasites, indicating the need to decrease the polarity of the amine group for optimal parasite growth inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Analogue <b>15</b>, with the alkyl amine group removed (log <i>D</i><sub>7.4</sub> = 2.45) was less potent <i>in vitro</i>, IC<sub>50</sub> = 79.0 nM (pIC<sub>50</sub> = 7.1 ± 0.132) against recombinant <i>Pf</i>CLK3 protein and in parasites, EC<sub>50</sub> = 1456 nM (pEC<sub>50</sub> = 5.8 ± 0.152). There was a 7-fold drop in the parasite growth inhibition, suggesting that the alkyl amine on ring A is important for antimalarial activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">To explore the importance of the methoxy group (OMe) on ring A, two analogues, hydroxyl <b>19</b> and <b>23</b>, with methoxy removed, were prepared. We first replaced the OMe group with a hydroxyl to investigate the role of polarity on activity (log <i>D</i><sub>7.4</sub> = 0.59). Next, we replaced the OMe group with hydrogen (<b>23</b>) to investigate the importance of this functionality for activity. For both compounds <b>19</b> and <b>23</b>, <i>in vitro</i> kinase potency was comparable, IC<sub>50</sub> = 22 nM (pIC<sub>50</sub> = 7.7 ± 0.115) and IC<sub>50</sub> = 25 nM (pIC<sub>50</sub> = 7.6 ± 0.089), respectively (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). When tested in parasites, <b>19</b> shows significant loss of activity, EC<sub>50</sub> = 3529 nM (pEC<sub>50</sub> = 5.5 ± 0.133). Interestingly, replacing the OMe group with a hydrogen, <b>23</b> also shows a 1.5-fold decrease in potency, EC<sub>50</sub> = 309 nM (pEC<sub>50</sub> = 6.5 ± 0.114) against parasites. These data demonstrated that the OMe group on ring A is required for <i>in vitro</i> kinase and parasite growth inhibition. Overall, analogues (<b>8a–c</b>, <b>12</b>, <b>15</b>, <b>19</b>, and <b>23</b>) showed good metabolic stability in mouse liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Next, we turned our attention to study the SAR of various functional groups on ring B. First, we examined the role of binding through van der Waals interactions <i>in vitro</i> and lipophilicity in parasites, imparted by the ring B isopropyl group, on antimalarial activity. In analogue <b>28</b> (log <i>D</i><sub>7.4</sub> = 0.66), the isopropyl group was replaced with methyl, whereas in analogue <b>29</b> (log <i>D</i><sub>7.4</sub> = 0.65), the isopropyl was removed and replaced with hydrogen. Analogues <b>28</b> and <b>29</b> had a modest increase on <i>in vitro</i> kinase activity, IC<sub>50</sub> = 24 nM (pIC<sub>50</sub> = 7.6 ± 0.10) and IC<sub>50</sub> = 34 nM (pIC<sub>50</sub> = 7.5 ± 0.089), respectively. However, a dramatic loss of potency was observed for both compounds <b>28</b> and <b>29</b> with EC<sub>50</sub> = 1185 nM (pEC<sub>50</sub> = 5.6 ± 0.097) and EC<sub>50</sub> = 3272 nM (pEC<sub>50</sub> = 5.5 ± 0.124), respectively, representing a 6-fold and 16-fold decrease in parasite growth inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Therefore, this group is not required for binding <i>in vitro</i>; however, the effect of lipophilicity appears to be very important for parasite growth inhibition. Analogues <b>28</b> and <b>29</b> were then evaluated for intrinsic clearance in mouse microsome. Analogue <b>28</b> (Cl<sub>int</sub> = 1.33 mL/min/g liver) showed a similar clearance value to that of <b>1</b> (TCMDC-051) in mouse liver microsomes, whereas <b>29</b> had a higher clearance under the same conditions (Cl<sub>int</sub> = 11.01 mL/min/g liver) indicating the importance of the isopropyl group.</div><div class="NLM_p">At this point, we decided to increase the lipophilicity and replace the isopropyl group to the larger <i>tert</i>-butyl group. However, due to a restriction of the chemistry of boronate esters (instability of <i>tert</i>-butyl anion required for S<sub>N</sub>Ar reaction), we could not synthesize the proposed molecule. From these data, the alkyl substituent on ring B appears not to be particularly important in the molecular recognition event with <i>Pf</i>CLK3, however is key for overall molecular lipophilicity that contributes to parasite growth inhibition.</div><div class="NLM_p">To investigate the requirements (i.e., ionic and H-bonding) of the carboxylic acid (ring B) for antimalarial activity, we employed a series of structural changes. The presence of carboxylic acid functionality in a drug molecule has several potential drawbacks, including limited permeability across biological membranes, metabolic instability, and potential idiosyncratic toxicities. A common isostere of a carboxylic acid, that overcomes many of these physicochemical limitations, is a tetrazole. We therefore designed tetrazole analogue <b>30</b>. This change was orchestrated to increase the lipophilicity of the molecule, retain H-bonding capability, and investigate the role of potential ionic interactions with the enzyme. The tetrazole analogue <b>30</b> shows improved <i>in vitro</i> kinase potency with an IC<sub>50</sub> = 19 nM (pIC<sub>50</sub> = 7.7 ± 0.089), with comparable parasite growth inhibition, EC<sub>50</sub> = 270 nM (pEC<sub>50</sub> = 6.6 ± 0.158) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The potency of analogue <b>30</b> was tested against resistant mutant <i>Pf</i>CLK3 (<i>Pf</i>CLK3_G449P) 3D7 parasites.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The parasiticidal activity of TCMDC-135051 <b>1</b> against asexual 3D7 parasites was 180 nM (pEC<sub>50</sub> = 6.7), and 1806 nM (pEC<sub>50</sub> = 5.74) against mutant G449P. A 15-fold shift in sensitivity to the inhibitor. The tetrazole <b>30</b>, with an EC<sub>50</sub> = 270 nM (pEC<sub>50</sub> = 6.6)  in wild type parasites showed a significant reduction is potency against the mutant G449P parasites, EC<sub>50</sub> = 3494 nM (pEC<sub>50</sub> = 5.4). This represents a 13-fold shift in potency.</div><div class="NLM_p">Analogue <b>31</b> where the carboxylic acid group was replaced with a hydrogen shows significant loss of <i>in vitro</i> kinase activity, IC<sub>50</sub> = 1300 nM (pIC<sub>50</sub> = 6.0 ± 0.091). Analogue <b>31</b> has high lipophilicity (log <i>D</i><sub>7.4</sub> = 4.45) and <i>in vitro</i> high intrinsic clearance (Cl<sub>int</sub> = 9.54 mL/min/g liver) demonstrating the importance of the carboxylic acid group (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">Analogue <b>9</b> has improved lipophilicity (log <i>D</i><sub>7.4</sub> = 2.45), yet the <i>in vitro</i> kinase potency was low, IC<sub>50</sub> = 390 nM (pIC<sub>50</sub> = 6.4 ± 0.087), indicating that the presence of a functional group capable of donating a hydrogen bond is important for activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This analogue was not tested in parasites because of the low potency against recombinant <i>Pf</i>CLK3 kinase.</div><div class="NLM_p">The final part of our SAR assessment was dedicated to exploring the possibility of orientation of key substituents. Varying the position of the OMe group from para to the ortho position <b>27</b> resulted in a 2-fold increase in <i>in vitro</i> kinase activity, IC<sub>50</sub> = 17 nM (pIC<sub>50</sub> = 7.7 ± 0.116). However, when <b>27</b> was tested in parasites, the activity was lowered by 15-fold, EC<sub>50</sub> = 3167 nM (pEC<sub>50</sub> = 5.6 ± 0.109) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">We next investigated the position of the isopropyl and carboxylic acid substituents of ring B <b>32</b> on antimalarial activity. The change of orientation of the substituent is detrimental for the <i>in vitro</i> kinase activity, IC<sub>50</sub> = 1385 nM (pIC<sub>50</sub> = 4.9 ± 0.093), and therefore was not tested in parasites. These data suggested that the positioning of the isopropyl and carboxylic acid group was essential for binding to its cellular target.</div><div class="NLM_p">No X-ray crystal structure has been reported for <i>Pf</i>CLK3 and so a homology model of <i>Pf</i>CLK3 was created using SWISS-MODEL to provide evidence of our proposed binding mechanism (i.e., hinge binder), which we hypothesized based on other literature examples of 7-azaindole scaffolds binding at the hinge region of the kinase domain. The structure of the human PRPF4B kinase domain was selected as the template as the closest homologue [PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CNH">6CNH</a> (sequence identity 53.2%)].<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Model accuracy was determined to be reasonable using SWISS-MODEL with QMEAN (qualitative model energy analysis) score = −2.26 and GMQE (global model quality estimation) = 0.77. Overlay with Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor bound (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AWI">4AWI</a>) facilitated identification of the proposed binding pocket.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Based on this model, we propose that the 7-aza-indole scaffold interacts with the hinge region in the flipped conformation, that is, H-bonding to the peptide backbone of the hinge region (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The benzoic acid on ring B appears to occupy the ribose pocket and interacts with Lys-394. In the model, the ring B isopropyl group occupies a hydrophobic back pocket. Ring A projects into the solvent-exposed space. The diethyl-amine and methoxy substituents are solvent exposed and may contribute to the orientation of the 7-azaindole in the flipped binding conformation.</div><div class="NLM_p">We previously demonstrated that TCMDC-135051 showed selective inhibition of <i>Pf</i>CLK3 when compared against the closely related human kinases (PRPF4B and CLK2), as well as the closest parasite kinase (<i>Pf</i>CLK1), and other parasite kinases (<i>Pf</i>PKG and <i>Pf</i>CDPK1).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> To further assess kinase selectivity, and the potential for off-target toxicity, TCMDC-135051 was screened against 140 human kinases at 1 μM concentration. Only nine kinases were found to have less than 20% activity at this concentration (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> TCMDC-135051 Inhibits the Growth of Clinical Field Isolates</h3><div class="NLM_p">An important property for next-generation antimalarials is effectiveness against parasites that are resistant to currently used antimalarials. To determine whether the parent molecule TCMDC-135051 <b>1</b> might offer such activity, we tested the efficacy of this compound against parasites that were collected from malaria patients in The Gambia. These parasite strains were sequenced and those that contained genetic markers of resistance were selected (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Parasites were then tested for resistance to pyrimethamine, a frontline antimalarial where resistance has been documented in parasites originating from The Gambia (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative binding mode of TCMDC-135051 <b>1</b> in a PfCLK3 homology model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Genotypes of Field Isolated Parasite Strains: Whole Genome Sanger Sequencing Identified Mutations in Three Parasite Genes (CRT, <i>Pf</i>MDR1, and <i>Pf</i>DHFR) Associated with Drug Resistance<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center"><i>Pf</i>CRT</th><th class="rowsep1 colsep0" colspan="3" align="center"><i>Pf</i>MDR1</th><th class="rowsep1 colsep0" colspan="4" align="center"><i>Pf</i>DHFR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sample ID</td><td class="colsep0 rowsep0" align="left">K76T</td><td class="colsep0 rowsep0" align="left">N86Y</td><td class="colsep0 rowsep0" align="left">Y184F</td><td class="colsep0 rowsep0" align="left">N1042D</td><td class="colsep0 rowsep0" align="left">N51I</td><td class="colsep0 rowsep0" align="left">C59R</td><td class="colsep0 rowsep0" align="left">S108N</td><td class="colsep0 rowsep0" align="left">I164L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0006</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0004</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0026</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB002</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0021</td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0048</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0071</td><td class="colsep0 rowsep0" align="left">X</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0087</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GB0020</td><td class="colsep0 rowsep0" align="left">T</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">Y</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">L</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Shown are the amino acid changes associated with each of these three genes and whether the parasite strain contained the mutation.</p></div></div></div><div class="NLM_p">This analysis identified nine parasite isolates from patients with varying degrees of resistance to pyrimethamine (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B) and which contained mutations in one or more of the three genes; <i>Pf</i>CRT (<i>P. falciparum</i> chloroquine-resistant transporter gene), <i>Pf</i>MDR1 (<i>P. falciparum</i> multidrug-resistant gene 1), and <i>Pf</i>DHFR (<i>P. falciparum</i> dihydrofolate reductase gene). The mutations identified in these genes (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) have previously been associated with resistance to commonly used antimalarials, including chloroquine and pyrimethamine.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> An EC<sub>50</sub> concentration of pyrimethamine was then determined using the laboratory strain parasite 3D7 (EC<sub>50</sub> = 18 nM). Using this concentration in parasite reduction rate (PRR) assays, all isolates showed a reduction in parasitemia by at least 70% except for three isolates (GB0020, GB002, and GB0026), which showed resistance to pyrimethamine treatment. These three isolates uniquely contained triple mutations in the <i>Pf</i>DHFR gene and a single mutation in <i>Pf</i>CRT (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). For these isolates, resistance was evident after 24 h of treatment with pyrimethamine where parasitemia was only reduced by 45, 64, and 36%, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Resistance to pyrimethamine of these three isolates was still evident after 72 h of drug treatment (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and in parasites exposed to 10× EC<sub>50</sub> (180 nM) of pyrimethamine (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PRR of clinical isolates comparing pyrimethamine and TCMDC-135051 at EC<sub>50</sub> and 10 times the EC<sub>50</sub> of each drug. This represent the average of triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In contrast, all isolates treated with the EC<sub>50</sub> of TCMDC-135051, as determined in 3D7 parasites (EC<sub>50</sub> = 180 nM), demonstrated total susceptibility, including isolates GB0020, GB002, and GB0026 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). This was true both at the EC<sub>50</sub> concentration and 10× EC<sub>50</sub> for TCMDC-135051 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Hence in the field isolates tested, TCMDC-135051 showed equivalent activity against parasites that carried genetic markers of resistance and those that showed actual resistance to a frontline antimalarial. This indicates the possibility that the parent molecule, and potentially analogues of this molecule, would be active against naturally circulating malaria parasites harboring mutations that promoted resistance to current antimalarial drugs. The PRR assay was setup using clinical isolates previously cryopreserved in liquid nitrogen (LN2). These were thawed and placed in culture for at least one cycle (∼48 h ± 2). The life cycle stage of the parasites was monitored using a blood film, and greater than 95% of the parasites are expected to egress and form new invading rings. These new rings, mainly 0–3 h old postinvasion, were used as time point 0 hours (<i>t</i> = 0) for the assay. The parasites are then cultured with drugs for 24, 48, and 72 h. For 24 h treatment, the drug was removed by washing twice with wash media and for longer treatments (48 and 72 h time points), drug was replenished with fresh drug every 24 h. After the treatment period, parasites were grown in fresh media for an additional 48 h in freshly stained erythrocytes to allow invasion from any viable parasites.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we report the synthesis of hit <i>Pf</i>CLK3 inhibitor TCMDC-135051 <b>1</b> (<i>Pf</i>CLK3 IC<sub>50</sub> = 40 nM, 3D7 EC<sub>50</sub> = 180 nM) and a series of related 7-azaindole-based analogues. Of the 14 analogues, 11 had low nanomolar activity and were further assessed in live parasite viability assays using the 3D7 (chloroquine-sensitive) strain of <i>P. falciparum</i>. Tetrazole analogue <b>30</b> was identified with improved <i>in vitro</i> kinase activity (<i>Pf</i>CLK3, IC<sub>50</sub> = 19 nM) and comparable activity in parasites 3D7 (EC<sub>50</sub> = 271 nM). SAR was established for both ring A, highlighting the importance of H-bonding functionality in the 4-aryl position, and for the alkyl amino group on ring B. Together these data provide a good starting point for the hit to lead development of novel <i>Pf</i>CLK3 inhibitors based on TCMDC-135051 (<b>1</b>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Information</h3><div class="NLM_p last">Chemicals and solvents were purchased from standard suppliers and used without additional purification. All glassware were dried with a flame under flushing argon gas or stored in the oven and allowed to cool under an inert atmosphere prior to use. Anhydrous solvents (THF, DCM, and Et<sub>2</sub>O) were obtained by passage through solvent filtration systems (Pure Solv), and solvents were transferred by the syringe. PET ether refers to petroleum (bp 40–60 °C, reagent grade, Fisher Scientific). All reactions were carried out under a blanket of nitrogen in an inert or dry atmosphere. Thin-layer chromatography (TLC) was performed using aluminium plates precoated with silica gel (0.25 mm, 60 A° pore-size) impregnated with a fluorescent indicator (254 nm). Visualization on TLC was achieved by the use of UV light (254 nm). Flash column chromatography was undertaken on silica gel (400–630 mesh). Proton nuclear magnetic resonance spectra (<sup>1</sup>H NMR) were recorded on an AVANCE III 400 Bruker (400 MHz). Proton chemical shifts are expressed in parts per million (ppm, δ scale) and are referenced to residual protium in the NMR solvent (CDCl<sub>3</sub>, δ 7.26; CD<sub>3</sub>OD, δ 3.31 and DMSO-<i>d</i><sub>6</sub>, δ 2.50). The following abbreviations were used to describe peak patterns when appropriate: br = broad, s = singlet, d = doublet, t = triplet, q = quadruplet, sept = septet, and m = multiplet. Coupling constants, <i>J</i>, were reported in hertz unit (Hz). Carbon 13 nuclear magnetic resonance spectroscopy (<sup>13</sup>C NMR) was recorded on an AVANCE III 400 Bruker (101 MHz) and was fully decoupled by broad-band decoupling. Chemical shifts were reported in ppm referenced to the centerline of a triplet at 77.0, 49.0, and 39.5 ppm of CDCl<sub>3</sub>, CD<sub>3</sub>OD, and DMSO-<i>d</i><sub>6</sub>. Low-resolution mass spectrometry was performed on a Thermo Scientific LCQ Fleet quadrupole mass spectrometer using electrospray ionization in the positive mode (ESI<sup>+</sup>), employing a 150 mm × 4 mm C18 column (Dr. Maisch Reprosil Gold). High-resolution mass spectrometry (HRMS) was performed on a Bruker microTOF-Q II (ESI<sup>+</sup>). Preparative high-performance liquid chromatography (HPLC) was carried out on a Dionex HPLC system equipped with Dionex P680 pumps and a Dionex UVD170U UV–vis detector (monitoring at 214 and 280 nm), using a Phenomenex, Gemini, C18, 5 μm, 250 × 21.2 mm column. Gradients were performed using solvents consisting of A (H<sub>2</sub>O + 0.1% TFA) and B (CH<sub>3</sub>CN + 0.1% TFA), and fractions were lyophilized on a Christ Alpha 2-4 LO plus freeze dryer. Final molecules were analyzed on a Shimadzu reverse-phase HPLC (RP-HPLC) system equipped with Shimadzu LC-20AT pumps, a SIL-20A autosampler, and a SPD-20A UV–vis detector (monitoring at 214 nm) using a Phenomenex, Aeris, 5 μm, peptide XB-C18, 150 × 4.6 mm column at a flow rate of 1 mL/min. RP-HPLC gradients were run using a solvent system consisting of solution A (5% CH<sub>3</sub>CN in H<sub>2</sub>O + 0.1% TFA) and B (5% H<sub>2</sub>O in CH<sub>3</sub>CN + 0.1% TFA). A gradient from 0 to 100% solution B over 20 min was run. Purity of all final compounds is >95%, as determined by RP-HPLC.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Experimental Procedures and Characterization Data</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>3</b>)</h4><div class="NLM_p last">To a solution of sodium hydride (1.83 g, 76.1 mmol, 3 equiv) and tetrabutylammonium bromide (0.25 g, 0.76 mmol, 0.03 equiv) in dichloromethane (80 mL) at 0 °C was added 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine, <b>2</b> (5 g, 25.4 mmol, 1 equiv). The mixture was then left to stir at 0 °C for 15 min. Toluene sulfonylchloride (5.81 g, 30.5 mmol, 1.2 equiv) in dichloromethane (20 mL) was slowly added over 5 min. The mixture was then left to warm up to room temperature and stirred for 1 h. The reaction was quenched by addition of water and extracted with dichloromethane. The organic layer was washed with brine and dried over magnesium sulfate. The residue was then purified by flash column chromatography (10% ethyl acetate–PET ether) to give <b>3</b> as a colorless solid (8.83 g, 99%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.22 (d, <i>J</i> = 5.2 Hz, 1H), 8.06 (d, <i>J</i> = 8.4 Hz, 2H), 7.78 (d, <i>J</i> = 4.0 Hz, 1H), 7.35 (d, <i>J</i> = 5.3 Hz, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 2H), 6.64 (d, <i>J</i> = 4.0 Hz, 1H), 2.37 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 146.8, 145.5, 145.0, 135.1, 129.7, 128.2, 127.0, 125.7, 124.4, 122.1, 104.9, 21.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>11</sub>BrN<sub>2</sub>NaO<sub>2</sub>S [M + Na]<sup>+</sup>, 372.9617; found, 372.9608 (Δ = 2.3 ppm).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-Bromo-2-iodo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>4</b>)</h4><div class="NLM_p last"><i>n</i>-Butyllithium (2.5 M; 6.3 mL, 15.6 mmol, 1.1 equiv) was added dropwise to diisopropylamine (2.4 mL, 17.2 mmol, 1.2 equiv) in diethyl ether (30 mL) at −78 °C over a period of 5 min. The resulting solution was stirred at −78 °C for 60 min and then slowly added <i>via</i> cannula to a solution of 4-bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine, <b>3</b> (5.0 g, 14.2 mmol, 1 equiv) and tetramethylethylenediamine (2.3 mL, 15.7 mmol, 1.1 equiv) in diethyl ether (170 mL) over a period of 10 min at −78 °C. The resulting solution was then stirred at −78 °C for 90 min. Iodine (5.4 g, 21.4 mmol, 1.5 equiv) was added in one portion, and the reaction mixture was stirred at −78 °C for 60 min. The reaction was quenched with saturated ammonium chloride solution, and the organic layer was washed with aqueous sodium thiosulfate and brine before drying over magnesium sulfate. The residue was then purified by column chromatography (20% ethyl acetate–PET ether) to give <b>4</b> as a colorless solid (5.59 g, 85%; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.11 (d, <i>J</i> = 5.2 Hz, 1H), 8.01 (d, <i>J</i> = 8.5 Hz, 2H), 7.23 (d, <i>J</i> = 5.2 Hz, 1H), 7.22–7.19 (m, 2H), 6.96 (s, 1H), 2.30 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 149.1, 145.7, 144.7, 135.4, 129.8, 128.3, 125.3, 123.6, 122.4, 119.4, 21.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>10</sub>BrIN<sub>2</sub>NaO<sub>2</sub>S [M + Na]<sup>+</sup>, 498.8583; found, 498.8602 (Δ = −3.8 ppm).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Method A: General Method of Suzuki Cross-Coupling</h3><div class="NLM_p last">To a solution of desired aryl bromide (1.0 equiv) and tetrakis(triphenylphosphine)palladium(0) (0.05 equiv) in 1,4-dioxane was added boronic acid/ester (1.1 equiv) under a nitrogen atmosphere. Aqueous sodium carbonate (2 M, 7.0 equiv) was then added, and the reaction mixture was left to stir at 110 °C for 18 h. Solvent was removed under vacuum, and the crude was dissolved in ethyl acetate and poured into water and extracted with ethyl acetate. The organic layer was washed with brine before drying over magnesium sulfate and purified by flash column chromatography as indicated.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Method B: Reductive Amination of Aldehydes</h3><div class="NLM_p last">To a solution of aryl aldehyde (1.0 equiv) in 1,4-dioxane was added amine (1.5 equiv), and the solution was allowed to stir for 2 min before the addition of sodium triacetoxyborohydride (2.5 equiv). The reaction mixture was stirred at room temperature for 18 h before quenching with ammonium hydroxide. The reaction mixture was extracted with ethyl acetate and washed with brine. The organic layer was dried over magnesium sulfate, and the residue was purified by flash column chromatography as indicated.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Method C: Deprotection of Azaindole</h3><div class="NLM_p last">To a solution of protected 7-azaindole (1 equiv) in methanol was added potassium carbonate (3.5 equiv) and refluxed for 18 h. The reaction was poured into a mixture of EtOAc (10 mL) and H<sub>2</sub>O in a separatory funnel. Solvent was then removed under vacuum, and the residue was then purified by flash column chromatography as indicated.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Method D: Suzuki Cross-Coupling with Boronate Ester</h3><div class="NLM_p last">To a 10 mL microwave vial containing the required bromo-7-azaindole (1 equiv) in 1,4-dioxane was added boronic acid/ester (1.1 equiv), Pd(dppf)Cl<sub>2</sub>·DCM complex (0.05 equiv) under a nitrogen atmosphere. The solution was purged with nitrogen for 5 min, and the reaction microwaved at 110 °C for 0.5 h. The reaction was allowed to cool to room temperature, and the mixture was filtered through Celite eluting with methanol. The filtrate was evaporated, and the resulting residue was purified by preparative HPLC: 10–95% acetonitrile in water + 0.1% TFA to give the desired products.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Method E: Synthesis of Boronate Ester</h3><div class="NLM_p">Boronate esters required for Suzuki coupling were prepared according to the procedure reported in the literature.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To a solution of aryl bromide (1 equiv), bis(pinacolato)diboron (1.5 equiv) and potassium acetate (3 equiv) in 1,4-dioxane (20 mL), PdCI<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> complex (0.1 equiv) were added under nitrogen and stirred at 100 °C for 3 h. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> and extracted with ethyl acetate. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to dryness. The crude product was purified by chromatography (20% ethyl acetate–PET ether) to give the desired boronate esters.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-[4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4-methoxybenzaldehyde (<b>5</b>)</h4><div class="NLM_p last">Prepared according to method A. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>5</b> as yellow oil (1.72 g, 70%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.90 (s, 1H), 8.15 (d, <i>J</i> = 5.2 Hz, 1H), 7.95 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.84 (d, <i>J</i> = 2.1 Hz, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 2H), 7.28 (d, <i>J</i> = 5.3 Hz, 1H), 7.13 (d, <i>J</i> = 8.2 Hz, 2H), 7.04 (d, <i>J</i> = 8.5 Hz, 1H), 6.52 (s, 1H), 3.85 (s, 3H), 2.27 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 190.4, 163.5, 148.7, 145.1, 144.8, 137.6, 135.8, 134.4, 131.4, 129.4, 129.4, 128.1, 125.1, 123.3, 123.1, 122.3, 110.6, 107.9, 56.1, 21.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>17</sub>BrN<sub>2</sub>NaO<sub>4</sub>S [M + Na]<sup>+</sup>, 506.9985; found, 506.9977 (Δ = 1.5 ppm).</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(3-(4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-4-methoxybenzyl)-<i>N</i>-Ethylethanamine (<b>6a</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>6a</b> as yellow oil (920 mg, 72%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.15 (d, <i>J</i> = 5.3 Hz, 1H), 7.76 (d, <i>J</i> = 8.4 Hz, 2H), 7.65 (dd, <i>J</i> = 8.5, 2.4 Hz, 1H), 7.62 (d, <i>J</i> = 2.3 Hz, 1H), 7.47 (d, <i>J</i> = 5.3 Hz, 1H), 7.31 (d, <i>J</i> = 8.0 Hz, 2H), 7.21 (d, <i>J</i> = 8.5 Hz, 1H), 6.65 (s, 1H), 4.45–4.35 (m, 2H), 3.81 (s, 3H), 3.31–3.23 (m, 4H), 2.36 (s, 3H), 1.38 (t, <i>J</i> = 7.3 Hz, 7H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 159.3, 148.4, 145.7, 144.3, 138.2, 135.5, 133.7, 133.6, 129.1, 127.6, 124.7, 123.3, 122.3, 122.3, 120.8, 111.1, 107.6, 55.2, 54.9, 20.1; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>28</sub>BrN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 541.1035; found, 542.1093 (Δ = 2.7 ppm).</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-({3-[4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4-methoxyphenyl}methyl)-<i>N</i>,<i>N</i>-dimethylamine (<b>6b</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>6b</b> as yellow oil (225 mg, 70%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.17 (d, <i>J</i> = 5.3 Hz, 1H), 7.78 (d, <i>J</i> = 8.4 Hz, 2H), 7.65 (dd, <i>J</i> = 8.5, 2.3 Hz, 1H), 7.61 (d, <i>J</i> = 2.3 Hz, 1H), 7.50 (d, <i>J</i> = 5.3 Hz, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 7.21 (d, <i>J</i> = 8.5 Hz, 1H), 6.66 (s, 1H), 4.27 (d, <i>J</i> = 14.4 Hz, 2H), 3.83 (s, 3H), 2.84 (s, 7H), 2.38 (s, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 156.2, 147.9, 142.1, 137.0, 131.0, 129.6, 129.5, 124.1, 122.6, 119.3, 118.8, 111.5, 98.8, 62.6, 55.0, 43.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>25</sub>BrN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 514.0795; found, 514.0790 (Δ = 0.9 ppm).</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-({3-[4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4 methoxyphenyl}methyl)pyrrolidine (<b>6c</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>6c</b> as yellow oil (330 mg, 97%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.13 (d, <i>J</i> = 5.2 Hz, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 2H), 7.65–7.67 (m, 2H), 7.42 (d, <i>J</i> = 5.3 Hz, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 2H), 7.15 (d, <i>J</i> = 9.1 Hz, 1H), 6.63 (s, 1H), 4.44–4.29 (m, 1H), 3.78 (s, 3H), 2.32 (s, 3H), 2.10–2.06 (p, 4H), 1.95 (s, 4H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 176.8, 159.1, 148.4, 145.6, 144.3, 138.6, 135.6, 129.2, 127.6, 124.6, 123.3, 122.8, 122.3, 122.1, 110.9, 107.5, 56.9, 54.9, 52.8, 22.5, 21.5, 20.2; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>27</sub>BrN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 540.0951; found, 540.0934 (Δ = 3.2 ppm).</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-({3-[4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4-methoxyphenyl}methyl)morpholine (<b>6d</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>6d</b> as yellow oil (270 mg, 80%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.03 (m, 3H), 7.71 (d, <i>J</i> = 7.9 Hz, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.31 (d, <i>J</i> = 4.8 Hz, 1H), 7.23–7.18 (m, 3H), 6.96 (s, 1H), 4.36 (s, 2H), 4.04 (s, 3H), 3.34 (t, <i>J</i> = 6.2 Hz, 4H), 2.08 (t, <i>J</i> = 6.2 Hz, 4H), 1.99 (s, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 157.5, 147.9, 142.5, 140.4, 136.2, 131.8, 130.4, 128.5, 125.6, 124.3, 123.6, 122.4, 120.1, 118.9, 112.2, 99.4, 62.9, 57.2, 55.2, 53.2, 22.5; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>27</sub>BrN<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 556.0900; found, 556.0902 (Δ = −0.2 ppm).</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(3-(4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-4-methoxybenzyl)-<i>N</i>-ethylethanamine (<b>7a</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>7a</b> as colorless oil (560 mg, 79%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.00 (d, <i>J</i> = 5.3 Hz, 1H), 7.83 (d, <i>J</i> = 2.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.29 (d, <i>J</i> = 5.3 Hz, 1H), 7.13 (d, <i>J</i> = 8.5 Hz, 1H), 6.91 (s, 1H), 4.00 (s, 3H), 3.75 (s, 2H), 3.31 (p, <i>J</i> = 1.6 Hz, 1H), 2.71 (q, <i>J</i> = 7.2 Hz, 4H), 1.15 (t, <i>J</i> = 7.2 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 156.3, 147.9, 142.1, 136.9, 131.2, 129.7, 124.11, 122.5, 119.4, 118.8, 111.6, 98.8, 56.1, 54.9, 9.4; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>22</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup>, 387.0946; found, 388.1008 (Δ = 2.7 ppm).</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-[(3-{4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}-4-methoxyphenyl)methyl]dimethylamine (<b>7b</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>7b</b> as colorless oil (280 mg, 92%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.91 (d, <i>J</i> = 5.3 Hz, 1H), 7.70 (d, <i>J</i> = 2.2 Hz, 1H), 7.23 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.20 (d, <i>J</i> = 5.3 Hz, 1H), 7.04 (d, <i>J</i> = 8.5 Hz, 1H), 6.82 (s, 1H), 3.91 (s, 3H), 3.44 (s, 2H), 2.21 (s, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 156.3, 147.9, 142.1, 137.0, 131.0, 129.7, 129.5, 124.1, 122.6, 119.3, 118.8, 111.5, 98.8, 62.6, 54.9, 43.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>19</sub>BrN<sub>3</sub>OS [M + H]<sup>+</sup>, 360.0706; found, 360.0701 (Δ = 1.4 ppm).</div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-[(3-{4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}-4-methoxyphenyl)methyl]pyrrolidine (<b>7c</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>7c</b> as yellow oil (165 mg, 77%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.88 (d, <i>J</i> = 5.2 Hz, 1H), 7.84 (d, <i>J</i> = 2.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.5, 2.3 Hz, 1H), 7.16 (dd, <i>J</i> = 8.5, 3.4 Hz, 1H), 7.04 (d, <i>J</i> = 8.6 Hz, 1H), 6.81 (s, 1H), 4.06 (s, 2H), 3.89 (s, 3H), 3.04 (t, <i>J</i> = 6.8 Hz, 4H), 1.91 (p, <i>J</i> = 3.2 Hz, 4H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 157.0, 148.0, 142.4, 136.5, 131.3, 130.0, 126.4, 124.2, 122.4, 119.9, 118.9, 112.0, 99.1, 58.1, 55.1, 53.4, 22.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup>, 386.0900; found, 386.0903 (Δ = 0.8 ppm).</div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-[(3-{4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}-4-methoxyphenyl)methyl]morpholine (<b>7d</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>7d</b> as yellow oil (269 mg, 80%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.18 (s, 1H), 8.08 (d, <i>J</i> = 5.1 Hz, 1H), 7.80 (d, <i>J</i> = 2.0 Hz, 1H), 7.65–7.60 (m, 2H), 7.58–7.55 (m, 1H), 7.33 (d, <i>J</i> = 5.1 Hz, 1H), 7.32 (d, <i>J</i> = 2.0 Hz, 1H), 7.15 (d, <i>J</i> = 8.5 Hz, 1H), 6.89 (d, <i>J</i> = 2.2 Hz, 1H), 3.94 (s, 3H), 3.58 (t, 4H), 3.47 (s, 2H), 2.38 (t, 4H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 156.2, 149.1, 143.5, 136.8, 132.5, 130.9, 129.7, 129.2, 123.4, 122.1, 119.4, 119.1, 112.4, 100.2, 66.7, 62.3, 56.2, 53.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 402.0812; found, 402.0810 (Δ = 0.5 ppm).</div></div><div id="sec4_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(2-(5-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid, <b>1</b></h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>1</b> in a (85 mg, 68%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.39 (d, <i>J</i> = 5.7 Hz, 1H), 8.01 (d, <i>J</i> = 2.2 Hz, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.91 (d, <i>J</i> = 1.8 Hz, 1H), 7.74 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.58 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 7.52 (d, <i>J</i> = 5.8 Hz, 1H), 7.32 (d, <i>J</i> = 8.6 Hz, 1H), 7.31 (s, 1H), 4.37 (s, 2H), 4.07 (s, 3H), 3.94 (p, <i>J</i> = 6.9 Hz, 1H), 3.25 (dq, <i>J</i> = 14.2, 7.1 Hz, 4H), 1.39–1.34 (m, 12H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.8, 157.9, 150.1, 145.6, 143.9, 140.0, 137.8, 136.8, 132.9, 131.8, 131.0, 130.3, 126.4, 125.6, 122.1, 121.8, 119.6, 114.9, 112.5, 100.3, 55.3, 55.2, 29.4, 23.0, 7.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 471.2522; found, 472.2576 (Δ = 2.1 ppm).</div></div><div id="sec4_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(2-{5-[(Dimethylamino)methyl]-2-methoxyphenyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-(propan-2-yl)benzoic Acid (<b>8a</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>8a</b> in a (11 mg, 29%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.27 (d, <i>J</i> = 5.4 Hz, 1H), 7.89 (d, <i>J</i> = 2.3 Hz, 1H), 7.87 (d, <i>J</i> = 8.1 Hz, 1H), 7.79 (d, <i>J</i> = 1.7 Hz, 1H), 7.63 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.44 (dd, <i>J</i> = 8.6, 2.3 Hz, 2H), 7.32 (d, <i>J</i> = 5.5 Hz, 1H), 7.23 (d, <i>J</i> = 8.6 Hz, 1H), 7.13 (s, 1H), 4.23 (s, 2H), 3.97 (s, 3H), 3.89–3.81 (m, 1H), 2.79 (s, 6H), 1.27 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.9, 158.1, 150.2, 146.7, 142.6, 139.6, 138.4, 135.1, 133.2, 132.2, 131.1, 130.4, 126.5, 125.7, 122.3, 120.4, 119.2, 115.0, 112.5, 100.5, 60.1, 55.3, 41.4, 29.5, 23.0; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 470.2438; found, 470.2433 (Δ = 1.1 ppm).</div></div><div id="sec4_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(2-{2-Methoxy-5-[(pyrrolidin-1-yl)methyl]phenyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-(propan-2-yl)benzoic Acid (<b>8b</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>8b</b> in a (27 mg, 37%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.27 (br s, 1H), 7.90 (s, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.79 (s, 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.46 (d, <i>J</i> = 8.6 Hz, 1H), 7.36 (s, 1H), 7.21–7.15 (m, 2H), 4.29 (s, 2H), 3.96 (s, 3H), 3.85–3.81 (m, 1H), 3.42 (br s, 2H), 3.14 (br s, 2H), 2.08 (br s, 2H), 1.93 (br s, 2H), 1.26 (d, <i>J</i> = 6.8 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.9, 157.9, 150.1, 144.5, 140.5, 137.4, 132.1, 131.5, 130.4, 130.3, 126.3, 125.5, 123.4, 119.9, 112.4, 100.0, 57.2, 55.2, 53.3, 29.4, 23.0, 22.4; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 470.2438; found, 470.2433 (Δ = 1.1 ppm).</div></div><div id="sec4_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(2-{2-Methoxy-5-[(morpholin-4-yl)methyl]phenyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-(propan-2-yl)benzoic Acid (<b>8c</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>8c</b> in a (34 mg, 60%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.43 (d, <i>J</i> = 5.8 Hz, 1H), 8.04 (d, <i>J</i> = 2.3 Hz, 1H), 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.93 (d, <i>J</i> = 1.8 Hz, 1H), 7.78 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.61 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.56 (d, <i>J</i> = 5.7 Hz, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H), 7.32 (s, 1H), 4.41 (s, 2H), 4.10 (s, 3H), 4.07 (s, 2H), 3.98–3.93 (m, 1H), 3.76 (s, 2H), 3.44 (s, 2H), 3.26 (s, 2H), 1.39 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (101 MHz DMSO-<i>d</i><sub>6</sub>): δ 170.3, 169.7, 149.6, 147.1, 136.0, 133.0, 133.0, 132.2, 132.1, 131.6, 131.3, 130.6, 128.3, 126.5, 125.9, 121.7, 120.6, 112.9, 100.5, 63.8, 59.4, 56.4, 51.2, 49.1, 29.4, 24.4, 24.3; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>32</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 486.2387; found, 486.2384 (Δ = 0.8 ppm).</div></div><div id="sec4_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Ethyl 4-(2-(5-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoate (<b>9</b>)</h4><div class="NLM_p last">Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>9</b> in a (36 mg, 98%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.39 (d, <i>J</i> = 5.6 Hz, 1H), 8.01 (d, <i>J</i> = 2.2 Hz, 1H), 7.92 (d, <i>J</i> = 8.2 Hz, 2H), 7.77–7.72 (m, 1H), 7.57 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.49 (d, <i>J</i> = 5.7 Hz, 1H), 7.33 (d, <i>J</i> = 8.6 Hz, 1H), 7.28 (s, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 2H), 4.37 (s, 2H), 4.07 (s, 3H), 3.82 (p, <i>J</i> = 6.9 Hz, 1H), 3.25 (p, <i>J</i> = 7.4 Hz, 4H), 1.50–1.29 (m, 16H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 168.1, 157.9, 149.9, 140.7, 138.8, 137.2, 132.6, 131.1, 130.9, 130.1, 126.4, 125.6, 122.0, 120.1, 114.9, 112.5, 99.9, 60.9, 55.3, 29.6, 22.9, 13.2, 7.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 499.2835; found, 500.2913 (Δ = 4.1 ppm).</div></div><div id="sec4_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-[4-Bromo-1-(4-methylbenzenesulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4-methoxybenzonitrile (<b>10</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>10</b> as yellow oil (586 mg, 87%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (d, <i>J</i> = 5.2 Hz, 1H), 8.03–7.99 (m, 2H), 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.61 (d, <i>J</i> = 5.2 Hz, 1H), 7.41–7.37 (m, 2H), 7.34–7.29 (m, 2H), 6.81 (s, 1H), 3.84 (s, 3H), 2.34 (s, 3H); <sup>13</sup>C NMR (101 MHz, DMSO- <i>d</i><sub><i>6</i></sub>): δ 161.8, 148.3, 145.9, 145.7, 143.5, 137.1, 136.4, 135.5, 134.8, 130.2, 128.2, 125.0, 123.0, 119.3, 112.4, 109.5, 108.3, 103.1, 56.6, 21.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>16</sub>BrN<sub>3</sub>NaO<sub>3</sub>S [M + Na]<sup>+</sup>, 503.9988; found, 503.9973 (Δ = 3.0 ppm).</div></div><div id="sec4_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-{4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}-4-methoxybenzonitrile (<b>11</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>11</b> as yellow oil (327 mg, 59%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.24 (s, 1H), 8.29 (d, <i>J</i> = 2.1 Hz, 1H), 8.06 (d, <i>J</i> = 5.1 Hz, 1H), 7.81 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.33–7.29 (m, 2H), 6.96 (s, 1H), 3.98 (s, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 207.0, 160.3, 149.1, 144.4, 134.3, 132.5, 124.1, 121.1, 119.4, 119.3, 113.7, 103.8, 101.8, 56.9, 31.2; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>11</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup>, 328.0080; found, 328.0076 (Δ = 1.1 ppm).</div></div><div id="sec4_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 4-{2-[5-(Aminomethyl)-2-methoxyphenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-2-(propan-2-yl)benzoic Acid (<b>12</b>)</h4><div class="NLM_p last">Prepared according to method D. The filtrate residue was dissolved in methanol (10 mL), CoCl<sub>2</sub>·6H<sub>2</sub>O (3 equiv) was then added before cooling to 0 °C. NaBH<sub>4</sub> (10 equiv) was slowly added to the reaction, and the mixture was allowed to stir at room temperature for further 1 h before filtration through Celite and purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>13</b> (26 mg, 60%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.01 (s, 1H), 8.30 (d, <i>J</i> = 5.0 Hz, 1H), 8.17 (br s, 2H), 7.94 (d, <i>J</i> = 2.3 Hz, 1H), 7.82–7.80 (m, 2H), 7.62 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.41 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 7.24 (d, <i>J</i> = 5.0 Hz, 1H), 7.18 (d, <i>J</i> = 8.6 Hz, 1H), 7.09 (s, 1H), 3.98 (q, <i>J</i> = 5.6 Hz, 2H), 3.89 (s, 3H), 3.83–3.76 (m, 1H), 1.25 (d, <i>J</i> = 6.9 Hz, 6H).; <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.7, 157.0, 149.6, 149.2, 142.9, 141.4, 140.4, 136.6, 131.4, 130.6, 130.6, 129.7, 126.7, 126.6, 125.9, 120.1, 119.0, 115.2, 112.7, 100.0, 56.3, 42.4, 29.4, 24.3; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 416.1969; found, 416.1968 (Δ = 0.2 ppm).</div></div><div id="sec4_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-Bromo-2-(2-methoxyphenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>)</h4><div class="NLM_p last">Prepared according to method A. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>14</b> as colorless oil (960 mg, 32%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.14 (d, <i>J</i> = 5.3 Hz, 1H), 7.78 (d, <i>J</i> = 8.4 Hz, 2H), 7.41 (td, <i>J</i> = 8.2, 1.7 Hz, 1H), 7.29–7.24 (m, 2H), 7.12 (d, <i>J</i> = 8.1 Hz, 2H), 6.99 (t, <i>J</i> = 7.5 Hz, 1H), 6.91 (d, <i>J</i> = 8.2 Hz, 1H), 6.45 (s, 1H), 3.73 (s, 3H), 2.27 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.3, 148.7, 144.8, 144.4, 139.4, 136.1, 131.1, 130.9, 129.2, 128.2, 124.8, 123.5, 122.1, 121.8, 120.0, 110.4, 107.3, 55.5, 21.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>17</sub>BrN<sub>2</sub>NaO<sub>3</sub>S [M + Na]<sup>+</sup>, 479.0035; found, 479.0035 (Δ = 0.0 ppm).</div></div><div id="sec4_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-Bromo-2-(2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>15</b> as colorless oil (300 mg 80%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.38 (s, 1H), 8.09 (d, <i>J</i> = 5.2 Hz, 1H), 7.92 (dd, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.41–7.34 (m, 1H), 7.30–7.25 (m, 2H), 7.14–7.07 (m, 2H), 6.89 (s, 1H), 4.04 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.1, 148.1, 143.0, 137.0, 129.9, 128.4, 124.3, 122.2, 121.6, 119.4, 119.3, 112.0, 97.8, 55.9; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>12</sub>BrN<sub>2</sub>O [M + H]<sup>+</sup>, 303.0128; found, 303.0122 (Δ = 1.8 ppm).</div></div><div id="sec4_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-[2-(2-Methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-2-(propan-2-yl)benzoic Acid (<b>15</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>16</b> in a (30 mg, 59%); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.05 (s, 1H), 8.32 (d, <i>J</i> = 5.0 Hz, 1H), 7.92 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.90 (d, <i>J</i> = 1.8 Hz, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.68 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.38 (ddd, <i>J</i> = 8.7, 7.4, 1.7 Hz, 1H), 7.27 (d, <i>J</i> = 5.0 Hz, 1H), 7.20–7.18 (m, 2H), 7.08 (td, <i>J</i> = 7.6, 1.0 Hz, 1H), 3.92 (s, 3H), 3.90–3.83 (m, 1H), 1.32 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.7, 157.1, 149.9, 149.6, 141.7, 136.5, 131.1, 130.7, 129.9, 126.5, 125.9, 121.2, 100.3, 45.4, 29.4; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 387.17034; found, 387.1710 (Δ = −1.7 ppm).</div></div><div id="sec4_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-4-(methoxymethoxy)benzaldehyde (<b>16</b>)</h4><div class="NLM_p last">Prepared according to method A. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>17</b> as colorless oil (850 mg, 77%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.92 (s, 1H), 8.16 (d, <i>J</i> = 5.3 Hz, 1H), 7.92 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.84 (d, <i>J</i> = 2.1 Hz, 1H), 7.69 (d, <i>J</i> = 8.4 Hz, 2H), 7.35 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (d, <i>J</i> = 5.3 Hz, 1H), 7.12 (d, <i>J</i> = 8.1 Hz, 3H), 6.53 (s, 1H), 5.26–5.22 (m, 2H), 3.46 (s, 3H), 2.27 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 190.6, 161.7, 148.6, 145.2, 144.9, 137.7, 135.5, 134.4, 131.0, 130.0, 129.4, 128.0, 125.1, 123.6, 122.3, 113.9, 108.0, 95.1, 56.9, 21.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>19</sub>BrN<sub>2</sub>NaO<sub>5</sub>S [M + Na]<sup>+</sup>, 537.0090; found, 537.0098 (Δ = −1.7 ppm).</div></div><div id="sec4_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> ({3-[4-Bromo-1-(4-methylbenzenesulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4-(methoxymethoxy)phenyl}methyl)diethylamine (<b>17</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>18</b> as colorless oil (672 mg, 87%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.16 (d, <i>J</i> = 5.3 Hz, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (d, <i>J</i> = 7.9 Hz, 2H), 7.50 (d, <i>J</i> = 5.3 Hz, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H), 7.31 (d, <i>J</i> = 8.2 Hz, 2H), 6.68 (s, 1H), 5.18 (br s, 1H), 5.28 (br s, 1H), 4.20 (d, <i>J</i> = 5.4 Hz, 2H), 3.43 (s, 3H), 3.10 (q, <i>J</i> = 7.1 Hz, 4H), 2.37 (s, 3H), 1.33 (t, <i>J</i> = 7.2 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 156.7, 148.4, 145.7, 144.3, 138.7, 135.5, 133.1, 132.9, 129.2, 127.6, 124.7, 123.3, 122.8, 122.4, 114.1, 107.5, 94.7, 55.4, 55.4, 46.2, 20.1, 8.4; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>31</sub>BrN<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 572.1213; found, 572.1208 (Δ = 0.9 ppm).</div></div><div id="sec4_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> [(3-{4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}-4-(methoxymethoxy)phenyl)methyl]diethylamine (<b>18</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>19</b> as yellow oil (420 mg, 69%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.03 (d, <i>J</i> = 5.2 Hz, 1H), 7.84 (d, <i>J</i> = 2.1 Hz, 1H), 7.34 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.31–7.28 (m, 2H), 6.96 (s, 1H), 5.39 (s, 2H), 4.88 (s, 3H), 3.73 (s, 2H), 3.50 (s, 3H), 2.70 (q, <i>J</i> = 7.2 Hz, 4H), 1.15 (t, <i>J</i> = 7.2 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 153.9, 148.0, 142.3, 136.7, 130.9, 130.5, 129.7, 124.2, 122.6, 120.4, 118.9, 115.2, 99.3, 94.7, 56.1, 55.4, 46.1, 9.5; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>25</sub>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 418.1113; found, 418.1112 (Δ = −0.2 ppm).</div></div><div id="sec4_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-[2-(2-Methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-2-(propan-2-yl)benzoic Acid (<b>19</b>)</h4><div class="NLM_p last">Prepared according to method D. The filter residue was then stirred in a mixture of acetonitrile/HCl (3:1) for 30 min before filtering through Celite and purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>21</b> in a (72 mg, 70%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.30 (d, <i>J</i> = 5.3 Hz, 1H), 7.92 (d, <i>J</i> = 2.2 Hz, 1H), 7.89 (d, <i>J</i> = 8.1 Hz, 1H), 7.84 (d, <i>J</i> = 1.6 Hz, 1H), 7.68 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.46 (d, <i>J</i> = 5.7 Hz, 1H), 7.3–7.31 (m, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 4.24 (s, 2H), 3.85 (sept, <i>J</i> = 6.9 Hz, 1H), 3.19–3.12 (m, 4H), 1.30–1.27 (m, 12H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.8, 156.5, 150.2, 139.7, 138.9, 135.4, 132.7, 132.1, 130.8, 130.4, 126.6, 125.7, 121.0, 117.4, 117.1, 115.0, 99.7, 55.4, 46.4, 29.5, 23.0; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 458.2438; found, 458.2430 (Δ = 1.8 ppm).</div></div><div id="sec4_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)benzaldehyde (<b>20</b>)</h4><div class="NLM_p last">Prepared according to method A. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>22</b> as colorless oil (500 mg, 76%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.04 (s, 1H), 8.23 (d, <i>J</i> = 5.2 Hz, 1H), 7.96 (t, <i>J</i> = 1.8 Hz, 1H), 7.93 (d, <i>J</i> = 7.7 Hz, 1H), 7.79 (d, <i>J</i> = 7.7 Hz, 1H), 7.70 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (t, <i>J</i> = 7.7 Hz, 1H), 7.33 (d, <i>J</i> = 5.3 Hz, 1H), 7.14 (d, <i>J</i> = 8.3 Hz, 2H), 6.56 (s, 1H), 2.29 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 191.8, 149.5, 145.5, 145.2, 141.0, 136.0, 135.9, 135.2, 133.3, 130.6, 130.3, 129.6, 128.5, 127.9, 125.3, 123.6, 122.9, 109.1, 21.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>15</sub>BrN<sub>2</sub>NaO<sub>3</sub>S [M + Na]<sup>+</sup>, 476.9879; found, 476.9884 (Δ = −1.0 ppm).</div></div><div id="sec4_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> ({3-[4-Bromo-1-(4-methylbenzenesulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]-4-(methoxymethoxy)phenyl}methyl)diethylamine (<b>21</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>23</b> as colorless oil (154 mg, 83%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.22 (d, <i>J</i> = 5.3 Hz, 1H), 7.87 (d, <i>J</i> = 1.9 Hz, 1H), 7.75–7.70 (m, 2H), 7.68 (d, <i>J</i> = 7.4 Hz, 1H), 7.62 (d, <i>J</i> = 8.4 Hz, 2H), 7.53 (d, <i>J</i> = 5.3 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 6.79 (s, 1H), 4.50 (s, 2H), 3.35–3.30 (m, 4H), 2.35 (s, 3H), 1.42 (t, <i>J</i> = 7.3 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 156.7, 148.4, 145.7, 144.3, 138.7, 135.5, 133.1, 132.9, 129.2, 127.6, 124.7, 123.3, 122.8, 122.4, 114.1, 107.5, 94.7, 55.4, 55.4, 46.2, 20.1, 8.4; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>27</sub>BrN<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 512.1002; found, 512.1013 (Δ = −2.3 ppm).</div></div><div id="sec4_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> [(3-{4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}phenyl)methyl]diethylamine (<b>22</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (10% methanol–dichloromethane) afforded <b>24</b> as colorless oil (95 mg, 89%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.92 (d, <i>J</i> = 5.3 Hz, 1H), 7.78 (s, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (t, <i>J</i> = 7.6 Hz, 1H), 7.29 (d, <i>J</i> = 7.6 Hz, 1H), 7.20 (d, <i>J</i> = 5.3 Hz, 1H), 6.76 (s, 1H), 3.70 (s, 2H), 2.62 (q, <i>J</i> = 7.2 Hz, 4H), 1.06 (t, <i>J</i> = 7.1 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 148.9, 142.4, 139.7, 131.5, 129.7, 128.9, 126.8, 124.7, 124.2, 123.2, 118.9, 96.9, 56.8, 46.3, 9.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>21</sub>BrN<sub>3</sub> [M + H]<sup>+</sup>, 358.0913; found, 358.0907 (Δ = 1.7 ppm).</div></div><div id="sec4_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-(2-{3-[(Diethylamino)methyl]phenyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-(propan-2-yl)benzoic Acid (<b>23</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>25</b> in a (30 mg, 70%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.25 (s, 1H), 7.94 (s, 1H), 7.91 (d, <i>J</i> = 6.9 Hz, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 1H), 7.73 (s, 1H), 7.62 (s, 2H), 7.53 (s, 2H), 7.45 (d, <i>J</i> = 7.7 Hz, 1H), 7.28 (d, <i>J</i> = 5.2 Hz, 1H), 7.04 (s, 1H), 4.32 (s, 2H), 3.83 (sept, <i>J</i> = 13.9, 6.9 Hz, 1H), 3.16 (br s, 4H), 1.27 (q, <i>J</i> = 7.2 Hz, 12H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 170.0, 150.1, 132.3, 130.8, 130.6, 130.3, 129.9, 128.1, 127.0, 126.2, 125.5, 115.1, 111.9, 97.8, 55.7, 46.7, 29.4, 23.0, 7.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 442.2489; found, 442.2476 (Δ = 3.0 ppm).</div></div><div id="sec4_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-(4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-2-methoxybenzaldehyde (<b>24</b>)</h4><div class="NLM_p last">Prepared according to method A. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>26</b> as colorless oil (990 mg, 72%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.49 (s, 1H), 8.28 (d, <i>J</i> = 5.3 Hz, 1H), 8.07–7.90 (m, 3H), 7.59 (dd, <i>J</i> = 7.4, 1.8 Hz, 1H), 7.41 (d, <i>J</i> = 5.3 Hz, 1H), 7.37–7.30 (m, 1H), 7.25 (d, <i>J</i> = 6.7 Hz, 2H), 6.66 (s, 1H), 3.75 (s, 3H), 2.38 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 189.6, 162.0, 148.7, 145.4, 145.0, 137.1, 137.1, 135.6, 130.2, 129.4, 129.0, 128.6, 127.3, 125.2, 123.7, 123.1, 122.5, 108.1, 63.6, 21.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>4</sub>SNa [M + Na]<sup>+</sup>, 507.9990; found, 508.0068 (Δ = 0.2 ppm).</div></div><div id="sec4_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(3-(4-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-2-methoxybenzyl)-<i>N</i>-ethylethanamine (<b>25</b>)</h4><div class="NLM_p last">Prepared according to method B. Purification by flash chromatography (50% ethyl acetate–PET ether) afforded <b>27</b> as yellow oil (765 mg, 81%; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.18 (d, <i>J</i> = 5.3 Hz, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 2H), 7.69 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.63 (dd, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.51 (d, <i>J</i> = 5.3 Hz, 1H), 7.41 (t, <i>J</i> = 7.7 Hz, 1H), 7.33–7.27 (m, 2H), 6.85 (s, 1H), 4.56 (d, <i>J</i> = 13.3 Hz, 1H), 4.28 (d, <i>J</i> = 13.3 Hz, 1H), 3.58 (s, 3H), 2.35 (s, 3H), 1.39 (t, <i>J</i> = 7.3 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 178.1, 158.6, 148.6, 145.9, 144.8, 138.4, 135.2, 133.7, 132.8, 129.2, 127.8, 126.4, 124.9, 124.2, 124.1, 123.2, 122.6, 108.0, 60.3, 50.2, 22.4, 20.2, 8.1; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>28</sub>BrN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 541.1035; found, 542.1095 (Δ = 3.6 ppm).</div></div><div id="sec4_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(3-(4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-2-methoxybenzyl)-<i>N</i>-Ethylethanamine (<b>26</b>)</h4><div class="NLM_p last">Prepared according to method C. Purification by flash chromatography (5% methanol–dichloromethane) afforded <b>28</b> as yellow oil (630 mg, 85%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.12 (d, <i>J</i> = 5.4 Hz, 1H), 7.92 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.59 (dd, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.46–7.37 (m, 2H), 7.03 (s, 1H), 4.43 (s, 2H), 3.69 (s, 3H), 3.32–3.28 (m, 4H), 1.43 (t, <i>J</i> = 7.3 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 157.0, 147.6, 142.1, 135.7, 132.8, 131.9, 125.6, 125.4, 125.3, 124.5, 123.2, 119.2, 100.5, 60.6, 50.9, 7.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>22</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup>, 387.0946; found, 388.1008 (Δ = 2.7 ppm).</div></div><div id="sec4_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(2-(3-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid (<b>27</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>29</b> in a (30 mg, 74%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.41 (s, 1H), 7.98–7.92 (m, 2H), 7.89 (d, <i>J</i> = 1.7 Hz, 1H), 7.73 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.58 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.47–7.43 (m, 1H), 7.41 (d, <i>J</i> = 7.7 Hz, 1H), 7.23 (s, 1H), 4.43 (s, 2H), 3.94 (p, <i>J</i> = 6.8 Hz, 1H), 3.72 (s, 3H), 3.31–3.25 (m, 5H), 1.42 (t, <i>J</i> = 7.3 Hz, 6H), 1.36 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.9, 157.1, 150.1, 140.6, 136.3, 132.8, 131.9, 131.4, 130.3, 126.3, 125.5, 125.4, 124.6, 100.5, 60.7, 50.8, 29.4, 23.0, 7.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 471.2522; found, 472.2579 (Δ = 3.4 ppm).</div></div><div id="sec4_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-(2-(5-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-methylbenzoic Acid (<b>28</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>30</b> in a (50 mg, 75%); <sup>1</sup>H NMR (101 MHz, CD<sub>3</sub>OD): δ 8.27 (d, <i>J</i> = 5.6 Hz, 1H), 8.04 (d, <i>J</i> = 8.7 Hz, 1H), 7.94 (d, <i>J</i> = 2.3 Hz, 1H), 7.70–7.61 (m, 2H), 7.46 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 7.36 (d, <i>J</i> = 5.6 Hz, 1H), 7.23 (d, <i>J</i> = 8.6 Hz, 1H), 7.16 (s, 1H), 4.27 (s, 2H), 3.99 (s, 3H), 3.15 (p, <i>J</i> = 7.2 Hz, 4H), 2.63 (s, 3H), 1.27 (t, <i>J</i> = 7.3 Hz, 6H); <sup>13</sup>C NMR (400 MHz, CD<sub>3</sub>OD): δ 168.9, 157.8, 140.9, 140.3, 136.5, 133.0, 131.5, 131.3, 131.2, 125.9, 122.2, 119.6, 115.1, 112.5, 99.7, 55.3, 20.6, 7.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 443.2209; found, 444.2214 (Δ = 1.4 ppm).</div></div><div id="sec4_7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-(2-(5-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzoic Acid (<b>29</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>31</b> in a (100 mg, 85%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.28 (d, <i>J</i> = 5.5 Hz, 1H), 8.16 (d, <i>J</i> = 8.5 Hz, 2H), 7.95 (d, <i>J</i> = 2.3 Hz, 1H), 7.87 (d, <i>J</i> = 8.6 Hz, 2H), 7.46 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 7.38 (d, <i>J</i> = 5.6 Hz, 1H), 7.23 (d, <i>J</i> = 8.6 Hz, 1H), 7.17 (s, 1H), 4.27 (s, 2H), 3.99 (s, 3H), 3.15 (p, <i>J</i> = 7.3 Hz, 4H), 1.27 (t, <i>J</i> = 7.3 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 168.0, 157.6, 148.6, 143.1, 142.4, 140.9, 136.3, 132.0, 130.9, 130.6, 129.9, 129.3, 128.3, 122.1, 120.8, 114.9, 112.4, 98.6, 55.5, 55.2, 7.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 429.2052; found, 430.2056 (Δ = 1.1 ppm).</div></div><div id="sec4_7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-Ethyl-<i>N</i>-(3-(4-(3-isopropyl-4-(1<i>H</i>-tetrazol-5-yl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-4-methoxybenzyl)ethanamine (<b>30</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>32</b> in a (27 mg, 62%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.39 (d, <i>J</i> = 5.8 Hz, 1H), 8.01 (d, <i>J</i> = 2.3 Hz, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.91 (d, <i>J</i> = 1.8 Hz, 1H), 7.74 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.58 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 7.52 (d, <i>J</i> = 5.8 Hz, 1H), 7.32 (d, <i>J</i> = 8.7 Hz, 1H), 7.31 (s, 1H), 4.37 (s, 2H), 4.07 (s, 3H), 3.94 (p, <i>J</i> = 6.9 Hz, 1H), 3.25 (dd, <i>J</i> = 12.2, 7.0 Hz, 4H), 1.42–1.33 (m, 12H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.8, 157.9, 150.1, 145.6, 143.9, 140.0, 137.8, 136.8, 132.9, 131.8, 131.0, 130.3, 126.4, 125.6, 122.1, 121.8, 119.6, 114.9, 112.5, 100.3, 55.3, 55.2, 29.4, 23.0, 7.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>33</sub>N<sub>7</sub>O [M + H]<sup>+</sup>, 495.2747; found, 496.2829 (Δ = 0.6 ppm).</div></div><div id="sec4_7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-Ethyl-<i>N</i>-(3-(4-(3-isopropylphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)-4-methoxybenzyl)ethanamine (<b>31</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>33</b> in a (67 mg, 82%); <sup>1</sup>H NMR (101 MHz, CD<sub>3</sub>OD): δ 8.37 (d, <i>J</i> = 5.9 Hz, 1H), 8.03 (d, <i>J</i> = 2.2 Hz, 1H), 7.75–7.68 (m, 2H), 7.61–7.54 (m, 2H), 7.50 (dd, <i>J</i> = 16.9, 6.8 Hz, 2H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 4.37 (s, 2H), 4.08 (s, 3H), 3.25 (p, <i>J</i> = 7.5 Hz, 4H), 3.08 (p, <i>J</i> = 6.9 Hz, 1H), 1.43–1.31 (m, 12H); <sup>13</sup>C NMR (400 MHz, CD<sub>3</sub>OD): δ 157.9, 149.9, 137.2, 132.8, 131.1, 128.9, 127.7, 126.5, 126.1, 122.1, 119.8, 114.9, 112.5, 100.3, 55.3, 34.1, 23.1, 7.6; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>33</sub>N<sub>3</sub>O [M + H]<sup>+</sup>, 427.2624; found, 428.2624 (Δ = 3.8 ppm).</div></div><div id="sec4_7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 5-(2-(5-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid (<b>32</b>)</h4><div class="NLM_p last">Prepared according to method D. Purification by preparative HPLC 10–95% MeCN/H<sub>2</sub>O to give <b>34</b> in a (55 mg, 78%); <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.41 (d, <i>J</i> = 5.7 Hz, 1H), 8.26 (d, <i>J</i> = 2.0 Hz, 1H), 7.99 (ddd, <i>J</i> = 9.3, 8.0, 1.9 Hz, 2H), 7.73 (d, <i>J</i> = 8.2 Hz, 1H), 7.60 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.53 (d, <i>J</i> = 5.7 Hz, 1H), 7.42 (t, <i>J</i> = 7.7 Hz, 1H), 7.36 (s, 1H), 4.43 (s, 2H), 3.92 (p, <i>J</i> = 6.9 Hz, 1H), 3.73 (s, 3H), 3.31–3.25 (m, 4H), 1.42 (t, <i>J</i> = 7.3 Hz, 6H), 1.34 (d, <i>J</i> = 6.9 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 169.8, 157.0, 151.0, 145.4, 144.8, 137.8, 136.9, 134.4, 133.1, 131.9, 131.6, 131.3, 129.8, 127.2, 125.4, 124.9, 124.7, 121.6, 114.9, 100.8, 60.7, 50.9, 29.4, 22.8, 7.7; HRMS <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>33</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 471.2522; found, 472.2579 (Δ = 3.4 ppm).</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Assay</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>P. falciparum</i> Culture and Synchronization</h4><div class="NLM_p last"><i>P. falciparum</i> cultures were maintained in RPMI-1640 media (Invitrogen) supplemented with 0.2% sodium bicarbonate, 0.5% AlbuMAX II, 2.0 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma), and 10 mg/L gentamycin. For continuous culture, the parasites were kept at 4% hematocrit in human erythrocytes from 0 + blood donors and between 0.5 and 3% parasitemia maintained in an incubator at 37 °C, 5% carbon dioxide (CO<sub>2</sub>), 5% oxygen (O<sub>2</sub>), and 90% nitrogen (N<sub>2</sub>). To obtain highly synchronous ring-stage parasites for the drug assays, cultures were double synchronized using Percoll and sorbitol synchronization, as previously described.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> First, highly segmented schizonts were enriched by centrifugation on a 70% Percoll (GE Healthcare) cushion gradient. The Schizont pellet was collected and washed before fresh erythrocytes were added to a final hematocrit of 4%. The schizonts were incubated for about 1–2 h shaking continuously to allow egress and reinvasion of new erythrocytes. Residual schizonts were then removed by treating the pellet with sorbitol to generate highly synchronous 1–2 h old ring-stage parasites.</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Determining the EC<sub>50</sub> of Compound Inhibitors and Drugs <i>Ex Vivo</i></h3><div class="NLM_p last">To determine the EC<sub>50</sub> of the molecules in parasites (<i>P. falciparum</i> 3D7) <i>ex vivo</i>, the molecules were diluted 1 in 3 from a starting concentration of 100 μM for 12 dilution points. In total, 50 mL of freshly diluted drugs, at twice the required final concentrations, were aliquoted into black 96-well plates. To the drug plates, 50 μL of parasites prepared at 8% hematocrit at parasitemia (0.3–0.5%) were added and mixed by pipetting up and down several times giving a final culture volume of 100 μL at the required drug concentration (top concentration of 100 μM) and 4% hematocrit. To the “no drug” control, growth media was added, and uninfected erythrocytes were included on the plate as blank. The outer wells were filled with media to reduce evaporation from the experimental wells, and the plates were incubated for 50 h (±2 h) to allow the parasites sufficient time to reinvade before they are collected and frozen. To quantify growth inhibition, the plates were thawed at room temperature for at least 1 h, and 100 μL of lysis buffer (20 mM Tris-HCl; 5 mM EDTA; 0.004% saponin and triton X-100) in PBS containing Sybr Green I (1 μL in 5 mL) was added to each well and mixed by pipetting up and down several times and incubated for 1 h in the dark with shaking. Using a Fluoroskan/ClarioStar plate reader at excitation of 485 nm and emission of 538 nm, plate absorbances were acquired. The data were normalized against the controls, and graphs were generated using GraphPad prism 8 to determine the EC<sub>50</sub> values using the nonlinear regression log (inhibitor) versus response (three parameter) curve.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> TR-FRET to Determine the IC<sub>50</sub> of the Inhibitors with Full-Length <i>Pf</i>CLK3 Recombinant Protein</h3><div class="NLM_p">The TR-FRET assays, a high-throughput inhibition assay, as described previously,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> was used to determine the potency of the small molecules generated against full-length <i>Pf</i>CLK3 recombinant protein in a kinase buffer (containing 50 mM HEPES, 10 mM MgCl<sub>2</sub>, 2 mM DTT, 0.01% Tween 20, and 1 mM EGTA), with the U<i>Light</i>-labeled peptide substrate MBP peptide (sequence: CFFKNIVTPRTPPPSQGK). First, in a 10 μL reaction volume, 5 μL of twice the required enzyme concentration (50 nM) and 2.5 μL of four times the required substrate concentration mix containing cold ATP, and the serially diluted drugs were mixed in a black 384-plate well plate and incubated at 37 °C for 1 h. The reaction was stopped after incubation by adding the stopping/detection solution (containing 30 mM EDTA in 1× Lance detection buffer and 3 nM Europium-labeled antiphospho-specific antibody) and incubated for another hour at RT before phosphorylation signals were measured using the ClarioStar.</div><div class="NLM_p">For each test compound, percent inhibition (response) which was calculated using the formula: <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_m001.gif" alt="" id="_i65" /></img></span> was plotted against the log molar concentration of compound to calculate the IC<sub>50</sub> (potency) of each inhibitor molecule and plotted using GraphPad prism software. All experiments were carried out in triplicates, and the data presented were the standard error of the mean (SEM) of three independent experiments run in triplicates.</div><div class="NLM_p last"><i>Pf</i>CLK3 phosphorylation of substrate results in the Europium-labeled antiphospho-specific antibody recognizing the phosphorylated site on the substrate. The Europium donor fluorophore is excited at 320 or 340 nm, and energy is transferred to the U<i>Light</i> acceptor dye on the substrate, which finally results in the emission of light at 665 nm. The level of <i>ULight</i> peptide phosphorylation correlates with the intensity of the emission. For normalization, a no kinase and a no inhibitor reaction wells were included, and all experiments were conducted in triplicates. Drug dilutions, protein concentrations, and incubation times were the same for easy comparison of results.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Microsomal Stability</h3><div class="NLM_p last">Compounds were incubated at 37 °C at a concentration of 1 μM with CD1 mouse liver microsomes (GIBCO, Thermo Fisher Scientific) in a suspension of 50 mM potassium phosphate buffer (pH 7.4) with a final protein concentration of 0.5 mg/mL. The reaction was started by the addition of excess NADPH and then quenched at several time points starting from time 0, then at 3, 6, 9, 15, and 30 min addition of acetonitrile to an aliquot of the sample. An internal standard was added to each sample before centrifugation to remove any precipitates before monitoring loss of parent compound by HPLC analysis using Shimadzu LC-20A (Shimadzu, UK). Prism (Graphpad, USA) was used to fit an exponential decay for substrate depletion and subsequently rate constant (<i>k</i>) from the peak area of the parent compound to the internal standard at each time point. The rate of intrinsic clearance (CL<sub>int</sub>) was then calculated according to the methods of Obach using the equation<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a><span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_m002.gif" alt="" id="_i67" /></img></span>where <i>V</i> is the incubation volume (volume/mg protein), and microsomal protein yield is assumed to be 52.5 mg protein/g liver with verapamil used as a positive control.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Distribution Coefficient (log <i>D</i><sub>7.4</sub>)</h3><div class="NLM_p last">Distribution coefficient (log <i>D</i><sub>7.4</sub>) was estimated by correlation of the compounds’ chromatographic retention properties to those of 10 standard compounds with known distribution coefficients ranging from −0.5 to 5.5 at pH 7.4. A fast gradient HPLC methodology was used based on the method developed by Valkó et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Kinase Screen Method</h3><div class="NLM_p last">Each enzyme is assayed in its linear range with 0.3 μM substrate in 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.01 mM DTT, and relevant Mg/ATP (5, 20, or 50 μM) for 30 min at room temp. Assays are stopped by the addition of 3% orthophosphoric acid and harvested onto a p81 filter paper using the PerkinElmer unifilter harvester. Once dried, they are read on a PerkinElmer Topcount NXT scintillation counter for 30 s/well.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00451" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00451?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00451</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures and characterization data for all compounds; copies of <sup>1</sup>H, <sup>13</sup>C, NMR spectra for all compounds; log <i>D</i><sub>7.4</sub> (distribution co-efficient), metabolic stability, and analytical HPLC traces for final compounds; and <i>P. falciparum</i> culture, synchronization, and TR-FRET assay data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf">jm0c00451_si_001.pdf (7.57 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_002.csv">jm0c00451_si_002.csv (1.15 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00451" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew B. Tobin</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1807-3123" title="Orcid link">http://orcid.org/0000-0002-1807-3123</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#88c9e6ecfaedffa6dce7eae1e6c8efe4e9fbefe7ffa6e9eba6fde3"><span class="__cf_email__" data-cfemail="e0a18e84928597ceb48f82898ea0878c8193878f97ce8183ce958b">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew G. Jamieson</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1726-7353" title="Orcid link">http://orcid.org/0000-0003-1726-7353</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2d4c43495f485a03474c4044485e4243031f6d4a414c5e4a425a034c4e035846"><span class="__cf_email__" data-cfemail="bddcd3d9cfd8ca93d7dcd0d4d8ced2d3938ffddad1dccedad2ca93dcde93c8d6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit Mahindra</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Omar Janha</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kopano Mapesa</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Sanchez-Azqueta</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular Cell and Systems Biology, University of Glasgow, Davidson Building, Glasgow G12 8QQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mahmood M. Alam</span> - <span class="hlFld-Affiliation affiliation">Wellcome
Centre for Integrative Parasitology and Centre for Translational Pharmacology,
Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alfred Amambua-Ngwa</span> - <span class="hlFld-Affiliation affiliation">MRC
Unit The Gambia at LSHTM, Atlantic Boulevard,
Fajara, P. O. Box 273, Banjul, The Gambia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davis C. Nwakanma</span> - <span class="hlFld-Affiliation affiliation">MRC
Unit The Gambia at LSHTM, Atlantic Boulevard,
Fajara, P. O. Box 273, Banjul, The Gambia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.M. and O.J. have contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the University of Glasgow (A.G.J. and A.B.T.), EPSRC (Research Project grant EP/N034260/2) (A.M.), and MRC Developmental Gap Fund (A.S.-A.) for financial support of this research. O.J. thanks the MRC Toxicology Unit and MRC Unit The Gambia for a PhD studentship. K.M. thanks the University of Glasgow for a Lord Kelvin Adam Smith Studentship. M.M.A. thanks the University of Glasgow for a Lord Kelvin Adam Smith Fellowship. The authors also thank Andrew Monaghan (HRMS, University of Glasgow) for providing technical assistance.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term"><i>Pf</i>CLK3</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> cyclin-dependent like kinase</p></td></tr><tr><td class="NLM_term">TCMDC</td><td class="NLM_def"><p class="first last">Tres cantos antimalarial set</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time resolve fluorescence energy transfer</p></td></tr><tr><td class="NLM_term">SRPK</td><td class="NLM_def"><p class="first last">serine–arginine-rich protein kinase</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr><tr><td class="NLM_term"><i>Pf</i>PKG</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> protein kinase G</p></td></tr><tr><td class="NLM_term"><i>Pf</i>CDPK1</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> calcium-dependent protein kinase 1</p></td></tr><tr><td class="NLM_term"><i>Pf</i>CRT</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> chloroquine-resistant transporter gene</p></td></tr><tr><td class="NLM_term"><i>Pf</i>MDR1</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> multidrug-resistant gene 1</p></td></tr><tr><td class="NLM_term"><i>Pf</i>DHFR</td><td class="NLM_def"><p class="first last"><i>P. falciparum</i> dihydrofolate reductase gene.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Organization, WHO</span>.  <i>World Malaria Report</i>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Organization%2C+WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadani, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacheux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urnov, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit-Vical, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">K13-propeller mutations confer artemisinin resistance in plasmodium falciparum clinical isolates</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1126/science.1260867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1126%2Fscience.1260867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25502314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=428-431&author=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=V.+Duruauthor=A.+P.+Ramadaniauthor=M.+Dacheuxauthor=N.+Khimauthor=L.+Zhangauthor=S.+Lamauthor=P.+D.+Gregoryauthor=F.+D.+Urnovauthor=O.+Mercereau-Puijalonauthor=F.+Benoit-Vicalauthor=R.+M.+Fairhurstauthor=D.+Menardauthor=D.+A.+Fidock&title=K13-propeller+mutations+confer+artemisinin+resistance+in+plasmodium+falciparum+clinical+isolates&doi=10.1126%2Fscience.1260867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span></div><div class="casAuthors">Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6220</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden.  We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients.  With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations.  Conversely, survival rates in wild-type parasites increased from ≤0.6% to 2 to 29% after the insertion of K13 mutations.  These mutations conferred elevated resistance to recent Cambodian isolates compared with that of ref. lines, suggesting a contemporary contribution of addnl. genetic factors.  Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ml-eUMKETLVg90H21EOLACvtfcHk0ljaLuHx53g9NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D&md5=5776238fb78428d16bcaed8d16fa73af</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1260867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1260867%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DRamadani%26aufirst%3DA.%2BP.%26aulast%3DDacheux%26aufirst%3DM.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DGregory%26aufirst%3DP.%2BD.%26aulast%3DUrnov%26aufirst%3DF.%2BD.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DK13-propeller%2520mutations%2520confer%2520artemisinin%2520resistance%2520in%2520plasmodium%2520falciparum%2520clinical%2520isolates%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D428%26epage%3D431%26doi%3D10.1126%2Fscience.1260867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beghain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bout, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ménard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandeur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barale, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit-Vical, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ménard, D.</span></span> <span> </span><span class="NLM_article-title">A molecular marker of artemisinin-resistant plasmodium falciparum malaria</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+M%C3%A9nardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+Le+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+M%C3%A9nard&title=A+molecular+marker+of+artemisinin-resistant+plasmodium+falciparum+malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eY2PPb9VvJ7ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DLe%2BBras%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DA%2520molecular%2520marker%2520of%2520artemisinin-resistant%2520plasmodium%2520falciparum%2520malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Try, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blessborn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullo, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span> <span> </span><span class="NLM_article-title">Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(15)00487-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2FS1473-3099%2815%2900487-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=26774243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=357-365&author=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=S.+Maoauthor=C.+Sophaauthor=B.+Samauthor=D.+Dekauthor=V.+Tryauthor=R.+Amatoauthor=D.+Blessbornauthor=L.+Songauthor=G.+S.+Tulloauthor=M.+P.+Fayauthor=J.+M.+Andersonauthor=J.+Tarningauthor=R.+M.+Fairhurst&title=Dihydroartemisinin-piperaquine+resistance+in+Plasmodium+falciparum+malaria+in+Cambodia%3A+a+multisite+prospective+cohort+study&doi=10.1016%2Fs1473-3099%2815%2900487-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study</span></div><div class="casAuthors">Amaratunga, Chanaki; Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Sopha, Chantha; Sam, Baramey; Dek, Dalin; Try, Vorleak; Amato, Roberto; Blessborn, Daniel; Song, Lijiang; Tullo, Gregory S.; Fay, Michael P.; Anderson, Jennifer M.; Tarning, Joel; Fairhurst, Rick M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies (ACTs), thus compromising global efforts to eliminate malaria.  Recent treatment failures with dihydroartemisinin-piperaquine, the current first-line ACT in Cambodia, suggest that piperaquine resistance may be emerging in this country.  We explored the relation between artemisinin resistance and dihydroartemisinin-piperaquine failures, and sought to confirm the presence of piperaquine-resistant P falciparum infections in Cambodia.  In this prospective cohort study, we enrolled patients aged 2-65 years with uncomplicated P falciparum malaria in three Cambodian provinces: Pursat, Preah Vihear, and Ratanakiri.  Participants were given std. 3-day courses of dihydroartemisinin-piperaquine.  Peripheral blood parasite densities were measured until parasites cleared and then weekly to 63 days.  The primary outcome was recrudescent P falciparum parasitemia within 63 days.  We measured piperaquine plasma concns. at baseline, 7 days, and day of recrudescence.  We assessed phenotypic and genotypic markers of drug resistance in parasite isolates.  The study is registered with ClinicalTrials.gov, no. NCT01736319.  Between Sept 4, 2012, and Dec 31, 2013, we enrolled 241 participants.  In Pursat, where artemisinin resistance is entrenched, 37 (46%) of 81 patients had parasite recrudescence.  In Preah Vihear, where artemisinin resistance is emerging, ten (16%) of 63 patients had recrudescence and in Ratanakiri, where artemisinin resistance is rare, one (2%) of 60 patients did.  Patients with recrudescent P falciparum infections were more likely to have detectable piperaquine plasma concns. at baseline compared with non-recrudescent patients, but did not differ significantly in age, initial parasite d., or piperaquine plasma concns. at 7 days.  Recrudescent parasites had a higher prevalence of kelch13 mutations, higher piperaquine 50% inhibitory concn. (IC50) values, and lower mefloquine IC50 values; none had multiple pfmdr1 copies, a genetic marker of mefloquine resistance.  Dihydroartemisinin-piperaquine failures are caused by both artemisinin and piperaquine resistance, and commonly occur in places where dihydroartemisinin-piperaquine has been used in the private sector.  In Cambodia, artesunate plus mefloquine may be a viable option to treat dihydroartemisinin-piperaquine failures, and a more effective first-line ACT in areas where dihydroartemisinin-piperaquine failures are common.  The use of single low-dose primaquine to eliminate circulating gametocytes is needed in areas where artemisinin and ACT resistance is prevalent.  National Institute of Allergy and Infectious Diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0RSM1qQzR7Vg90H21EOLACvtfcHk0ljaLuHx53g9NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D&md5=b2b62ae0ef4f2b67f7446a2a5718654d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900487-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900487-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DDek%26aufirst%3DD.%26aulast%3DTry%26aufirst%3DV.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DBlessborn%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTullo%26aufirst%3DG.%2BS.%26aulast%3DFay%26aufirst%3DM.%2BP.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26atitle%3DDihydroartemisinin-piperaquine%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%2520in%2520Cambodia%253A%2520a%2520multisite%2520prospective%2520cohort%2520study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3D357%26epage%3D365%26doi%3D10.1016%2Fs1473-3099%2815%2900487-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouth, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Char, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domergue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span> <span> </span><span class="NLM_article-title">Evidence of plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4719</span>– <span class="NLM_lpage">4726</span>, <span class="refDoi"> DOI: 10.1128/aac.00835-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1128%2FAAC.00835-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=26014949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KntLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=4719-4726&author=R.+Leangauthor=W.+R.+J.+Taylorauthor=D.+M.+Bouthauthor=L.+Songauthor=J.+Tarningauthor=M.+C.+Charauthor=S.+Kimauthor=B.+Witkowskiauthor=V.+Duruauthor=A.+Domergueauthor=N.+Khimauthor=P.+Ringwaldauthor=D.+Menard&title=Evidence+of+plasmodium+falciparum+malaria+multidrug+resistance+to+artemisinin+and+piperaquine+in+western+Cambodia%3A+dihydroartemisinin-piperaquine+open-label+multicenter+clinical+assessment&doi=10.1128%2Faac.00835-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment</span></div><div class="casAuthors">Leang, Rithea; Taylor, Walter R. J.; Bouth, Denis Mey; Song, Lijiang; Tarning, Joel; Char, Meng Chuor; Kim, Saorin; Witkowski, Benoit; Duru, Valentine; Domergue, Anais; Khim, Nimol; Ringwald, Pascal; Menard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4719-4726</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Western Cambodia is recognized as the epicenter of Plasmodium falciparum multidrug resistance.  Recent reports of the efficacy of dihydroartemisinin (DHA)-piperaquine (PP), the latest of the artemisinin-based combination therapies (ACTs) recommended by the WHO, have prompted further investigations.  The clin. efficacy of dihydroartemisinin-piperaquine in uncomplicated falciparum malaria was assessed in western and eastern Cambodia over 42 days.  Day 7 plasma piperaquine concns. were measured and day 0 isolates tested for in vitro susceptibilities to piperaquine and mefloquine, polymorphisms in the K13 gene, and the copy no. of the Pfmdr-1 gene.  A total of 425 patients were recruited in 2011 to 2013.  The proportion of patients with recrudescent infections was significantly higher in western (15.4%) than in eastern (2.5%) Cambodia (P < 10-3).  Day 7 plasma PP concns. and median 50% inhibitory concns. (IC50) of PP were independent of treatment outcomes, in contrast to median mefloquine IC50, which were found to be lower for isolates from patients with recrudescent infections (18.7 vs. 39.7 nM; P = 0.005).  The most significant risk factor assocd. with DHA-PP treatment failure was infection by parasites carrying the K13 mutant allele (odds ratio [OR], 17.5; 95% confidence interval [CI], 1 to 308; P = 0.04).  Our data show evidence of P. falciparum resistance to PP in western Cambodia, an area of widespread artemisinin resistance.  New therapeutic strategies, such as the use of triple ACTs, are urgently needed and must be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM6ayLCgXm1bVg90H21EOLACvtfcHk0lgeNm3vtwULtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KntLzF&md5=642a0306149f3edba42a166a4ce8749d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FAAC.00835-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00835-15%26sid%3Dliteratum%253Aachs%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DW.%2BR.%2BJ.%26aulast%3DBouth%26aufirst%3DD.%2BM.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DChar%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DDomergue%26aufirst%3DA.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DMenard%26aufirst%3DD.%26atitle%3DEvidence%2520of%2520plasmodium%2520falciparum%2520malaria%2520multidrug%2520resistance%2520to%2520artemisinin%2520and%2520piperaquine%2520in%2520western%2520Cambodia%253A%2520dihydroartemisinin-piperaquine%2520open-label%2520multicenter%2520clinical%2520assessment%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D4719%26epage%3D4726%26doi%3D10.1128%2Faac.00835-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bland, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschenlauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorin-Semblat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nivez, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semblat, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reininger, L.</span></span> <span> </span><span class="NLM_article-title">Malaria: targeting parasite and host cell kinomes</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">604</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2Fj.bbapap.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=19840874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=604-612&author=C.+Doerigauthor=A.+Abdiauthor=N.+Blandauthor=S.+Eschenlauerauthor=D.+Dorin-Semblatauthor=C.+Fennellauthor=J.+Halbertauthor=Z.+Hollandauthor=M.-P.+Nivezauthor=J.-P.+Semblatauthor=A.+Sicardauthor=L.+Reininger&title=Malaria%3A+targeting+parasite+and+host+cell+kinomes&doi=10.1016%2Fj.bbapap.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria: Targeting parasite and host cell kinomes</span></div><div class="casAuthors">Doerig, Christian; Abdi, Abdirahman; Bland, Nicholas; Eschenlauer, Sylvain; Dorin-Semblat, Dominique; Fennell, Clare; Halbert, Jean; Holland, Zoe; Nivez, Marie-Paule; Semblat, Jean-Philippe; Sicard, Audrey; Reininger, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-612</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Malaria still remains one of the deadliest infectious diseases, and has a tremendous morbidity and mortality impact in the developing world.  The propensity of the parasites to develop drug resistance, and the relative reluctance of the pharmaceutical industry to invest massively in the developments of drugs that would offer only limited marketing prospects, are major issues in antimalarial drug discovery.  Protein kinases (PKs) have become a major family of targets for drug discovery research in a no. of disease contexts, which has generated considerable resources such as kinase-directed libraries and high throughput kinase inhibition assays.  The phylogenetic distance between malaria parasites and their human host translates into important divergences in their resp. kinomes, and most Plasmodium kinases display atypical properties (as compared to mammalian PKs) that can be exploited towards selective inhibition.  Here, we discuss the taxon-specific kinases possessed by malaria parasites, and give an overview of target PKs that have been validated by reverse genetics, either in the human malaria parasite Plasmodium falciparum or in the rodent model Plasmodium berghei.  We also briefly allude to the possibility of attacking Plasmodium through the inhibition of human PKs that are required for survival of this obligatory intracellular parasite, and which are targets for other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaEZOKIim0lLVg90H21EOLACvtfcHk0lgeNm3vtwULtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yms74%253D&md5=2ea0d11a5754384a0037065c7525b57c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DAbdi%26aufirst%3DA.%26aulast%3DBland%26aufirst%3DN.%26aulast%3DEschenlauer%26aufirst%3DS.%26aulast%3DDorin-Semblat%26aufirst%3DD.%26aulast%3DFennell%26aufirst%3DC.%26aulast%3DHalbert%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DZ.%26aulast%3DNivez%26aufirst%3DM.-P.%26aulast%3DSemblat%26aufirst%3DJ.-P.%26aulast%3DSicard%26aufirst%3DA.%26aulast%3DReininger%26aufirst%3DL.%26atitle%3DMalaria%253A%2520targeting%2520parasite%2520and%2520host%2520cell%2520kinomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D604%26epage%3D612%26doi%3D10.1016%2Fj.bbapap.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A. B.</span></span> <span> </span><span class="NLM_article-title">Post-translational protein modifications in malaria parasites</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fnrmicro3402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25659318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlShu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=160-172&author=C.+Doerigauthor=J.+C.+Raynerauthor=A.+Scherfauthor=A.+B.+Tobin&title=Post-translational+protein+modifications+in+malaria+parasites&doi=10.1038%2Fnrmicro3402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational protein modifications in malaria parasites</span></div><div class="casAuthors">Doerig, Christian; Rayner, Julian C.; Scherf, Artur; Tobin, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">160-172</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications play crucial parts in regulating protein function and thereby control several fundamental aspects of eukaryotic biol., including cell signaling, protein trafficking, epigenetic control of gene expression, cell-cell interactions, and cell proliferation and differentiation.  Here, the authors discuss protein modifications that have been shown to play a key role in malaria parasite biol. and pathogenesis.  The authors focus on phosphorylation, acetylation, methylation, and lipidation.  The authors provide an overview of the biol. significance of these modifications and discuss prospects and progress in antimalarial drug discovery based on the inhibition of the enzymes that mediate these modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJjsdKp9DJV7Vg90H21EOLACvtfcHk0li7RK3Tuct72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlShu7Y%253D&md5=576e6bfd6e143f420c749383422d6a33</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3402%26sid%3Dliteratum%253Aachs%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DRayner%26aufirst%3DJ.%2BC.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26atitle%3DPost-translational%2520protein%2520modifications%2520in%2520malaria%2520parasites%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2015%26volume%3D13%26spage%3D160%26epage%3D172%26doi%3D10.1038%2Fnrmicro3402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solyakov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semblat, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorin-Semblat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reininger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottrill, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, Z.</span></span> <span> </span><span class="NLM_article-title">Global kinomic and phospho-proteomic analyses of the human malaria parasite plasmodium falciparum</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">565</span>, <span class="refDoi"> DOI: 10.1038/ncomms1558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fncomms1558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22127061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fjs1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=565&author=L.+Solyakovauthor=J.+Halbertauthor=M.+M.+Alamauthor=J.+P.+Semblatauthor=D.+Dorin-Semblatauthor=L.+Reiningerauthor=A.+R.+Bottrillauthor=S.+Mistryauthor=A.+Abdiauthor=C.+Fennellauthor=Z.+Holland&title=Global+kinomic+and+phospho-proteomic+analyses+of+the+human+malaria+parasite+plasmodium+falciparum&doi=10.1038%2Fncomms1558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum</span></div><div class="casAuthors">Solyakov Lev; Halbert Jean; Alam Mahmood M; Semblat Jean-Philippe; Dorin-Semblat Dominique; Reininger Luc; Bottrill Andrew R; Mistry Sharad; Abdi Abdirhaman; Fennell Clare; Holland Zoe; Demarta Claudia; Bouza Yvan; Sicard Audrey; Nivez Marie-Paule; Eschenlauer Sylvain; Lama Tenzing; Thomas Divya Catherine; Sharma Pushkar; Agarwal Shruti; Kern Selina; Pradel Gabriele; Graciotti Michele; Tobin Andrew B; Doerig Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">565</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The role of protein phosphorylation in the life cycle of malaria parasites is slowly emerging.  Here we combine global phospho-proteomic analysis with kinome-wide reverse genetics to assess the importance of protein phosphorylation in Plasmodium falciparum asexual proliferation.  We identify 1177 phosphorylation sites on 650 parasite proteins that are involved in a wide range of general cellular activities such as DNA synthesis, transcription and metabolism as well as key parasite processes such as invasion and cyto-adherence.  Several parasite protein kinases are themselves phosphorylated on putative regulatory residues, including tyrosines in the activation loop of PfGSK3 and PfCLK3; we show that phosphorylation of PfCLK3 Y526 is essential for full kinase activity.  A kinome-wide reverse genetics strategy identified 36 parasite kinases as likely essential for erythrocytic schizogony.  These studies not only reveal processes that are regulated by protein phosphorylation, but also define potential anti-malarial drug targets within the parasite kinome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTASTzJ3P0nSRe4jJGKT5N0fW6udTcc2eY2E2BWUMYgl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fjs1SrtQ%253D%253D&md5=8887de8eb952447f55afe5b773875981</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fncomms1558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1558%26sid%3Dliteratum%253Aachs%26aulast%3DSolyakov%26aufirst%3DL.%26aulast%3DHalbert%26aufirst%3DJ.%26aulast%3DAlam%26aufirst%3DM.%2BM.%26aulast%3DSemblat%26aufirst%3DJ.%2BP.%26aulast%3DDorin-Semblat%26aufirst%3DD.%26aulast%3DReininger%26aufirst%3DL.%26aulast%3DBottrill%26aufirst%3DA.%2BR.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DAbdi%26aufirst%3DA.%26aulast%3DFennell%26aufirst%3DC.%26aulast%3DHolland%26aufirst%3DZ.%26atitle%3DGlobal%2520kinomic%2520and%2520phospho-proteomic%2520analyses%2520of%2520the%2520human%2520malaria%2520parasite%2520plasmodium%2520falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D565%26doi%3D10.1038%2Fncomms1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talevich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, N.</span></span> <span> </span><span class="NLM_article-title">Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa</span>. <i>BMC Evol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">321</span>, <span class="refDoi"> DOI: 10.1186/1471-2148-11-321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1186%2F1471-2148-11-321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22047078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=321&author=E.+Talevichauthor=A.+Mirzaauthor=N.+Kannan&title=Structural+and+evolutionary+divergence+of+eukaryotic+protein+kinases+in+Apicomplexa&doi=10.1186%2F1471-2148-11-321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa</span></div><div class="casAuthors">Talevich, Eric; Mirza, Amar; Kannan, Natarajan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Evolutionary Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321</span>CODEN:
                <span class="NLM_cas:coden">BEBMCG</span>;
        ISSN:<span class="NLM_cas:issn">1471-2148</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The Apicomplexa constitute an evolutionarily divergent phylum of protozoan pathogens responsible for widespread parasitic diseases such as malaria and toxoplasmosis.  Many cellular functions in these medically important organisms are controlled by protein kinases, which have emerged as promising drug targets for parasitic diseases.  However, an incomplete understanding of how apicomplexan kinases structurally and mechanistically differ from their host counterparts has hindered drug development efforts to target parasite kinases.  We used the wealth of sequence data recently made available for 15 apicomplexan species to identify the kinome of each species and quantify the evolutionary constraints imposed on each family of apicomplexan kinases.  Our anal. revealed lineage-specific adaptations in selected families, namely cyclin-dependent kinase (CDK), calcium-dependent protein kinase (CDPK) and CLK/LAMMER, which have been identified as important in the pathogenesis of these organisms.  Bayesian anal. of selective constraints imposed on these families identified the sequence and structural features that most distinguish apicomplexan protein kinases from their homologs in model organisms and other eukaryotes.  In particular, in a subfamily of CDKs orthologous to Plasmodium falciparum crk-5, the activation loop contains a novel PTxC motif which is absent from all CDKs outside Apicomplexa.  Our anal. also suggests a convergent mode of regulation in a subset of apicomplexan CDPKs and mammalian MAPKs involving a commonly conserved arginine in the αC helix.  In all recognized apicomplexan CLKs, we find a set of co-conserved residues involved in substrate recognition and docking that are distinct from metazoan CLKs.  We pinpoint key conserved residues that can be predicted to mediate functional differences from eukaryotic homologs in three identified kinase families.  We discuss the structural, functional and evolutionary implications of these lineage-specific variations and propose specific hypotheses for exptl. investigation.  The apicomplexan-specific kinase features reported in this study can be used in the design of selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEQKvKIWM-PbVg90H21EOLACvtfcHk0li7RK3Tuct72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyhsLw%253D&md5=06e5e9471e75f772a31d2ada25d60d46</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1471-2148-11-321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2148-11-321%26sid%3Dliteratum%253Aachs%26aulast%3DTalevich%26aufirst%3DE.%26aulast%3DMirza%26aufirst%3DA.%26aulast%3DKannan%26aufirst%3DN.%26atitle%3DStructural%2520and%2520evolutionary%2520divergence%2520of%2520eukaryotic%2520protein%2520kinases%2520in%2520Apicomplexa%26jtitle%3DBMC%2520Evol.%2520Biol.%26date%3D2011%26volume%3D11%26spage%3D321%26doi%3D10.1186%2F1471-2148-11-321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.-D.</span></span> <span> </span><span class="NLM_article-title">Regulation of splicing by SR proteins and SR protein-specific kinases</span>. <i>Chromosoma</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1007/s00412-013-0407-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1007%2Fs00412-013-0407-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23525660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotVSks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=191-207&author=Z.+Zhouauthor=X.-D.+Fu&title=Regulation+of+splicing+by+SR+proteins+and+SR+protein-specific+kinases&doi=10.1007%2Fs00412-013-0407-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of splicing by SR proteins and SR protein-specific kinases</span></div><div class="casAuthors">Zhou, Zhihong; Fu, Xiang-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Chromosoma</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-207</span>CODEN:
                <span class="NLM_cas:coden">CHROAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-5915</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Genomic sequencing reveals similar but limited nos. of protein-coding genes in different genomes, which begs the question of how organismal diversities are generated.  Alternative pre-mRNA splicing, a widespread phenomenon in higher eukaryotic genomes, is thought to provide a mechanism to increase the complexity of the proteome and introduce addnl. layers for regulating gene expression in different cell types and during development.  Among a large no. of factors implicated in the splicing regulation are the SR protein family of splicing factors and SR protein-specific kinases.  Here, we summarize the rules for SR proteins to function as splicing regulators, which depend on where they bind in exons vs. intronic regions, on alternative exons vs. flanking competing exons, and on cooperative as well as competitive binding between different SR protein family members on many of those locations.  We review the importance of cycles of SR protein phosphorylation/dephosphorylation in the splicing reaction with emphasis on the recent mol. insight into the role of SR protein phosphorylation in early steps of spliceosome assembly.  Finally, we highlight recent discoveries of SR protein-specific kinases in transducing growth signals to regulate alternative splicing in the nucleus and the connection of both SR proteins and SR protein kinases to human diseases, particularly cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7RFihroI_ubVg90H21EOLACvtfcHk0li7RK3Tuct72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotVSks7s%253D&md5=6f10045aad1b2a57c85284500892c96c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00412-013-0407-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00412-013-0407-z%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DX.-D.%26atitle%3DRegulation%2520of%2520splicing%2520by%2520SR%2520proteins%2520and%2520SR%2520protein-specific%2520kinases%26jtitle%3DChromosoma%26date%3D2013%26volume%3D122%26spage%3D191%26epage%3D207%26doi%3D10.1007%2Fs00412-013-0407-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehring, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strödke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brügl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abodo, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandekar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the SR protein-phosphorylating CLK kinases of plasmodium falciparum impairs blood stage replication and malaria transmission</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e105732</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0105732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1371%2Fjournal.pone.0105732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25188378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12isL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=S.+Kernauthor=S.+Agarwalauthor=K.+Huberauthor=A.+P.+Gehringauthor=B.+Str%C3%B6dkeauthor=C.+C.+Wirthauthor=T.+Br%C3%BCglauthor=L.+O.+Abodoauthor=T.+Dandekarauthor=C.+Doerigauthor=R.+Fischer&title=Inhibition+of+the+SR+protein-phosphorylating+CLK+kinases+of+plasmodium+falciparum+impairs+blood+stage+replication+and+malaria+transmission&doi=10.1371%2Fjournal.pone.0105732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission</span></div><div class="casAuthors">Kern, Selina; Agarwal, Shruti; Huber, Kilian; Gehring, Andre P.; Stroedke, Benjamin; Wirth, Christine C.; Bruegl, Thomas; Abodo, Liliane Onambele; Dandekar, Thomas; Doerig, Christian; Fischer, Rainer; Tobin, Andrew B.; Alam, Mahmood M.; Bracher, Franz; Pradel, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105732/1-e105732/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cyclin-dependent kinase-like kinases (CLKs) are dual specificity protein kinases that phosphorylate Serine/Arginine-rich (SR) proteins involved in pre-mRNA processing.  Four CLKs, termed PfCLK-1-4, can be identified in the human malaria parasite Plasmodium falciparum, which show homol. with the yeast SR protein kinase Sky1p.  The four PfCLKs are present in the nucleus and cytoplasm of the asexual blood stages and of gametocytes, sexual precursor cells crucial for malaria parasite transmission from humans to mosquitoes.  We identified three plasmodial SR proteins, PfSRSF12, PfSFRS4 and PfSF-1, which are predominantly present in the nucleus of blood stage trophozoites, PfSRSF12 and PfSF-1 are further detectable in the nucleus of gametocytes.  We found that recombinantly expressed SR proteins comprising the Arginine/Serine (RS)-rich domains were phosphorylated by the four PfCLKs in in vitro kinase assays, while a recombinant PfSF-1 peptide lacking the RS-rich domain was not phosphorylated.  Since it was hitherto not possible to knock-out the pfclk genes by conventional gene disruption, we aimed at chem. knock-outs for phenotype anal.  We identified five human CLK inhibitors, belonging to the oxo-β-carbolines and aminopyrimidines, as well as the antiseptic chlorhexidine as PfCLK-targeting compds.  The six inhibitors block P. falciparum blood stage replication in the low micromolar to nanomolar range by preventing the trophozoite-to-schizont transformation.  In addn., the inhibitors impair gametocyte maturation and gametogenesis in in vitro assays.  The combined data show that the four PfCLKs are involved in phosphorylation of SR proteins with essential functions for the blood and sexual stages of the malaria parasite, thus pointing to the kinases as promising targets for antimalarial and transmission blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfvbpkO4I6f7Vg90H21EOLACvtfcHk0lhxqs3gYBYTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12isL3K&md5=4d340a30e45d135fe95707d4745bacf4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105732%26sid%3Dliteratum%253Aachs%26aulast%3DKern%26aufirst%3DS.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DGehring%26aufirst%3DA.%2BP.%26aulast%3DStr%25C3%25B6dke%26aufirst%3DB.%26aulast%3DWirth%26aufirst%3DC.%2BC.%26aulast%3DBr%25C3%25BCgl%26aufirst%3DT.%26aulast%3DAbodo%26aufirst%3DL.%2BO.%26aulast%3DDandekar%26aufirst%3DT.%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520the%2520SR%2520protein-phosphorylating%2520CLK%2520kinases%2520of%2520plasmodium%2520falciparum%2520impairs%2520blood%2520stage%2520replication%2520and%2520malaria%2520transmission%26jtitle%3DPloS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0105732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przyborski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandekar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradel, G.</span></span> <span> </span><span class="NLM_article-title">Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1295</span>– <span class="NLM_lpage">1310</span>, <span class="refDoi"> DOI: 10.1002/jcb.23034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1002%2Fjcb.23034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=21312235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFelt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2011&pages=1295-1310&author=S.+Agarwalauthor=S.+Kernauthor=J.+Halbertauthor=J.+M.+Przyborskiauthor=S.+Baumeisterauthor=T.+Dandekarauthor=C.+Doerigauthor=G.+Pradel&title=Two+nucleus-localized+CDK-like+kinases+with+crucial+roles+for+malaria+parasite+erythrocytic+replication+are+involved+in+phosphorylation+of+splicing+factor&doi=10.1002%2Fjcb.23034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor</span></div><div class="casAuthors">Agarwal, Shruti; Kern, Selina; Halbert, Jean; Przyborski, Jude M.; Baumeister, Stefan; Dandekar, Thomas; Doerig, Christian; Pradel, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1295-1310</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The kinome of the human malaria parasite Plasmodium falciparum comprises representatives of most eukaryotic protein kinase groups, including kinases which regulate proliferation and differentiation processes.  Despite extensive research on most plasmodial enzymes, little information is available regarding the four identified members of the cyclin-dependent kinase-like kinase (CLK) family.  In other eukaryotes, CLKs regulate mRNA splicing through phosphorylation of Serine/Arginine-rich proteins.  Here, we investigate two of the PfCLKs, the Lammer kinase homolog PfCLK-1, and PfCLK-2.  Both PfCLKs show homol. with the yeast Serine/Arginine protein kinase Sky1p and are transcribed throughout the asexual blood stages and in gametocytes.  PfCLK-1/Lammer possesses two nuclear localization signal sites and PfCLK-2 possesses one of these signal sites upstream of the C-terminal catalytic domains.  Indirect immunofluorescence, Western blot, and electron microscopy data confirm that the kinases are primarily localized in the parasite nucleus, and PfCLK-2 is further present in the cytoplasm.  The two kinases are important for completion of the asexual replication cycle of P. falciparum, as demonstrated by reverse genetics approaches.  In vitro kinase assays show substrate phosphorylation by the PfCLKs, including the Sky1p substrate, splicing factor Npl3p, and the plasmodial alternative splicing factor PfASF-1.  Mass spectrometric anal. of co-immunopptd. proteins indicates assembly of the two PfCLKs with proteins with predicted nuclease, phosphatase, or helicase functions.  Our data indicate a crucial role of PfCLKs for malaria blood stage parasites, presumably by participating in gene regulation through the post-transcriptional modification of mRNA.  J. Cell. Biochem. 112: 1295-1310, 2011. © 2011 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvBjtIs7EGXrVg90H21EOLACvtfcHk0lhxqs3gYBYTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFelt7k%253D&md5=0875ea79cab6cefdd9d15df88e6f19c7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fjcb.23034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.23034%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DKern%26aufirst%3DS.%26aulast%3DHalbert%26aufirst%3DJ.%26aulast%3DPrzyborski%26aufirst%3DJ.%2BM.%26aulast%3DBaumeister%26aufirst%3DS.%26aulast%3DDandekar%26aufirst%3DT.%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DPradel%26aufirst%3DG.%26atitle%3DTwo%2520nucleus-localized%2520CDK-like%2520kinases%2520with%2520crucial%2520roles%2520for%2520malaria%2520parasite%2520erythrocytic%2520replication%2520are%2520involved%2520in%2520phosphorylation%2520of%2520splicing%2520factor%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D112%26spage%3D1295%26epage%3D1310%26doi%3D10.1002%2Fjcb.23034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Azqueta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janha, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahindra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mapesa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Char, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriranganadane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancucci, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simwela, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millar, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinwale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitcheson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solyakov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nwakanma, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colmenarejo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvaro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranford-Cartwright, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A. B.</span></span> <span> </span><span class="NLM_article-title">Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>365</i></span>, <span class="NLM_elocation-id">eaau1682</span> <span class="refDoi"> DOI: 10.1126/science.aau1682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1126%2Fscience.aau1682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=31467193" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2019&author=M.+M.+Alamauthor=A.+Sanchez-Azquetaauthor=O.+Janhaauthor=E.+L.+Flanneryauthor=A.+Mahindraauthor=K.+Mapesaauthor=A.+B.+Charauthor=D.+Sriranganadaneauthor=N.+M.+B.+Brancucciauthor=Y.+Antonova-Kochauthor=K.+Crouchauthor=N.+V.+Simwelaauthor=S.+B.+Millarauthor=J.+Akinwaleauthor=D.+Mitchesonauthor=L.+Solyakovauthor=K.+Dudekauthor=C.+Jonesauthor=C.+Zapateroauthor=C.+Doerigauthor=D.+C.+Nwakanmaauthor=M.+J.+V%C3%A1zquezauthor=G.+Colmenarejoauthor=M.+J.+Lafuente-Monasterioauthor=M.+L.+Leonauthor=P.+H.+C.+Godoiauthor=J.+M.+Elkinsauthor=A.+P.+Watersauthor=A.+G.+Jamiesonauthor=E.+F.+%C3%81lvaroauthor=L.+C.+Ranford-Cartwrightauthor=M.+Martiauthor=E.+A.+Winzelerauthor=F.+J.+Gamoauthor=A.+B.+Tobin&title=Validation+of+the+protein+kinase+PfCLK3+as+a+multistage+cross-species+malarial+drug+target&doi=10.1126%2Fscience.aau1682"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aau1682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aau1682%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DM.%2BM.%26aulast%3DSanchez-Azqueta%26aufirst%3DA.%26aulast%3DJanha%26aufirst%3DO.%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DMahindra%26aufirst%3DA.%26aulast%3DMapesa%26aufirst%3DK.%26aulast%3DChar%26aufirst%3DA.%2BB.%26aulast%3DSriranganadane%26aufirst%3DD.%26aulast%3DBrancucci%26aufirst%3DN.%2BM.%2BB.%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DCrouch%26aufirst%3DK.%26aulast%3DSimwela%26aufirst%3DN.%2BV.%26aulast%3DMillar%26aufirst%3DS.%2BB.%26aulast%3DAkinwale%26aufirst%3DJ.%26aulast%3DMitcheson%26aufirst%3DD.%26aulast%3DSolyakov%26aufirst%3DL.%26aulast%3DDudek%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DZapatero%26aufirst%3DC.%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DNwakanma%26aufirst%3DD.%2BC.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DM.%2BJ.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DLeon%26aufirst%3DM.%2BL.%26aulast%3DGodoi%26aufirst%3DP.%2BH.%2BC.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26aulast%3DJamieson%26aufirst%3DA.%2BG.%26aulast%3D%25C3%2581lvaro%26aufirst%3DE.%2BF.%26aulast%3DRanford-Cartwright%26aufirst%3DL.%2BC.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26atitle%3DValidation%2520of%2520the%2520protein%2520kinase%2520PfCLK3%2520as%2520a%2520multistage%2520cross-species%2520malarial%2520drug%2520target%26jtitle%3DScience%26date%3D2019%26volume%3D365%26doi%3D10.1126%2Fscience.aau1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawa, M.</span></span> <span> </span><span class="NLM_article-title">7-Azaindole: A versatile scaffold for developing kinase inhibitors</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1248/cpb.c17-00380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1248%2Fcpb.c17-00380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=29311509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOntr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=29-36&author=T.+Irieauthor=M.+Sawa&title=7-Azaindole%3A+A+versatile+scaffold+for+developing+kinase+inhibitors&doi=10.1248%2Fcpb.c17-00380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azaindole: a versatile scaffold for developing kinase inhibitors</span></div><div class="casAuthors">Irie, Takayuki; Sawa, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  This review summarized recent examples of 7-azaindole-based kinase inhibitors and discusses their binding interactions with the kinase hinge regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9QuvBOqQ8GrVg90H21EOLACvtfcHk0liuYjPIza_NAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOntr%252FK&md5=69a5097cb54f2598d2e02414e74b3e6b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c17-00380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c17-00380%26sid%3Dliteratum%253Aachs%26aulast%3DIrie%26aufirst%3DT.%26aulast%3DSawa%26aufirst%3DM.%26atitle%3D7-Azaindole%253A%2520A%2520versatile%2520scaffold%2520for%2520developing%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D66%26spage%3D29%26epage%3D36%26doi%3D10.1248%2Fcpb.c17-00380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallamo, J. P.</span></span> <span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5149</span>– <span class="NLM_lpage">5171</span>, <span class="refDoi"> DOI: 10.1021/jm800475y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery&doi=10.1021%2Fjm800475y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0liuYjPIza_NAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171%26doi%3D10.1021%2Fjm800475y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent and selective Pim kinase inhibitors by targeting unique structure of ATP-binding pocket</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00518</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=504-509&author=H.+Nakanoauthor=T.+Hasegawaauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Nagano&title=Design+and+synthesis+of+potent+and+selective+Pim+kinase+inhibitors+by+targeting+unique+structure+of+ATP-binding+pocket&doi=10.1021%2Facsmedchemlett.6b00518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket</span></div><div class="casAuthors">Nakano, Hirofumi; Hasegawa, Tsukasa; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the development of kinase inhibitors, one of the major concerns is selectivity.  An effective strategy to achieve high selectivity is to utilize structural differences among kinases to inform inhibitor design.  Here, we set out to improve the PIM (proviral integration site for Moloney murine leukemia virus) kinase-inhibitory selectivity of our previously reported 7-azaindole deriv. 2, which has promising ADMET properties, by targeting a unique bulge in the ATP-binding pocket. 6-Substituted 7-azaindoles, esp. the 6-chlorinated derivs., proved to be potent and selective PIM kinase inhibitors and appear to be promising lead compds. for future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBu3SXcZr8bVg90H21EOLACvtfcHk0liuYjPIza_NAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D&md5=b4393c5c6f77ddfa140ebf669b552e44</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00518%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520Pim%2520kinase%2520inhibitors%2520by%2520targeting%2520unique%2520structure%2520of%2520ATP-binding%2520pocket%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D504%26epage%3D509%26doi%3D10.1021%2Facsmedchemlett.6b00518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">The azaindole framework in the design of kinase inhibitors</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">19935</span>– <span class="NLM_lpage">19979</span>, <span class="refDoi"> DOI: 10.3390/molecules191219935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.3390%2Fmolecules191219935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25460315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=19935-19979&author=J.-Y.+M%C3%A9rourauthor=F.+Buronauthor=K.+Pl%C3%A9author=P.+Bonnetauthor=S.+Routier&title=The+azaindole+framework+in+the+design+of+kinase+inhibitors&doi=10.3390%2Fmolecules191219935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The azaindole framework in the design of kinase inhibitors</span></div><div class="casAuthors">Merour, Jean-Yves; Buron, Frederic; Ple, Karen; Bonnet, Pascal; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">19935-19979, 45 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This review article illustrates the growing use of azaindole derivs. as kinase inhibitors and their contribution to drug discovery and innovation.  The different protein kinases which have served as targets and the known mols. which have emerged from medicinal chem. and Fragment-Based Drug Discovery (FBDD) programs are presented.  The various synthetic routes used to access these compds. and the chem. pathways leading to their synthesis are also discussed.  An anal. of their mode of binding based on X-ray crystallog. data gives structural insights for the design of more potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLtZrGItBQbVg90H21EOLACvtfcHk0liZ7BOYy-bAAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO&md5=7797450a99abb4a4c8e2492eb8a43dd7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191219935%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DPl%25C3%25A9%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DThe%2520azaindole%2520framework%2520in%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D19935%26epage%3D19979%26doi%3D10.3390%2Fmolecules191219935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurwitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massagué, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/376313a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2F376313a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=7630397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaK2MXnt1Sjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=313-320&author=P.+D.+Jeffreyauthor=A.+A.+Russoauthor=K.+Polyakauthor=E.+Gibbsauthor=J.+Hurwitzauthor=J.+Massagu%C3%A9author=N.+P.+Pavletich&title=Mechanism+of+CDK+activation+revealed+by+the+structure+of+a+cyclinA-CDK2+complex&doi=10.1038%2F376313a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex</span></div><div class="casAuthors">Jeffrey, Philip D.; Russo, Alicia A.; Polyak, Kornelia; Gibbs, Emma; Hurwitz, Jerard; Massague, Joan; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6538</span>),
    <span class="NLM_cas:pages">313-20</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of the human cyclin A-cyclin-dependent kinase 2 (CDK2)-ATP complex was detd. at 2.3 Å resoln.  Cyclin A was found to bind to one side of the catalytic cleft of CDK2, inducing large conformational changes in its PSTAIRE helix and T-loop.  These changes activate the kinase by realigning active site residues and relieving the steric blockade at the entrance of the catalytic cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj6tVVZjR6SrVg90H21EOLACvtfcHk0liZ7BOYy-bAAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt1Sjsrk%253D&md5=582f0a3741e0417ff650c3172b39249c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F376313a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376313a0%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPolyak%26aufirst%3DK.%26aulast%3DGibbs%26aufirst%3DE.%26aulast%3DHurwitz%26aufirst%3DJ.%26aulast%3DMassagu%25C3%25A9%26aufirst%3DJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DMechanism%2520of%2520CDK%2520activation%2520revealed%2520by%2520the%2520structure%2520of%2520a%2520cyclinA-CDK2%2520complex%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D313%26epage%3D320%26doi%3D10.1038%2F376313a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horatscheck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basarab, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyermann, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Plasmodial kinase inhibitors: license to cure?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8061</span>– <span class="NLM_lpage">8077</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12ltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8061-8077&author=D.+G.+Cabreraauthor=A.+Horatscheckauthor=C.+R.+Wilsonauthor=G.+Basarabauthor=C.+J.+Eyermannauthor=K.+Chibale&title=Plasmodial+kinase+inhibitors%3A+license+to+cure%3F&doi=10.1021%2Facs.jmedchem.8b00329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodial Kinase Inhibitors: License to Cure?</span></div><div class="casAuthors">Cabrera, Diego Gonzalez; Horatscheck, Andre; Wilson, Colin R.; Basarab, Greg; Eyermann, Charles J.; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8061-8077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Advances in the genetics, function, and stage-specificity of Plasmodium kinases has driven robust efforts to identify targets for the design of antimalarial therapies.  Reverse genomics following phenotypic screening against Plasmodia or related parasites has uncovered vulnerable kinase targets including PI4K, PKG, and GSK-3, an approach bolstered by access to human disease-directed kinase libraries.  Alternatively, screening compd. libraries against Plasmodium kinases has successfully led to inhibitors with antiplasmodial activity.  As with other therapeutic areas, optimizing compd. ADMET and PK properties in parallel with target inhibitory potency and whole cell activity becomes paramount toward advancing compds. as clin. candidates.  These and other considerations will be discussed in the context of progress achieved toward deriving important, novel mode-of-action kinase-inhibiting antimalarial medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI0bcml4uRWbVg90H21EOLACvtfcHk0lh1OGB3aKBdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12ltrg%253D&md5=274df0d629d4cf4fcb7a158e9e72aaab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00329%26sid%3Dliteratum%253Aachs%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DHoratscheck%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DC.%2BR.%26aulast%3DBasarab%26aufirst%3DG.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DPlasmodial%2520kinase%2520inhibitors%253A%2520license%2520to%2520cure%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8061%26epage%3D8077%26doi%3D10.1021%2Facs.jmedchem.8b00329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwicke, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koretke-Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newlander, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleykowski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarpong, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3973</span>– <span class="NLM_lpage">4001</span>, <span class="refDoi"> DOI: 10.1021/jm901870q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901870q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3973-4001&author=N.+D.+Adamsauthor=J.+L.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=R.+A.+Copelandauthor=C.+A.+Donatelliauthor=D.+H.+Drewryauthor=K.+E.+Fisherauthor=T.+Hamajimaauthor=M.+A.+Hardwickeauthor=W.+F.+Huffmanauthor=K.+K.+Koretke-Brownauthor=Z.+V.+Laiauthor=O.+B.+McDonaldauthor=H.+Nakamuraauthor=K.+A.+Newlanderauthor=C.+A.+Oleykowskiauthor=C.+A.+Parrishauthor=D.+R.+Patrickauthor=R.+Plantauthor=M.+A.+Sarpongauthor=K.+Sasakiauthor=S.+J.+Schmidtauthor=D.+J.+Silvaauthor=D.+Suttonauthor=J.+Tangauthor=C.+S.+Thompsonauthor=P.+J.+Tumminoauthor=J.+C.+Wangauthor=H.+Xiangauthor=J.+Yangauthor=D.+Dhanak&title=Discovery+of+GSK1070916%2C+a+potent+and+selective+inhibitor+of+Aurora+B%2FC+kinase&doi=10.1021%2Fjm901870q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase</span></div><div class="casAuthors">Adams, Nicholas D.; Adams, Jerry L.; Burgess, Joelle L.; Chaudhari, Amita M.; Copeland, Robert A.; Donatelli, Carla A.; Drewry, David H.; Fisher, Kelly E.; Hamajima, Toshihiro; Hardwicke, Mary Ann; Huffman, William F.; Koretke-Brown, Kristin K.; Lai, Zhihong V.; McDonald, Octerloney B.; Nakamura, Hiroko; Newlander, Ken A.; Oleykowski, Catherine A.; Parrish, Cynthia A.; Patrick, Denis R.; Plant, Ramona; Sarpong, Martha A.; Sasaki, Kosuke; Schmidt, Stanley J.; Silva, Domingos J.; Sutton, David; Tang, Jun; Thompson, Christine S.; Tummino, Peter J.; Wang, Jamin C.; Xiang, Hong; Yang, Jingsong; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3973-4001</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Aurora kinases play crit. roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors.  Selective inhibitors may provide a new therapy for the treatment of tumors with Aurora kinase amplification.  Herein we describe our lead optimization efforts within a 7-azaindole-based series culminating in the identification of GSK1070916 (17k).  Key to the advancement of the series was the introduction of a 2-aryl group contg. a basic amine onto the azaindole leading to significantly improved cellular activity.  Compd. 17k is a potent and selective ATP-competitive inhibitor of Aurora B and C with Ki* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, resp., and is >250-fold selective over Aurora A.  Biochem. characterization revealed that compd. 17k has an extremely slow dissocn. half-life from Aurora B (>480 min), distinguishing it from clin. compds. 1 and 2.  In vitro treatment of A549 human lung cancer cells with compd. 17k results in a potent antiproliferative effect (EC50 = 7 nM).  I.p. administration of 17k in mice bearing human tumor xenografts leads to inhibition of histone H3 phosphorylation at serine 10 in human colon cancer (Colo205) and tumor regression in human leukemia (HL-60).  Compd. 17k is being progressed to human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9vBAsDJpiNrVg90H21EOLACvtfcHk0lh1OGB3aKBdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChtrk%253D&md5=250f76a1ca89afdb94c7cbac4f37d11f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901870q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901870q%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DHamajima%26aufirst%3DT.%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DHuffman%26aufirst%3DW.%2BF.%26aulast%3DKoretke-Brown%26aufirst%3DK.%2BK.%26aulast%3DLai%26aufirst%3DZ.%2BV.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DOleykowski%26aufirst%3DC.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DPlant%26aufirst%3DR.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DSilva%26aufirst%3DD.%2BJ.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DC.%2BS.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK1070916%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520Aurora%2520B%252FC%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3973%26epage%3D4001%26doi%3D10.1021%2Fjm901870q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verbiscar, A. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 1-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol as a potential antimalarial agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1021/jm00272a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00272a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaE38XhtlGku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=149-152&author=A.+J.+Verbiscar&title=Synthesis+of+1-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol+as+a+potential+antimalarial+agent&doi=10.1021%2Fjm00272a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1-p-chlorobenzyl-7-azaindole-3-α-piperidylmethanol as a potential antimalarial agent</span></div><div class="casAuthors">Verbiscar, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-52</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">1-P-chlorobenzyl-7-azaindole-3-α-piperidylmethanol (I) [27413-43-0] was prepd. from 7-azaindole-3-carboxaldehyde, obtained by a Duff formylation of 7-azaindole with hexamethylenetetraamine in AcOH.  1-Alkylation gave 1-p-chlorobenzyl-7-azaindole-3-carboxaldehyde which was condensed with 2-pyridyllithium followed by low pressure hydrogenation to give I as mixed diastereoisomers.  A single diastereoisomer of I (obtained by fractional crystn.) has antimalarial activity against Plasmodium berghei in mice; 320 mg/kg increased mean survival time by 3.1 days.  The low activity of the mixed diastereoisomers indicated that one of the isomers was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMU9KtbFO7orVg90H21EOLACvtfcHk0lh1OGB3aKBdAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XhtlGku70%253D&md5=d3f42494e964d504643a435765fba2a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00272a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00272a008%26sid%3Dliteratum%253Aachs%26aulast%3DVerbiscar%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520of%25201-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol%2520as%2520a%2520potential%2520antimalarial%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D149%26epage%3D152%26doi%3D10.1021%2Fjm00272a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapozza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, D.</span></span> <span> </span><span class="NLM_article-title">Differences in conformational dynamics between plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2524</span>– <span class="NLM_lpage">2535</span>, <span class="refDoi"> DOI: 10.1021/jm401801t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401801t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlOlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2524-2535&author=T.+Wangauthor=W.+H.+Bissonauthor=P.+M%C3%A4serauthor=L.+Scapozzaauthor=D.+Picard&title=Differences+in+conformational+dynamics+between+plasmodium+falciparum+and+human+Hsp90+orthologues+enable+the+structure-based+discovery+of+pathogen-selective+inhibitors&doi=10.1021%2Fjm401801t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in Conformational Dynamics between Plasmodium falciparum and Human Hsp90 Orthologues Enable the Structure-Based Discovery of Pathogen-Selective Inhibitors</span></div><div class="casAuthors">Wang, Tai; Bisson, William H.; Maser, Pascal; Scapozza, Leonardo; Picard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2524-2535</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The high sequence conservation of druggable pockets of closely related proteins can make it challenging to develop selective inhibitors.  The authors designed a new drug discovery approach that exploits both the static and dynamic differences of two orthologues.  The authors applied it, as a proof of concept, to identify compds. that discriminate between the mol. chaperone Hsp90 of the protozoan pathogen Plasmodium falciparum (Pf) and that of its human host.  The authors found that the ATP-binding pocket has a Pf-specific extension, whose sequence lining is identical in human Hsp90 but which differs by tertiary structure and dynamics.  Using these insights for a structure-based drug screen, the authors discovered novel 7-azaindole compds. that exclusively bind the recombinant N-terminal domain of PfHsp90 but not of human Hsp90 nor of a PfHsp90 mutant with "human-like" dynamics.  Moreover, these compds. preferentially inhibit the growth of yeast complemented by PfHsp90 and block the growth of Pf in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHtrYEZf7JI7Vg90H21EOLACvtfcHk0lhy-pBbFP_3Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlOlsb8%253D&md5=748c9874b0d5e0e5beb03c70d16fe981</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm401801t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401801t%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBisson%26aufirst%3DW.%2BH.%26aulast%3DM%25C3%25A4ser%26aufirst%3DP.%26aulast%3DScapozza%26aufirst%3DL.%26aulast%3DPicard%26aufirst%3DD.%26atitle%3DDifferences%2520in%2520conformational%2520dynamics%2520between%2520plasmodium%2520falciparum%2520and%2520human%2520Hsp90%2520orthologues%2520enable%2520the%2520structure-based%2520discovery%2520of%2520pathogen-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2524%26epage%3D2535%26doi%3D10.1021%2Fjm401801t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barberis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorcroft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Mazza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majid, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of N -substituted 7-azaindoles as PIM1 kinase inhibitors - Part I</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4730</span>– <span class="NLM_lpage">4734</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.08.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2Fj.bmcl.2017.08.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=28947155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOisL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4730-4734&author=C.+Barberisauthor=N.+Moorcroftauthor=C.+Arendtauthor=M.+Levitauthor=S.+Moreno-Mazzaauthor=J.+Batchelorauthor=I.+Mechinauthor=T.+Majid&title=Discovery+of+N+-substituted+7-azaindoles+as+PIM1+kinase+inhibitors+-+Part+I&doi=10.1016%2Fj.bmcl.2017.08.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-substituted 7-azaindoles as PIM1 kinase inhibitors - Part I</span></div><div class="casAuthors">Barberis, Claude; Moorcroft, Neil; Arendt, Chris; Levit, Mikhail; Moreno-Mazza, Sandra; Batchelor, Joseph; Mechin, Ingrid; Majid, Tahir</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4730-4734</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel N-substituted azaindoles have been discovered as PIM1 inhibitors.  X-ray structures have played a significant role in orienting the chem. effort in the initial phase of hit confirmation.  Disclosure of an unconventional binding mode for 1 and 2, as demonstrated by X-ray crystallog., is presented and was an important factor in selecting and advancing a lead series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYw_Bc_I4re7Vg90H21EOLACvtfcHk0lhy-pBbFP_3Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOisL%252FI&md5=d24157fcc92dbf59d9e40936816a0467</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.08.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.08.069%26sid%3Dliteratum%253Aachs%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMoorcroft%26aufirst%3DN.%26aulast%3DArendt%26aufirst%3DC.%26aulast%3DLevit%26aufirst%3DM.%26aulast%3DMoreno-Mazza%26aufirst%3DS.%26aulast%3DBatchelor%26aufirst%3DJ.%26aulast%3DMechin%26aufirst%3DI.%26aulast%3DMajid%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520N%2520-substituted%25207-azaindoles%2520as%2520PIM1%2520kinase%2520inhibitors%2520-%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4730%26epage%3D4734%26doi%3D10.1016%2Fj.bmcl.2017.08.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zadjura, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiGiugno Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesenberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggers, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowicka-Sans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicker, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7778</span>– <span class="NLM_lpage">7787</span>, <span class="refDoi"> DOI: 10.1021/jm900843g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900843g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKns7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7778-7787&author=T.+Wangauthor=Z.+Yinauthor=Z.+Zhangauthor=J.+A.+Benderauthor=Z.+Yangauthor=G.+Johnsonauthor=Z.+Yangauthor=L.+M.+Zadjuraauthor=C.+J.+D%E2%80%99Arienzoauthor=D.+DiGiugno+Parkerauthor=C.+Gesenbergauthor=G.+A.+Yamanakaauthor=Y.-F.+Gongauthor=H.-T.+Hoauthor=H.+Fangauthor=N.+Zhouauthor=B.+V.+McAuliffeauthor=B.+J.+Eggersauthor=L.+Fanauthor=B.+Nowicka-Sansauthor=I.+B.+Dickerauthor=Q.+Gaoauthor=R.+J.+Colonnoauthor=P.-F.+Linauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Inhibitors+of+Human+Immunodeficiency+Virus+Type+1+%28HIV-1%29+Attachment.+5.+An+Evolution+from+Indole+to+Azaindoles+Leading+to+the+Discovery+of+1-%284-Benzoylpiperazin-1-yl%29-2-%284%2C7-dimethoxy-1H-pyrrolo%5B2%2C3-c%5Dpyridin-3-yl%29ethane-1%2C2-dione+%28BMS-488043%29%2C+a+Drug+Candidate+That+Demonstrates+Antiviral+Activity+in+HIV-1-Infected+Subjects&doi=10.1021%2Fjm900843g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects</span></div><div class="casAuthors">Wang, Tao; Yin, Zhiwei; Zhang, Zhongxing; Bender, John A.; Yang, Zhong; Johnson, Graham; Yang, Zheng; Zadjura, Lisa M.; D'Arienzo, Celia J.; DiGiugno Parker, Dawn; Gesenberg, Christophe; Yamanaka, Gregory A.; Gong, Yi-Fei; Ho, Hsu-Tso; Fang, Hua; Zhou, Nannan; McAuliffe, Brian V.; Eggers, Betsy J.; Fan, Li; Nowicka-Sans, Beata; Dicker, Ira B.; Gao, Qi; Colonno, Richard J.; Lin, Pin-Fang; Meanwell, Nicholas A.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7778-7787</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Azaindole derivs. derived from the screening lead 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione were prepd. and characterized to assess their potential as inhibitors of HIV-1 attachment.  Systematic replacement of each of the unfused carbon atoms in the Ph ring of the indole moiety by a nitrogen atom provided four different azaindole derivs. that displayed a clear SAR for antiviral activity and all of which displayed marked improvements in pharmaceutical properties.  Optimization of these azaindole leads resulted in the identification of two compds. that were advanced to clin. studies: (R)-1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione I, and 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione, II.  In a preliminary clin. study, II administered as monotherapy for 8 days, reduced viremia in HIV-1-infected subjects, providing proof of concept for this mechanistic class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr84dI0I-kTkrVg90H21EOLACvtfcHk0lhy-pBbFP_3Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKns7zK&md5=c381dc8129dcc2a36547db53aae3a654</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm900843g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900843g%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DJohnson%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZadjura%26aufirst%3DL.%2BM.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DDiGiugno%2BParker%26aufirst%3DD.%26aulast%3DGesenberg%26aufirst%3DC.%26aulast%3DYamanaka%26aufirst%3DG.%2BA.%26aulast%3DGong%26aufirst%3DY.-F.%26aulast%3DHo%26aufirst%3DH.-T.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DMcAuliffe%26aufirst%3DB.%2BV.%26aulast%3DEggers%26aufirst%3DB.%2BJ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DNowicka-Sans%26aufirst%3DB.%26aulast%3DDicker%26aufirst%3DI.%2BB.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DLin%26aufirst%3DP.-F.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DInhibitors%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520%2528HIV-1%2529%2520Attachment.%25205.%2520An%2520Evolution%2520from%2520Indole%2520to%2520Azaindoles%2520Leading%2520to%2520the%2520Discovery%2520of%25201-%25284-Benzoylpiperazin-1-yl%2529-2-%25284%252C7-dimethoxy-1H-pyrrolo%255B2%252C3-c%255Dpyridin-3-yl%2529ethane-1%252C2-dione%2520%2528BMS-488043%2529%252C%2520a%2520Drug%2520Candidate%2520That%2520Demonstrates%2520Antiviral%2520Activity%2520in%2520HIV-1-Infected%2520Subjects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7778%26epage%3D7787%26doi%3D10.1021%2Fjm900843g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span> <span> </span><span class="NLM_article-title">Vemurafenib: the first drug approved for BRAF-mutant cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1038/nrd3847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fnrd3847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23060265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=873-886&author=G.+Bollagauthor=J.+Tsaiauthor=J.+Zhangauthor=C.+Zhangauthor=P.+Ibrahimauthor=K.+Nolopauthor=P.+Hirth&title=Vemurafenib%3A+the+first+drug+approved+for+BRAF-mutant+cancer&doi=10.1038%2Fnrd3847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Vemurafenib: the first drug approved for BRAF-mutant cancer</span></div><div class="casAuthors">Bollag, Gideon; Tsai, James; Zhang, Jiazhong; Zhang, Chao; Ibrahim, Prabha; Nolop, Keith; Hirth, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">873-886</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The identification of driver oncogenes has provided important targets for drugs that can change the landscape of cancer therapies.  One such example is the BRAF oncogene, which is found in about half of all melanomas as well as several other cancers.  As a druggable kinase, oncogenic BRAF has become a crucial target of small-mol. drug discovery efforts.  Following a rapid clin. development path, vemurafenib (Zelboraf; Plexxikon/Roche) was approved for the treatment of BRAF-mutated metastatic melanoma in the United States in August 2011 and the European Union in Feb. 2012.  This Review describes the underlying biol. of BRAF, the technol. used to identify vemurafenib and its clin. development milestones, along with future prospects based on lessons learned during its development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT6Fbb43oRTbVg90H21EOLACvtfcHk0lgZ-4n9_roh7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rsLjL&md5=b1b38cad542be9b3a30060b77c584bc1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3847%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26atitle%3DVemurafenib%253A%2520the%2520first%2520drug%2520approved%2520for%2520BRAF-mutant%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D873%26epage%3D886%26doi%3D10.1038%2Fnrd3847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carias, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesch, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5689</span>– <span class="NLM_lpage">5694</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219457110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1073%2Fpnas.1219457110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23493555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5689-5694&author=C.+Zhangauthor=P.+N.+Ibrahimauthor=J.+Zhangauthor=E.+A.+Burtonauthor=G.+Habetsauthor=Y.+Zhangauthor=B.+Powellauthor=B.+L.+Westauthor=B.+Matusowauthor=G.+Tsangauthor=R.+Shellooeauthor=H.+Cariasauthor=H.+Nguyenauthor=A.+Marimuthuauthor=K.+Y.+J.+Zhangauthor=A.+Ohauthor=R.+Bremerauthor=C.+R.+Hurtauthor=D.+R.+Artisauthor=G.+Wuauthor=M.+Nespiauthor=W.+Spevakauthor=P.+Linauthor=K.+Nolopauthor=P.+Hirthauthor=G.+H.+Teschauthor=G.+Bollag&title=Design+and+pharmacology+of+a+highly+specific+dual+FMS+and+KIT+kinase+inhibitor&doi=10.1073%2Fpnas.1219457110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span></div><div class="casAuthors">Zhang, Chao; Ibrahim, Prabha N.; Zhang, Jiazhong; Burton, Elizabeth A.; Habets, Gaston; Zhang, Ying; Powell, Ben; West, Brian L.; Matusow, Bernice; Tsang, Garson; Shellooe, Rafe; Carias, Heidi; Nguyen, Hoa; Marimuthu, Adhirai; Zhang, Kam Y. J.; Oh, Angela; Bremer, Ryan; Hurt, Clarence R.; Artis, Dean R.; Wu, Guoxian; Nespi, Marika; Spevak, Wayne; Lin, Paul; Nolop, Keith; Hirth, Peter; Tesch, Greg H.; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5689-5694, S5689/1-S5689/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inflammation and cancer, two therapeutic areas historically addressed by sep. drug discovery efforts, are now coupled in treatment approaches by a growing understanding of the dynamic mol. dialogues between immune and cancer cells.  Agents that target specific compartments of the immune system, therefore, not only bring new disease modifying modalities to inflammatory diseases, but also offer a new avenue to cancer therapy by disrupting immune components of the microenvironment that foster tumor growth, progression, immune evasion, and treatment resistance.  McDonough feline sarcoma viral (v-fms) oncogene homolog (FMS) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) are two hematopoietic cell surface receptors that regulate the development and function of macrophages and mast cells, resp.  The authors disclose a highly specific dual FMS and KIT kinase inhibitor developed from a multifaceted chem. scaffold.  As expected, this inhibitor blocks the activation of macrophages, osteoclasts, and mast cells controlled by these two receptors.  More importantly, the dual FMS and KIT inhibition profile has translated into a combination of benefits in preclin. disease models of inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofECnjzEONuLVg90H21EOLACvtfcHk0lgZ-4n9_roh7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D&md5=e4fbca9d41f95718a5119a08a54f5acc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219457110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219457110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCarias%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DHurt%26aufirst%3DC.%2BR.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTesch%26aufirst%3DG.%2BH.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDesign%2520and%2520pharmacology%2520of%2520a%2520highly%2520specific%2520dual%2520FMS%2520and%2520KIT%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D5689%26epage%3D5694%26doi%3D10.1073%2Fpnas.1219457110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crafter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, R. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2059</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1021/jm301762v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301762v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2059-2073&author=M.+Addieauthor=P.+Ballardauthor=D.+Buttarauthor=C.+Crafterauthor=G.+Currieauthor=B.+R.+Daviesauthor=J.+Debreczeniauthor=H.+Dryauthor=P.+Dudleyauthor=R.+Greenwoodauthor=P.+D.+Johnsonauthor=J.+G.+Kettleauthor=C.+Laneauthor=G.+Lamontauthor=A.+Leachauthor=R.+W.+A.+Lukeauthor=J.+Morrisauthor=D.+Ogilvieauthor=K.+Pageauthor=M.+Passauthor=S.+Pearsonauthor=L.+Ruston&title=Discovery+of+4-Amino-N-%5B%281S%29-1-%284-chlorophenyl%29-3-hydroxypropyl%5D-1-%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29piperidine-4-carboxamide+%28AZD5363%29%2C+an+Orally+Bioavailable%2C+Potent+Inhibitor+of+Akt+Kinases&doi=10.1021%2Fjm301762v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases</span></div><div class="casAuthors">Addie, Matt; Ballard, Peter; Buttar, David; Crafter, Claire; Currie, Gordon; Davies, Barry R.; Debreczeni, Judit; Dry, Hannah; Dudley, Philippa; Greenwood, Ryan; Johnson, Paul D.; Kettle, Jason G.; Lane, Clare; Lamont, Gillian; Leach, Andrew; Luke, Richard W. A.; Morris, Jeff; Ogilvie, Donald; Page, Ken; Pass, Martin; Pearson, Stuart; Ruston, Linette</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2059-2073</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-aralkyl aminopyrrolopyrimidinylpiperidinecarboxamides such as I (AZD5363) were prepd. as inhibitors of Akt kinases, particularly Akt1, Akt2, and Akt3 kinases, for potential use as antitumor agents based on a collaboratively-identified ATP-competitive pyrrolopyrimidine inhibitor of Akt kinases.  The selectivities of N-aralkyl aminopyrrolopyrimidinylpiperidinecarboxamides for Akt 1, Akt2, and Akt3 over ROCK2 and the hERG ion channel, their octanol-water partition coeffs., and their aq. solubilities were detd.  The oral pharmacokinetics of I in mice, rats, and dogs and the plasma protein binding of I in people, the inhibition of a panel of 75 kinases by I, and the activity of I against human cancer cell lines (particularly breast and prostate cancer) were detd.; I showed pharmacodynamic knockdown of phosphorylation of Akt and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.  The structure of I bound to Akt1 was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFU3WrUUalYLVg90H21EOLACvtfcHk0ljyDeco1BJG8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsrw%253D&md5=847a03b036460fc14d85c860b0d08f5a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301762v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301762v%26sid%3Dliteratum%253Aachs%26aulast%3DAddie%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DButtar%26aufirst%3DD.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DCurrie%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DDry%26aufirst%3DH.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DLane%26aufirst%3DC.%26aulast%3DLamont%26aufirst%3DG.%26aulast%3DLeach%26aufirst%3DA.%26aulast%3DLuke%26aufirst%3DR.%2BW.%2BA.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DOgilvie%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DPearson%26aufirst%3DS.%26aulast%3DRuston%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204-Amino-N-%255B%25281S%2529-1-%25284-chlorophenyl%2529-3-hydroxypropyl%255D-1-%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529piperidine-4-carboxamide%2520%2528AZD5363%2529%252C%2520an%2520Orally%2520Bioavailable%252C%2520Potent%2520Inhibitor%2520of%2520Akt%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2059%26epage%3D2073%26doi%3D10.1021%2Fjm301762v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van
Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeuvray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span> <span> </span><span class="NLM_article-title">Designing the next generation of medicines for malaria control and eradication</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">187</span>, <span class="refDoi"> DOI: 10.1186/1475-2875-12-187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1186%2F1475-2875-12-187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23742293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=187&author=J.+N.+Burrowsauthor=R.+Hooft+van%0AHuijsduijnenauthor=J.+J.+M%C3%B6hrleauthor=C.+Oeuvrayauthor=T.+N.+Wells&title=Designing+the+next+generation+of+medicines+for+malaria+control+and+eradication&doi=10.1186%2F1475-2875-12-187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Designing the next generation of medicines for malaria control and eradication</span></div><div class="casAuthors">Burrows Jeremy N; van Huijsduijnen Rob Hooft; Mohrle Jorg J; Oeuvray Claude; Wells Timothy N C</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the fight against malaria new medicines are an essential weapon.  For the parts of the world where the current gold standard artemisinin combination therapies are active, significant improvements can still be made: for example combination medicines which allow for single dose regimens, cheaper, safer and more effective medicines, or improved stability under field conditions.  For those parts of the world where the existing combinations show less than optimal activity, the priority is to have activity against emerging resistant strains, and other criteria take a secondary role.  For new medicines to be optimal in malaria control they must also be able to reduce transmission and prevent relapse of dormant forms: additional constraints on a combination medicine.  In the absence of a highly effective vaccine, new medicines are also needed to protect patient populations.  In this paper, an outline definition of the ideal and minimally acceptable characteristics of the types of clinical candidate molecule which are needed (target candidate profiles) is suggested.  In addition, the optimal and minimally acceptable characteristics of combination medicines are outlined (target product profiles).  MMV presents now a suggested framework for combining the new candidates to produce the new medicines.  Sustained investment over the next decade in discovery and development of new molecules is essential to enable the long-term delivery of the medicines needed to combat malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjy7sj0k3cHtFxYDaSSP8XfW6udTcc2eYzOz1cIJvTd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D&md5=c4283af83b04bc217f40528dde196e23</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-187%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DOeuvray%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DDesigning%2520the%2520next%2520generation%2520of%2520medicines%2520for%2520malaria%2520control%2520and%2520eradication%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D187%26doi%3D10.1186%2F1475-2875-12-187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span> <span> </span><span class="NLM_article-title">New developments in anti-malarial target candidate and product profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>, <span class="refDoi"> DOI: 10.1186/s12936-017-1809-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+H.+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+M%C3%B6hrleauthor=T.+N.+Wells&title=New+developments+in+anti-malarial+target+candidate+and+product+profiles&doi=10.1186%2Fs12936-017-1809-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0ljyDeco1BJG8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DNew%2520developments%2520in%2520anti-malarial%2520target%2520candidate%2520and%2520product%2520profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26doi%3D10.1186%2Fs12936-017-1809-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H. C.</span>, <span class="NLM_string-name">Santiago, A. S.</span>, <span class="NLM_string-name">Ramos, P. Z.</span>, <span class="NLM_string-name">Fala, A. M.</span>, <span class="NLM_string-name">Salmazo, A. P. T.</span>, <span class="NLM_string-name">Counago, R. M.</span>, <span class="NLM_string-name">Righetto, G. L.</span>, <span class="NLM_string-name">Silva, P. N. B.</span>, <span class="NLM_string-name">Gileadi, O.</span>, <span class="NLM_string-name">Guimaraes, C. R. W.</span>, <span class="NLM_string-name">Massirer, K. B.</span>, <span class="NLM_string-name">Arruda, P.</span>, <span class="NLM_string-name">Elkins, J. M.</span>, <span class="NLM_string-name">Edwards, A. M.</span></span> <i>Crystal structure of the human PRPF4B in complex with Rebastinib</i>; <span class="NLM_publisher-name">Structural Genomics Consortium (SGC)</span> <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+H.+C.+Godoi&author=A.+S.+Santiago&author=P.+Z.+Ramos&author=A.+M.+Fala&author=A.+P.+T.+Salmazo&author=R.+M.+Counago&author=G.+L.+Righetto&author=P.+N.+B.+Silva&author=O.+Gileadi&author=C.+R.+W.+Guimaraes&author=K.+B.+Massirer&author=P.+Arruda&author=J.+M.+Elkins&author=A.+M.+Edwards&title=Crystal+structure+of+the+human+PRPF4B+in+complex+with+Rebastinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGodoi%26aufirst%3DP.%2BH.%2BC.%26jtitle%3DCrystal%2520structure%2520of%2520the%2520human%2520PRPF4B%2520in%2520complex%2520with%2520Rebastinib%26pub%3DStructural%2520Genomics%2520Consortium%2520%2528SGC%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liddle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousins, R. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heathcote, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Molina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tape, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, R. A.</span></span> <span> </span><span class="NLM_article-title">4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5222</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2Fj.bmcl.2012.06.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22801646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5222&author=J.+Liddleauthor=P.+Bamboroughauthor=M.+D.+Barkerauthor=S.+Camposauthor=C.-W.+Chungauthor=R.+P.+C.+Cousinsauthor=P.+Faulderauthor=M.+L.+Heathcoteauthor=H.+Hobbsauthor=D.+S.+Holmesauthor=C.+Ioannouauthor=C.+Ramirez-Molinaauthor=M.+A.+Morseauthor=R.+Osbornauthor=J.+J.+Payneauthor=J.+M.+Pritchardauthor=W.+L.+Rumseyauthor=D.+T.+Tapeauthor=G.+Vicentiniauthor=C.+Whitworthauthor=R.+A.+Williamson&title=4-Phenyl-7-azaindoles+as+potent%2C+selective+and+bioavailable+IKK2+inhibitors+demonstrating+good+in+vivo+efficacy&doi=10.1016%2Fj.bmcl.2012.06.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy</span></div><div class="casAuthors">Liddle, John; Bamborough, Paul; Barker, Michael D.; Campos, Sebastien; Chung, Chun-Wa; Cousins, Rick P. C.; Faulder, Paul; Heathcote, Michelle L.; Hobbs, Heather; Holmes, Duncan S.; Ioannou, Chris; Ramirez-Molina, Cesar; Morse, Mary A.; Osborn, Ruth; Payne, Jeremy J.; Pritchard, John M.; Rumsey, William L.; Tape, Daniel T.; Vicentini, Giorgia; Whitworth, Caroline; Williamson, Rick A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5222-5226</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The lead optimization of a series of potent azaindole IKK2 inhibitors is described.  Optimization of the human whole blood activity and selectivity over IKK1 in parallel led to the discovery of 16, a potent and selective IKK2 inhibitor showing good efficacy in a rat model of neutrophil activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDgiw_Aw0Bc7Vg90H21EOLACvtfcHk0lhbhD2vq4-5Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjsbvE&md5=0cf65e328cf53e8ba1f72b1f08ad22bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBarker%26aufirst%3DM.%2BD.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCousins%26aufirst%3DR.%2BP.%2BC.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DHeathcote%26aufirst%3DM.%2BL.%26aulast%3DHobbs%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DIoannou%26aufirst%3DC.%26aulast%3DRamirez-Molina%26aufirst%3DC.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOsborn%26aufirst%3DR.%26aulast%3DPayne%26aufirst%3DJ.%2BJ.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DTape%26aufirst%3DD.%2BT.%26aulast%3DVicentini%26aufirst%3DG.%26aulast%3DWhitworth%26aufirst%3DC.%26aulast%3DWilliamson%26aufirst%3DR.%2BA.%26atitle%3D4-Phenyl-7-azaindoles%2520as%2520potent%252C%2520selective%2520and%2520bioavailable%2520IKK2%2520inhibitors%2520demonstrating%2520good%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5222%26doi%3D10.1016%2Fj.bmcl.2012.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nwakanma, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amambua-Ngwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oriero, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojang, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakeley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacInnis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D. J.</span></span> <span> </span><span class="NLM_article-title">Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>209</i></span>,  <span class="NLM_fpage">1126</span>, <span class="refDoi"> DOI: 10.1093/infdis/jit618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1093%2Finfdis%2Fjit618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=24265439" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2013&pages=1126&author=D.+C.+Nwakanmaauthor=C.+W.+Duffyauthor=A.+Amambua-Ngwaauthor=E.+C.+Orieroauthor=K.+A.+Bojangauthor=M.+Pinderauthor=C.+J.+Drakeleyauthor=C.+J.+Sutherlandauthor=P.+J.+Milliganauthor=B.+MacInnisauthor=D.+P.+Kwiatkowskiauthor=T.+G.+Clarkauthor=B.+M.+Greenwoodauthor=D.+J.+Conway&title=Changes+in+malaria+parasite+drug+resistance+in+an+endemic+population+over+a+25-year+period+with+resulting+genomic+evidence+of+selection&doi=10.1093%2Finfdis%2Fjit618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjit618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjit618%26sid%3Dliteratum%253Aachs%26aulast%3DNwakanma%26aufirst%3DD.%2BC.%26aulast%3DDuffy%26aufirst%3DC.%2BW.%26aulast%3DAmambua-Ngwa%26aufirst%3DA.%26aulast%3DOriero%26aufirst%3DE.%2BC.%26aulast%3DBojang%26aufirst%3DK.%2BA.%26aulast%3DPinder%26aufirst%3DM.%26aulast%3DDrakeley%26aufirst%3DC.%2BJ.%26aulast%3DSutherland%26aufirst%3DC.%2BJ.%26aulast%3DMilligan%26aufirst%3DP.%2BJ.%26aulast%3DMacInnis%26aufirst%3DB.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DClark%26aufirst%3DT.%2BG.%26aulast%3DGreenwood%26aufirst%3DB.%2BM.%26aulast%3DConway%26aufirst%3DD.%2BJ.%26atitle%3DChanges%2520in%2520malaria%2520parasite%2520drug%2520resistance%2520in%2520an%2520endemic%2520population%2520over%2520a%252025-year%2520period%2520with%2520resulting%2520genomic%2520evidence%2520of%2520selection%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D209%26spage%3D1126%26doi%3D10.1093%2Finfdis%2Fjit618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amambua-Ngwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okebe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceesay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Fatouri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joof, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, O.</span></span> <span> </span><span class="NLM_article-title">Sustained ex vivo susceptibility of plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in The Gambia</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e00759</span> <span class="refDoi"> DOI: 10.1128/aac.00759-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1128%2FAAC.00759-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=28971859" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=A.+Amambua-Ngwaauthor=J.+Okebeauthor=H.+Mbyeauthor=S.+Ceesayauthor=F.+El-Fatouriauthor=F.+Joofauthor=H.+Nyangauthor=R.+Janhaauthor=M.+Affaraauthor=A.+Ahmadauthor=O.+Kolly&title=Sustained+ex+vivo+susceptibility+of+plasmodium+falciparum+to+artemisinin+derivatives+but+increasing+tolerance+to+artemisinin+combination+therapy+partner+quinolines+in+The+Gambia&doi=10.1128%2Faac.00759-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FAAC.00759-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00759-17%26sid%3Dliteratum%253Aachs%26aulast%3DAmambua-Ngwa%26aufirst%3DA.%26aulast%3DOkebe%26aufirst%3DJ.%26aulast%3DMbye%26aufirst%3DH.%26aulast%3DCeesay%26aufirst%3DS.%26aulast%3DEl-Fatouri%26aufirst%3DF.%26aulast%3DJoof%26aufirst%3DF.%26aulast%3DNyang%26aufirst%3DH.%26aulast%3DJanha%26aufirst%3DR.%26aulast%3DAffara%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DKolly%26aufirst%3DO.%26atitle%3DSustained%2520ex%2520vivo%2520susceptibility%2520of%2520plasmodium%2520falciparum%2520to%2520artemisinin%2520derivatives%2520but%2520increasing%2520tolerance%2520to%2520artemisinin%2520combination%2520therapy%2520partner%2520quinolines%2520in%2520The%2520Gambia%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2Faac.00759-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chausset-Boissarie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Àrvai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guénée, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kündig, E. P.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of (+)-vertine and (+)-lythrine</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6473</span>– <span class="NLM_lpage">6479</span>, <span class="refDoi"> DOI: 10.1039/c2ob25880c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1039%2Fc2ob25880c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22763639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSlsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=6473-6479&author=L.+Chausset-Boissarieauthor=R.+%C3%80rvaiauthor=G.+R.+Cummingauthor=L.+Gu%C3%A9n%C3%A9eauthor=E.+P.+K%C3%BCndig&title=Asymmetric+synthesis+of+%28%2B%29-vertine+and+%28%2B%29-lythrine&doi=10.1039%2Fc2ob25880c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of (+)-vertine and (+)-lythrine</span></div><div class="casAuthors">Chausset-Boissarie, Laetitia; Arvai, Roman; Cumming, Graham R.; Guenee, Laure; Kundig, E. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">6473-6479</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The total syntheses of the Lythracea alkaloids (+)-vertine and (+)-lythrine are described.  Enantioenriched pelletierine is used as a chiral building block and engaged into a two step pelletierine condensation leading to two quinolizidin-2-one diastereomers in a 8:1 ratio.  The major product is used in the synthesis of (+)-vertine (I) via aryl-aryl coupling and ring closing metathesis to provide a Z-alkene α to the lactone carbonyl function.  The same procedure was used for (+)-lythrine after base induced epimerization of the main quinolizidin-2-one diastereomer.  Alternative classical ring closure strategies like macrolactonization or aryl-aryl coupling failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7P9wTZFNNLVg90H21EOLACvtfcHk0lhbhD2vq4-5Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSlsLbF&md5=aa9583e5ffae311f2155bda21e52714e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25880c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25880c%26sid%3Dliteratum%253Aachs%26aulast%3DChausset-Boissarie%26aufirst%3DL.%26aulast%3D%25C3%2580rvai%26aufirst%3DR.%26aulast%3DCumming%26aufirst%3DG.%2BR.%26aulast%3DGu%25C3%25A9n%25C3%25A9e%26aufirst%3DL.%26aulast%3DK%25C3%25BCndig%26aufirst%3DE.%2BP.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%2528%252B%2529-vertine%2520and%2520%2528%252B%2529-lythrine%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D6473%26epage%3D6479%26doi%3D10.1039%2Fc2ob25880c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dluzewski, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’donnell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withers-Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M. J.</span></span> <span> </span><span class="NLM_article-title">Molecular identification of a malaria merozoite surface sheddase</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e29</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.0010029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1371%2Fjournal.ppat.0010029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&author=P.+K.+Harrisauthor=S.+Yeohauthor=A.+R.+Dluzewskiauthor=R.+A.+O%E2%80%99donnellauthor=C.+Withers-Martinezauthor=F.+Hackettauthor=L.+H.+Bannisterauthor=G.+H.+Mitchellauthor=M.+J.+Blackman&title=Molecular+identification+of+a+malaria+merozoite+surface+sheddase&doi=10.1371%2Fjournal.ppat.0010029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.0010029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.0010029%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DYeoh%26aufirst%3DS.%26aulast%3DDluzewski%26aufirst%3DA.%2BR.%26aulast%3DO%25E2%2580%2599donnell%26aufirst%3DR.%2BA.%26aulast%3DWithers-Martinez%26aufirst%3DC.%26aulast%3DHackett%26aufirst%3DF.%26aulast%3DBannister%26aufirst%3DL.%2BH.%26aulast%3DMitchell%26aufirst%3DG.%2BH.%26aulast%3DBlackman%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520identification%2520of%2520a%2520malaria%2520merozoite%2520surface%2520sheddase%26jtitle%3DPLoS%2520Pathog.%26date%3D2005%26volume%3D1%26doi%3D10.1371%2Fjournal.ppat.0010029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roncalés, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span> <span> </span><span class="NLM_article-title">In Vitro culture of plasmodium falciparum obtention of synchronous asexual erythrocytic stages</span>. <i>Open J. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>05</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.4236/ojepi.2015.51010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.4236%2Fojepi.2015.51010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=05&publication_year=2015&pages=71-80&author=M.+Roncal%C3%A9sauthor=J.+Vidalauthor=P.+A.+Torresauthor=E.+Herreros&title=In+Vitro+culture+of+plasmodium+falciparum+obtention+of+synchronous+asexual+erythrocytic+stages&doi=10.4236%2Fojepi.2015.51010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4236%2Fojepi.2015.51010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fojepi.2015.51010%26sid%3Dliteratum%253Aachs%26aulast%3DRoncal%25C3%25A9s%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DTorres%26aufirst%3DP.%2BA.%26aulast%3DHerreros%26aufirst%3DE.%26atitle%3DIn%2520Vitro%2520culture%2520of%2520plasmodium%2520falciparum%2520obtention%2520of%2520synchronous%2520asexual%2520erythrocytic%2520stages%26jtitle%3DOpen%2520J.%2520Epidemiol.%26date%3D2015%26volume%3D05%26spage%3D71%26epage%3D80%26doi%3D10.4236%2Fojepi.2015.51010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lh9onRyNo9iow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valkó, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D.</span></span> <span> </span><span class="NLM_article-title">Chromatographic hydrophobicity index by fast-gradient RP-HPLC: a high-throughput alternative to log P/log D</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2022</span>– <span class="NLM_lpage">2029</span>, <span class="refDoi"> DOI: 10.1021/ac961242d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac961242d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaK2sXivVertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=2022-2029&author=K.+Valk%C3%B3author=C.+Bevanauthor=D.+Reynolds&title=Chromatographic+hydrophobicity+index+by+fast-gradient+RP-HPLC%3A+a+high-throughput+alternative+to+log+P%2Flog+D&doi=10.1021%2Fac961242d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to Log P/log D</span></div><div class="casAuthors">Valko, Klara; Bevan, Chris; Reynolds, Derek</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2022-2029</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new chromatog. hydrophobicity index (CHI) is described which can be used as part of a protocol for high-throughput (50-100 compds./day) physicochem. property profiling for rational drug design.  The index is derived from retention times (tR) obsd. in a fast gradient reversed-phase HPLC method.  The isocratic retention factors (log k') were measured for a series of 76 structurally unrelated compds. by using various concns. of acetonitrile in the mobile phase.  By plotting the log k' as a function of the acetonitrile concn., the slope (S) and the intercept (log k'w) values were calcd.  The previously validated index of hydrophobicity φ0 was calcd. as -log k'w/S.  A good linear correlation was obtained between the gradient retention time values, tR and the isocratically detd. φ0 values for the 76 compds.  The consts. of this linear correlation can be used to calc. CHI.  For most compds., CHI is between 0 and 100 and in this range it approximates to the percentage (by vol.) of acetonitrile required to achieve an equal distribution of compd. between the mobile and the stationary phases.  CHI values can be measured using acidic, neutral, or slightly basic eluents.  Values corresponding to the neutral form of mols. could be measured for 52 of the compds. and showed good correlation (r = 0.851) to the calcd. octanol/water partition coeff. (c log P) values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozvQI1B1cnpbVg90H21EOLACvtfcHk0lh9onRyNo9iow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVertLs%253D&md5=fcbb641105c12dc490d4a20db8fc5032</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fac961242d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac961242d%26sid%3Dliteratum%253Aachs%26aulast%3DValk%25C3%25B3%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DChromatographic%2520hydrophobicity%2520index%2520by%2520fast-gradient%2520RP-HPLC%253A%2520a%2520high-throughput%2520alternative%2520to%2520log%2520P%252Flog%2520D%26jtitle%3DAnal.%2520Chem.%26date%3D1997%26volume%3D69%26spage%3D2022%26epage%3D2029%26doi%3D10.1021%2Fac961242d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/bj20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2Fbj20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lj-mEwOPHgPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2Fbj20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lauren B. Arendse, Susan Wyllie, Kelly Chibale, <span class="NLM_string-name hlFld-ContribAuthor">Ian H. Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (3)
                                     , 518-534. <a href="https://doi.org/10.1021/acsinfecdis.0c00724" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00724%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DPlasmodium%252BKinases%252Bas%252BPotential%252BDrug%252BTargets%252Bfor%252BMalaria%25253A%252BChallenges%252Band%252BOpportunities%26aulast%3DArendse%26aufirst%3DLauren%2BB.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15102020%26date%3D16022021%26volume%3D7%26issue%3D3%26spage%3D518%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattias F.  Lindberg</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 6047. <a href="https://doi.org/10.3390/ijms22116047" title="DOI URL">https://doi.org/10.3390/ijms22116047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22116047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22116047%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual-Specificity%25252C%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRKs%252529%252Band%252Bcdc2-Like%252BKinases%252B%252528CLKs%252529%252Bin%252BHuman%252BDisease%25252C%252Ban%252BOverview%26aulast%3DLindberg%26aufirst%3DMattias%2BF.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D6047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack  Adderley</span>, <span class="hlFld-ContribAuthor ">Tayla  Williamson</span>, <span class="hlFld-ContribAuthor ">Christian  Doerig</span>. </span><span class="cited-content_cbyCitation_article-title">Parasite and Host Erythrocyte Kinomics of Plasmodium Infection. </span><span class="cited-content_cbyCitation_journal-name">Trends in Parasitology</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.1016/j.pt.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.pt.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pt.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pt.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Parasitology%26atitle%3DParasite%252Band%252BHost%252BErythrocyte%252BKinomics%252Bof%252BPlasmodium%252BInfection%26aulast%3DAdderley%26aufirst%3DJack%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Mustière</span>, <span class="hlFld-ContribAuthor ">Patrice  Vanelle</span>, <span class="hlFld-ContribAuthor ">Nicolas  Primas</span>. </span><span class="cited-content_cbyCitation_article-title">Plasmodial Kinase Inhibitors Targeting Malaria: Recent Developments. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5949. <a href="https://doi.org/10.3390/molecules25245949" title="DOI URL">https://doi.org/10.3390/molecules25245949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245949%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPlasmodial%252BKinase%252BInhibitors%252BTargeting%252BMalaria%25253A%252BRecent%252BDevelopments%26aulast%3DMusti%25C3%25A8re%26aufirst%3DRomain%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Martín Moyano</span>, <span class="hlFld-ContribAuthor ">Václav  Němec</span>, <span class="hlFld-ContribAuthor ">Kamil  Paruch</span>. </span><span class="cited-content_cbyCitation_article-title">Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7549. <a href="https://doi.org/10.3390/ijms21207549" title="DOI URL">https://doi.org/10.3390/ijms21207549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207549%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCdc-Like%252BKinases%252B%252528CLKs%252529%25253A%252BBiology%25252C%252BChemical%252BProbes%25252C%252Band%252BTherapeutic%252BPotential%26aulast%3DMart%25C3%25ADn%2BMoyano%26aufirst%3DPaula%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and biological profile of hit PfCLK3 inhibitor TCMDC-135051, <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Aurora kinase inhibitor GSK1070916, (B) 1-<i>p</i>-chlorobenzyl-7-azaindole-3-α-piperidylmethanol has in vivo activity against <i>P. berghei</i>, (C) PfHsp90 inhibitor IND31119, and (D) drug candidates incorporating a core 7-azaindole scaffold, vemurafenib, PLX3397, and AZD5363.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of TCMDC-135051 <b>1</b> and Analogues <b>8a–c</b> & <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) TsCl, NaH, THF, 0 °C, 2 h; (ii) LDA, I<sub>2</sub>, THF, −78 °C, 3 h; (iii) (5-formyl-2-methoxyphenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 12 h; (iv) amine, NaBH(AcO)<sub>3</sub>, 1,4-dioxane, 20 °C, 12 h; (v) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 55 °C, 18 h; (vi) 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 0.5 h, MW; and (vii) SOCl<sub>2</sub>, CH<sub>3</sub>CH<sub>2</sub>OH, reflux, 18 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-(2-(5-(Aminomethyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 18 h; (ii) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 55 °C, 18 h; (iii) 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, Pd(dppf)Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 0.5 h, MW; and (iv) CoCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, CH<sub>3</sub>OH.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Isopropyl-4-(2-(2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzoic Acid <b>15</b>, 4-(2-(5-((Diethylamino)methyl)-2-hydroxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid <b>19</b>, 4-(2-(3-((Diethylamino)methyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid <b>23</b> and [4-(2-(3-((Diethylamino)methyl)-2-methoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2-isopropylbenzoic Acid] <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (2-methoxyphenyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 12 h; (ii) CH<sub>3</sub>OH, K<sub>2</sub>CO<sub>3</sub>, 55 °C, 18 h; (iii) 2-isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 0.5 h, MW; (iv) 4-(methoxymethoxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde or 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, 18 h; (v) Et<sub>2</sub>NH, NaBH(AcO)<sub>3</sub>, 1,4-dioxane, rt, 18 h; and (vi) HCl, MeCN/H<sub>2</sub>O 3:1.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-Aryl-7-azaindole Analogues, <b>28</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) boronate esters, Pd(dppf)Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1-4-dioxane, 110 °C, 0.5 h, MW.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative binding mode of TCMDC-135051 <b>1</b> in a PfCLK3 homology model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/medium/jm0c00451_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. PRR of clinical isolates comparing pyrimethamine and TCMDC-135051 at EC<sub>50</sub> and 10 times the EC<sub>50</sub> of each drug. This represent the average of triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00451/20200903/images/large/jm0c00451_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00451&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Organization, WHO</span>.  <i>World Malaria Report</i>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Organization%2C+WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadani, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacheux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urnov, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit-Vical, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">K13-propeller mutations confer artemisinin resistance in plasmodium falciparum clinical isolates</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1126/science.1260867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1126%2Fscience.1260867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25502314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=428-431&author=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=V.+Duruauthor=A.+P.+Ramadaniauthor=M.+Dacheuxauthor=N.+Khimauthor=L.+Zhangauthor=S.+Lamauthor=P.+D.+Gregoryauthor=F.+D.+Urnovauthor=O.+Mercereau-Puijalonauthor=F.+Benoit-Vicalauthor=R.+M.+Fairhurstauthor=D.+Menardauthor=D.+A.+Fidock&title=K13-propeller+mutations+confer+artemisinin+resistance+in+plasmodium+falciparum+clinical+isolates&doi=10.1126%2Fscience.1260867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span></div><div class="casAuthors">Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6220</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden.  We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients.  With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations.  Conversely, survival rates in wild-type parasites increased from ≤0.6% to 2 to 29% after the insertion of K13 mutations.  These mutations conferred elevated resistance to recent Cambodian isolates compared with that of ref. lines, suggesting a contemporary contribution of addnl. genetic factors.  Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ml-eUMKETLVg90H21EOLACvtfcHk0lji2tLLx0Vs0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D&md5=5776238fb78428d16bcaed8d16fa73af</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1260867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1260867%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DRamadani%26aufirst%3DA.%2BP.%26aulast%3DDacheux%26aufirst%3DM.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DGregory%26aufirst%3DP.%2BD.%26aulast%3DUrnov%26aufirst%3DF.%2BD.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DMenard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DK13-propeller%2520mutations%2520confer%2520artemisinin%2520resistance%2520in%2520plasmodium%2520falciparum%2520clinical%2520isolates%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D428%26epage%3D431%26doi%3D10.1126%2Fscience.1260867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ariey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beghain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bout, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ménard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandeur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barale, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit-Vical, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercereau-Puijalon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ménard, D.</span></span> <span> </span><span class="NLM_article-title">A molecular marker of artemisinin-resistant plasmodium falciparum malaria</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+M%C3%A9nardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+Le+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+M%C3%A9nard&title=A+molecular+marker+of+artemisinin-resistant+plasmodium+falciparum+malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eZXul5fTi07Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DLe%2BBras%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DA%2520molecular%2520marker%2520of%2520artemisinin-resistant%2520plasmodium%2520falciparum%2520malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Try, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blessborn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullo, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span> <span> </span><span class="NLM_article-title">Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(15)00487-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2FS1473-3099%2815%2900487-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=26774243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=357-365&author=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=S.+Maoauthor=C.+Sophaauthor=B.+Samauthor=D.+Dekauthor=V.+Tryauthor=R.+Amatoauthor=D.+Blessbornauthor=L.+Songauthor=G.+S.+Tulloauthor=M.+P.+Fayauthor=J.+M.+Andersonauthor=J.+Tarningauthor=R.+M.+Fairhurst&title=Dihydroartemisinin-piperaquine+resistance+in+Plasmodium+falciparum+malaria+in+Cambodia%3A+a+multisite+prospective+cohort+study&doi=10.1016%2Fs1473-3099%2815%2900487-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study</span></div><div class="casAuthors">Amaratunga, Chanaki; Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Sopha, Chantha; Sam, Baramey; Dek, Dalin; Try, Vorleak; Amato, Roberto; Blessborn, Daniel; Song, Lijiang; Tullo, Gregory S.; Fay, Michael P.; Anderson, Jennifer M.; Tarning, Joel; Fairhurst, Rick M.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-365</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies (ACTs), thus compromising global efforts to eliminate malaria.  Recent treatment failures with dihydroartemisinin-piperaquine, the current first-line ACT in Cambodia, suggest that piperaquine resistance may be emerging in this country.  We explored the relation between artemisinin resistance and dihydroartemisinin-piperaquine failures, and sought to confirm the presence of piperaquine-resistant P falciparum infections in Cambodia.  In this prospective cohort study, we enrolled patients aged 2-65 years with uncomplicated P falciparum malaria in three Cambodian provinces: Pursat, Preah Vihear, and Ratanakiri.  Participants were given std. 3-day courses of dihydroartemisinin-piperaquine.  Peripheral blood parasite densities were measured until parasites cleared and then weekly to 63 days.  The primary outcome was recrudescent P falciparum parasitemia within 63 days.  We measured piperaquine plasma concns. at baseline, 7 days, and day of recrudescence.  We assessed phenotypic and genotypic markers of drug resistance in parasite isolates.  The study is registered with ClinicalTrials.gov, no. NCT01736319.  Between Sept 4, 2012, and Dec 31, 2013, we enrolled 241 participants.  In Pursat, where artemisinin resistance is entrenched, 37 (46%) of 81 patients had parasite recrudescence.  In Preah Vihear, where artemisinin resistance is emerging, ten (16%) of 63 patients had recrudescence and in Ratanakiri, where artemisinin resistance is rare, one (2%) of 60 patients did.  Patients with recrudescent P falciparum infections were more likely to have detectable piperaquine plasma concns. at baseline compared with non-recrudescent patients, but did not differ significantly in age, initial parasite d., or piperaquine plasma concns. at 7 days.  Recrudescent parasites had a higher prevalence of kelch13 mutations, higher piperaquine 50% inhibitory concn. (IC50) values, and lower mefloquine IC50 values; none had multiple pfmdr1 copies, a genetic marker of mefloquine resistance.  Dihydroartemisinin-piperaquine failures are caused by both artemisinin and piperaquine resistance, and commonly occur in places where dihydroartemisinin-piperaquine has been used in the private sector.  In Cambodia, artesunate plus mefloquine may be a viable option to treat dihydroartemisinin-piperaquine failures, and a more effective first-line ACT in areas where dihydroartemisinin-piperaquine failures are common.  The use of single low-dose primaquine to eliminate circulating gametocytes is needed in areas where artemisinin and ACT resistance is prevalent.  National Institute of Allergy and Infectious Diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd0RSM1qQzR7Vg90H21EOLACvtfcHk0ljf4NXRyl5H0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWhsg%253D%253D&md5=b2b62ae0ef4f2b67f7446a2a5718654d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900487-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900487-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DDek%26aufirst%3DD.%26aulast%3DTry%26aufirst%3DV.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DBlessborn%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTullo%26aufirst%3DG.%2BS.%26aulast%3DFay%26aufirst%3DM.%2BP.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26atitle%3DDihydroartemisinin-piperaquine%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%2520in%2520Cambodia%253A%2520a%2520multisite%2520prospective%2520cohort%2520study%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3D357%26epage%3D365%26doi%3D10.1016%2Fs1473-3099%2815%2900487-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouth, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Char, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domergue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringwald, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, D.</span></span> <span> </span><span class="NLM_article-title">Evidence of plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4719</span>– <span class="NLM_lpage">4726</span>, <span class="refDoi"> DOI: 10.1128/aac.00835-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1128%2FAAC.00835-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=26014949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KntLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=4719-4726&author=R.+Leangauthor=W.+R.+J.+Taylorauthor=D.+M.+Bouthauthor=L.+Songauthor=J.+Tarningauthor=M.+C.+Charauthor=S.+Kimauthor=B.+Witkowskiauthor=V.+Duruauthor=A.+Domergueauthor=N.+Khimauthor=P.+Ringwaldauthor=D.+Menard&title=Evidence+of+plasmodium+falciparum+malaria+multidrug+resistance+to+artemisinin+and+piperaquine+in+western+Cambodia%3A+dihydroartemisinin-piperaquine+open-label+multicenter+clinical+assessment&doi=10.1128%2Faac.00835-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment</span></div><div class="casAuthors">Leang, Rithea; Taylor, Walter R. J.; Bouth, Denis Mey; Song, Lijiang; Tarning, Joel; Char, Meng Chuor; Kim, Saorin; Witkowski, Benoit; Duru, Valentine; Domergue, Anais; Khim, Nimol; Ringwald, Pascal; Menard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4719-4726</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Western Cambodia is recognized as the epicenter of Plasmodium falciparum multidrug resistance.  Recent reports of the efficacy of dihydroartemisinin (DHA)-piperaquine (PP), the latest of the artemisinin-based combination therapies (ACTs) recommended by the WHO, have prompted further investigations.  The clin. efficacy of dihydroartemisinin-piperaquine in uncomplicated falciparum malaria was assessed in western and eastern Cambodia over 42 days.  Day 7 plasma piperaquine concns. were measured and day 0 isolates tested for in vitro susceptibilities to piperaquine and mefloquine, polymorphisms in the K13 gene, and the copy no. of the Pfmdr-1 gene.  A total of 425 patients were recruited in 2011 to 2013.  The proportion of patients with recrudescent infections was significantly higher in western (15.4%) than in eastern (2.5%) Cambodia (P < 10-3).  Day 7 plasma PP concns. and median 50% inhibitory concns. (IC50) of PP were independent of treatment outcomes, in contrast to median mefloquine IC50, which were found to be lower for isolates from patients with recrudescent infections (18.7 vs. 39.7 nM; P = 0.005).  The most significant risk factor assocd. with DHA-PP treatment failure was infection by parasites carrying the K13 mutant allele (odds ratio [OR], 17.5; 95% confidence interval [CI], 1 to 308; P = 0.04).  Our data show evidence of P. falciparum resistance to PP in western Cambodia, an area of widespread artemisinin resistance.  New therapeutic strategies, such as the use of triple ACTs, are urgently needed and must be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM6ayLCgXm1bVg90H21EOLACvtfcHk0ljf4NXRyl5H0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KntLzF&md5=642a0306149f3edba42a166a4ce8749d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FAAC.00835-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00835-15%26sid%3Dliteratum%253Aachs%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DW.%2BR.%2BJ.%26aulast%3DBouth%26aufirst%3DD.%2BM.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DChar%26aufirst%3DM.%2BC.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DDomergue%26aufirst%3DA.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DMenard%26aufirst%3DD.%26atitle%3DEvidence%2520of%2520plasmodium%2520falciparum%2520malaria%2520multidrug%2520resistance%2520to%2520artemisinin%2520and%2520piperaquine%2520in%2520western%2520Cambodia%253A%2520dihydroartemisinin-piperaquine%2520open-label%2520multicenter%2520clinical%2520assessment%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D4719%26epage%3D4726%26doi%3D10.1128%2Faac.00835-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bland, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschenlauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorin-Semblat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nivez, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semblat, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reininger, L.</span></span> <span> </span><span class="NLM_article-title">Malaria: targeting parasite and host cell kinomes</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1804</i></span>,  <span class="NLM_fpage">604</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2009.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2Fj.bbapap.2009.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=19840874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=604-612&author=C.+Doerigauthor=A.+Abdiauthor=N.+Blandauthor=S.+Eschenlauerauthor=D.+Dorin-Semblatauthor=C.+Fennellauthor=J.+Halbertauthor=Z.+Hollandauthor=M.-P.+Nivezauthor=J.-P.+Semblatauthor=A.+Sicardauthor=L.+Reininger&title=Malaria%3A+targeting+parasite+and+host+cell+kinomes&doi=10.1016%2Fj.bbapap.2009.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria: Targeting parasite and host cell kinomes</span></div><div class="casAuthors">Doerig, Christian; Abdi, Abdirahman; Bland, Nicholas; Eschenlauer, Sylvain; Dorin-Semblat, Dominique; Fennell, Clare; Halbert, Jean; Holland, Zoe; Nivez, Marie-Paule; Semblat, Jean-Philippe; Sicard, Audrey; Reininger, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-612</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Malaria still remains one of the deadliest infectious diseases, and has a tremendous morbidity and mortality impact in the developing world.  The propensity of the parasites to develop drug resistance, and the relative reluctance of the pharmaceutical industry to invest massively in the developments of drugs that would offer only limited marketing prospects, are major issues in antimalarial drug discovery.  Protein kinases (PKs) have become a major family of targets for drug discovery research in a no. of disease contexts, which has generated considerable resources such as kinase-directed libraries and high throughput kinase inhibition assays.  The phylogenetic distance between malaria parasites and their human host translates into important divergences in their resp. kinomes, and most Plasmodium kinases display atypical properties (as compared to mammalian PKs) that can be exploited towards selective inhibition.  Here, we discuss the taxon-specific kinases possessed by malaria parasites, and give an overview of target PKs that have been validated by reverse genetics, either in the human malaria parasite Plasmodium falciparum or in the rodent model Plasmodium berghei.  We also briefly allude to the possibility of attacking Plasmodium through the inhibition of human PKs that are required for survival of this obligatory intracellular parasite, and which are targets for other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaEZOKIim0lLVg90H21EOLACvtfcHk0ljf4NXRyl5H0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yms74%253D&md5=2ea0d11a5754384a0037065c7525b57c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DAbdi%26aufirst%3DA.%26aulast%3DBland%26aufirst%3DN.%26aulast%3DEschenlauer%26aufirst%3DS.%26aulast%3DDorin-Semblat%26aufirst%3DD.%26aulast%3DFennell%26aufirst%3DC.%26aulast%3DHalbert%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DZ.%26aulast%3DNivez%26aufirst%3DM.-P.%26aulast%3DSemblat%26aufirst%3DJ.-P.%26aulast%3DSicard%26aufirst%3DA.%26aulast%3DReininger%26aufirst%3DL.%26atitle%3DMalaria%253A%2520targeting%2520parasite%2520and%2520host%2520cell%2520kinomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D604%26epage%3D612%26doi%3D10.1016%2Fj.bbapap.2009.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A. B.</span></span> <span> </span><span class="NLM_article-title">Post-translational protein modifications in malaria parasites</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1038/nrmicro3402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fnrmicro3402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25659318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlShu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=160-172&author=C.+Doerigauthor=J.+C.+Raynerauthor=A.+Scherfauthor=A.+B.+Tobin&title=Post-translational+protein+modifications+in+malaria+parasites&doi=10.1038%2Fnrmicro3402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational protein modifications in malaria parasites</span></div><div class="casAuthors">Doerig, Christian; Rayner, Julian C.; Scherf, Artur; Tobin, Andrew B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">160-172</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications play crucial parts in regulating protein function and thereby control several fundamental aspects of eukaryotic biol., including cell signaling, protein trafficking, epigenetic control of gene expression, cell-cell interactions, and cell proliferation and differentiation.  Here, the authors discuss protein modifications that have been shown to play a key role in malaria parasite biol. and pathogenesis.  The authors focus on phosphorylation, acetylation, methylation, and lipidation.  The authors provide an overview of the biol. significance of these modifications and discuss prospects and progress in antimalarial drug discovery based on the inhibition of the enzymes that mediate these modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJjsdKp9DJV7Vg90H21EOLACvtfcHk0liI1KIx7IFspQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlShu7Y%253D&md5=576e6bfd6e143f420c749383422d6a33</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3402%26sid%3Dliteratum%253Aachs%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DRayner%26aufirst%3DJ.%2BC.%26aulast%3DScherf%26aufirst%3DA.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26atitle%3DPost-translational%2520protein%2520modifications%2520in%2520malaria%2520parasites%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2015%26volume%3D13%26spage%3D160%26epage%3D172%26doi%3D10.1038%2Fnrmicro3402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solyakov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semblat, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorin-Semblat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reininger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottrill, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, Z.</span></span> <span> </span><span class="NLM_article-title">Global kinomic and phospho-proteomic analyses of the human malaria parasite plasmodium falciparum</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">565</span>, <span class="refDoi"> DOI: 10.1038/ncomms1558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fncomms1558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22127061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A280%3ADC%252BC38%252Fjs1SrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=565&author=L.+Solyakovauthor=J.+Halbertauthor=M.+M.+Alamauthor=J.+P.+Semblatauthor=D.+Dorin-Semblatauthor=L.+Reiningerauthor=A.+R.+Bottrillauthor=S.+Mistryauthor=A.+Abdiauthor=C.+Fennellauthor=Z.+Holland&title=Global+kinomic+and+phospho-proteomic+analyses+of+the+human+malaria+parasite+plasmodium+falciparum&doi=10.1038%2Fncomms1558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum</span></div><div class="casAuthors">Solyakov Lev; Halbert Jean; Alam Mahmood M; Semblat Jean-Philippe; Dorin-Semblat Dominique; Reininger Luc; Bottrill Andrew R; Mistry Sharad; Abdi Abdirhaman; Fennell Clare; Holland Zoe; Demarta Claudia; Bouza Yvan; Sicard Audrey; Nivez Marie-Paule; Eschenlauer Sylvain; Lama Tenzing; Thomas Divya Catherine; Sharma Pushkar; Agarwal Shruti; Kern Selina; Pradel Gabriele; Graciotti Michele; Tobin Andrew B; Doerig Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">565</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The role of protein phosphorylation in the life cycle of malaria parasites is slowly emerging.  Here we combine global phospho-proteomic analysis with kinome-wide reverse genetics to assess the importance of protein phosphorylation in Plasmodium falciparum asexual proliferation.  We identify 1177 phosphorylation sites on 650 parasite proteins that are involved in a wide range of general cellular activities such as DNA synthesis, transcription and metabolism as well as key parasite processes such as invasion and cyto-adherence.  Several parasite protein kinases are themselves phosphorylated on putative regulatory residues, including tyrosines in the activation loop of PfGSK3 and PfCLK3; we show that phosphorylation of PfCLK3 Y526 is essential for full kinase activity.  A kinome-wide reverse genetics strategy identified 36 parasite kinases as likely essential for erythrocytic schizogony.  These studies not only reveal processes that are regulated by protein phosphorylation, but also define potential anti-malarial drug targets within the parasite kinome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTASTzJ3P0nSRe4jJGKT5N0fW6udTcc2eaooW4rfdwTj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252Fjs1SrtQ%253D%253D&md5=8887de8eb952447f55afe5b773875981</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fncomms1558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1558%26sid%3Dliteratum%253Aachs%26aulast%3DSolyakov%26aufirst%3DL.%26aulast%3DHalbert%26aufirst%3DJ.%26aulast%3DAlam%26aufirst%3DM.%2BM.%26aulast%3DSemblat%26aufirst%3DJ.%2BP.%26aulast%3DDorin-Semblat%26aufirst%3DD.%26aulast%3DReininger%26aufirst%3DL.%26aulast%3DBottrill%26aufirst%3DA.%2BR.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DAbdi%26aufirst%3DA.%26aulast%3DFennell%26aufirst%3DC.%26aulast%3DHolland%26aufirst%3DZ.%26atitle%3DGlobal%2520kinomic%2520and%2520phospho-proteomic%2520analyses%2520of%2520the%2520human%2520malaria%2520parasite%2520plasmodium%2520falciparum%26jtitle%3DNat.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D565%26doi%3D10.1038%2Fncomms1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talevich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kannan, N.</span></span> <span> </span><span class="NLM_article-title">Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa</span>. <i>BMC Evol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">321</span>, <span class="refDoi"> DOI: 10.1186/1471-2148-11-321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1186%2F1471-2148-11-321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22047078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=321&author=E.+Talevichauthor=A.+Mirzaauthor=N.+Kannan&title=Structural+and+evolutionary+divergence+of+eukaryotic+protein+kinases+in+Apicomplexa&doi=10.1186%2F1471-2148-11-321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa</span></div><div class="casAuthors">Talevich, Eric; Mirza, Amar; Kannan, Natarajan</div><div class="citationInfo"><span class="NLM_cas:title">BMC Evolutionary Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">321</span>CODEN:
                <span class="NLM_cas:coden">BEBMCG</span>;
        ISSN:<span class="NLM_cas:issn">1471-2148</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The Apicomplexa constitute an evolutionarily divergent phylum of protozoan pathogens responsible for widespread parasitic diseases such as malaria and toxoplasmosis.  Many cellular functions in these medically important organisms are controlled by protein kinases, which have emerged as promising drug targets for parasitic diseases.  However, an incomplete understanding of how apicomplexan kinases structurally and mechanistically differ from their host counterparts has hindered drug development efforts to target parasite kinases.  We used the wealth of sequence data recently made available for 15 apicomplexan species to identify the kinome of each species and quantify the evolutionary constraints imposed on each family of apicomplexan kinases.  Our anal. revealed lineage-specific adaptations in selected families, namely cyclin-dependent kinase (CDK), calcium-dependent protein kinase (CDPK) and CLK/LAMMER, which have been identified as important in the pathogenesis of these organisms.  Bayesian anal. of selective constraints imposed on these families identified the sequence and structural features that most distinguish apicomplexan protein kinases from their homologs in model organisms and other eukaryotes.  In particular, in a subfamily of CDKs orthologous to Plasmodium falciparum crk-5, the activation loop contains a novel PTxC motif which is absent from all CDKs outside Apicomplexa.  Our anal. also suggests a convergent mode of regulation in a subset of apicomplexan CDPKs and mammalian MAPKs involving a commonly conserved arginine in the αC helix.  In all recognized apicomplexan CLKs, we find a set of co-conserved residues involved in substrate recognition and docking that are distinct from metazoan CLKs.  We pinpoint key conserved residues that can be predicted to mediate functional differences from eukaryotic homologs in three identified kinase families.  We discuss the structural, functional and evolutionary implications of these lineage-specific variations and propose specific hypotheses for exptl. investigation.  The apicomplexan-specific kinase features reported in this study can be used in the design of selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEQKvKIWM-PbVg90H21EOLACvtfcHk0liI1KIx7IFspQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyhsLw%253D&md5=06e5e9471e75f772a31d2ada25d60d46</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1471-2148-11-321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2148-11-321%26sid%3Dliteratum%253Aachs%26aulast%3DTalevich%26aufirst%3DE.%26aulast%3DMirza%26aufirst%3DA.%26aulast%3DKannan%26aufirst%3DN.%26atitle%3DStructural%2520and%2520evolutionary%2520divergence%2520of%2520eukaryotic%2520protein%2520kinases%2520in%2520Apicomplexa%26jtitle%3DBMC%2520Evol.%2520Biol.%26date%3D2011%26volume%3D11%26spage%3D321%26doi%3D10.1186%2F1471-2148-11-321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.-D.</span></span> <span> </span><span class="NLM_article-title">Regulation of splicing by SR proteins and SR protein-specific kinases</span>. <i>Chromosoma</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1007/s00412-013-0407-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1007%2Fs00412-013-0407-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23525660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotVSks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=191-207&author=Z.+Zhouauthor=X.-D.+Fu&title=Regulation+of+splicing+by+SR+proteins+and+SR+protein-specific+kinases&doi=10.1007%2Fs00412-013-0407-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of splicing by SR proteins and SR protein-specific kinases</span></div><div class="casAuthors">Zhou, Zhihong; Fu, Xiang-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Chromosoma</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-207</span>CODEN:
                <span class="NLM_cas:coden">CHROAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-5915</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Genomic sequencing reveals similar but limited nos. of protein-coding genes in different genomes, which begs the question of how organismal diversities are generated.  Alternative pre-mRNA splicing, a widespread phenomenon in higher eukaryotic genomes, is thought to provide a mechanism to increase the complexity of the proteome and introduce addnl. layers for regulating gene expression in different cell types and during development.  Among a large no. of factors implicated in the splicing regulation are the SR protein family of splicing factors and SR protein-specific kinases.  Here, we summarize the rules for SR proteins to function as splicing regulators, which depend on where they bind in exons vs. intronic regions, on alternative exons vs. flanking competing exons, and on cooperative as well as competitive binding between different SR protein family members on many of those locations.  We review the importance of cycles of SR protein phosphorylation/dephosphorylation in the splicing reaction with emphasis on the recent mol. insight into the role of SR protein phosphorylation in early steps of spliceosome assembly.  Finally, we highlight recent discoveries of SR protein-specific kinases in transducing growth signals to regulate alternative splicing in the nucleus and the connection of both SR proteins and SR protein kinases to human diseases, particularly cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7RFihroI_ubVg90H21EOLACvtfcHk0liHYuwepYT4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotVSks7s%253D&md5=6f10045aad1b2a57c85284500892c96c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00412-013-0407-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00412-013-0407-z%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DX.-D.%26atitle%3DRegulation%2520of%2520splicing%2520by%2520SR%2520proteins%2520and%2520SR%2520protein-specific%2520kinases%26jtitle%3DChromosoma%26date%3D2013%26volume%3D122%26spage%3D191%26epage%3D207%26doi%3D10.1007%2Fs00412-013-0407-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehring, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strödke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brügl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abodo, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandekar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the SR protein-phosphorylating CLK kinases of plasmodium falciparum impairs blood stage replication and malaria transmission</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e105732</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0105732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1371%2Fjournal.pone.0105732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25188378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12isL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=S.+Kernauthor=S.+Agarwalauthor=K.+Huberauthor=A.+P.+Gehringauthor=B.+Str%C3%B6dkeauthor=C.+C.+Wirthauthor=T.+Br%C3%BCglauthor=L.+O.+Abodoauthor=T.+Dandekarauthor=C.+Doerigauthor=R.+Fischer&title=Inhibition+of+the+SR+protein-phosphorylating+CLK+kinases+of+plasmodium+falciparum+impairs+blood+stage+replication+and+malaria+transmission&doi=10.1371%2Fjournal.pone.0105732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission</span></div><div class="casAuthors">Kern, Selina; Agarwal, Shruti; Huber, Kilian; Gehring, Andre P.; Stroedke, Benjamin; Wirth, Christine C.; Bruegl, Thomas; Abodo, Liliane Onambele; Dandekar, Thomas; Doerig, Christian; Fischer, Rainer; Tobin, Andrew B.; Alam, Mahmood M.; Bracher, Franz; Pradel, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105732/1-e105732/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cyclin-dependent kinase-like kinases (CLKs) are dual specificity protein kinases that phosphorylate Serine/Arginine-rich (SR) proteins involved in pre-mRNA processing.  Four CLKs, termed PfCLK-1-4, can be identified in the human malaria parasite Plasmodium falciparum, which show homol. with the yeast SR protein kinase Sky1p.  The four PfCLKs are present in the nucleus and cytoplasm of the asexual blood stages and of gametocytes, sexual precursor cells crucial for malaria parasite transmission from humans to mosquitoes.  We identified three plasmodial SR proteins, PfSRSF12, PfSFRS4 and PfSF-1, which are predominantly present in the nucleus of blood stage trophozoites, PfSRSF12 and PfSF-1 are further detectable in the nucleus of gametocytes.  We found that recombinantly expressed SR proteins comprising the Arginine/Serine (RS)-rich domains were phosphorylated by the four PfCLKs in in vitro kinase assays, while a recombinant PfSF-1 peptide lacking the RS-rich domain was not phosphorylated.  Since it was hitherto not possible to knock-out the pfclk genes by conventional gene disruption, we aimed at chem. knock-outs for phenotype anal.  We identified five human CLK inhibitors, belonging to the oxo-β-carbolines and aminopyrimidines, as well as the antiseptic chlorhexidine as PfCLK-targeting compds.  The six inhibitors block P. falciparum blood stage replication in the low micromolar to nanomolar range by preventing the trophozoite-to-schizont transformation.  In addn., the inhibitors impair gametocyte maturation and gametogenesis in in vitro assays.  The combined data show that the four PfCLKs are involved in phosphorylation of SR proteins with essential functions for the blood and sexual stages of the malaria parasite, thus pointing to the kinases as promising targets for antimalarial and transmission blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfvbpkO4I6f7Vg90H21EOLACvtfcHk0liHYuwepYT4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12isL3K&md5=4d340a30e45d135fe95707d4745bacf4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105732%26sid%3Dliteratum%253Aachs%26aulast%3DKern%26aufirst%3DS.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DGehring%26aufirst%3DA.%2BP.%26aulast%3DStr%25C3%25B6dke%26aufirst%3DB.%26aulast%3DWirth%26aufirst%3DC.%2BC.%26aulast%3DBr%25C3%25BCgl%26aufirst%3DT.%26aulast%3DAbodo%26aufirst%3DL.%2BO.%26aulast%3DDandekar%26aufirst%3DT.%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520the%2520SR%2520protein-phosphorylating%2520CLK%2520kinases%2520of%2520plasmodium%2520falciparum%2520impairs%2520blood%2520stage%2520replication%2520and%2520malaria%2520transmission%26jtitle%3DPloS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0105732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przyborski, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandekar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradel, G.</span></span> <span> </span><span class="NLM_article-title">Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1295</span>– <span class="NLM_lpage">1310</span>, <span class="refDoi"> DOI: 10.1002/jcb.23034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1002%2Fjcb.23034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=21312235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFelt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2011&pages=1295-1310&author=S.+Agarwalauthor=S.+Kernauthor=J.+Halbertauthor=J.+M.+Przyborskiauthor=S.+Baumeisterauthor=T.+Dandekarauthor=C.+Doerigauthor=G.+Pradel&title=Two+nucleus-localized+CDK-like+kinases+with+crucial+roles+for+malaria+parasite+erythrocytic+replication+are+involved+in+phosphorylation+of+splicing+factor&doi=10.1002%2Fjcb.23034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Two nucleus-localized CDK-like kinases with crucial roles for malaria parasite erythrocytic replication are involved in phosphorylation of splicing factor</span></div><div class="casAuthors">Agarwal, Shruti; Kern, Selina; Halbert, Jean; Przyborski, Jude M.; Baumeister, Stefan; Dandekar, Thomas; Doerig, Christian; Pradel, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1295-1310</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The kinome of the human malaria parasite Plasmodium falciparum comprises representatives of most eukaryotic protein kinase groups, including kinases which regulate proliferation and differentiation processes.  Despite extensive research on most plasmodial enzymes, little information is available regarding the four identified members of the cyclin-dependent kinase-like kinase (CLK) family.  In other eukaryotes, CLKs regulate mRNA splicing through phosphorylation of Serine/Arginine-rich proteins.  Here, we investigate two of the PfCLKs, the Lammer kinase homolog PfCLK-1, and PfCLK-2.  Both PfCLKs show homol. with the yeast Serine/Arginine protein kinase Sky1p and are transcribed throughout the asexual blood stages and in gametocytes.  PfCLK-1/Lammer possesses two nuclear localization signal sites and PfCLK-2 possesses one of these signal sites upstream of the C-terminal catalytic domains.  Indirect immunofluorescence, Western blot, and electron microscopy data confirm that the kinases are primarily localized in the parasite nucleus, and PfCLK-2 is further present in the cytoplasm.  The two kinases are important for completion of the asexual replication cycle of P. falciparum, as demonstrated by reverse genetics approaches.  In vitro kinase assays show substrate phosphorylation by the PfCLKs, including the Sky1p substrate, splicing factor Npl3p, and the plasmodial alternative splicing factor PfASF-1.  Mass spectrometric anal. of co-immunopptd. proteins indicates assembly of the two PfCLKs with proteins with predicted nuclease, phosphatase, or helicase functions.  Our data indicate a crucial role of PfCLKs for malaria blood stage parasites, presumably by participating in gene regulation through the post-transcriptional modification of mRNA.  J. Cell. Biochem. 112: 1295-1310, 2011. © 2011 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvBjtIs7EGXrVg90H21EOLACvtfcHk0liHYuwepYT4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFelt7k%253D&md5=0875ea79cab6cefdd9d15df88e6f19c7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fjcb.23034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.23034%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DKern%26aufirst%3DS.%26aulast%3DHalbert%26aufirst%3DJ.%26aulast%3DPrzyborski%26aufirst%3DJ.%2BM.%26aulast%3DBaumeister%26aufirst%3DS.%26aulast%3DDandekar%26aufirst%3DT.%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DPradel%26aufirst%3DG.%26atitle%3DTwo%2520nucleus-localized%2520CDK-like%2520kinases%2520with%2520crucial%2520roles%2520for%2520malaria%2520parasite%2520erythrocytic%2520replication%2520are%2520involved%2520in%2520phosphorylation%2520of%2520splicing%2520factor%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D112%26spage%3D1295%26epage%3D1310%26doi%3D10.1002%2Fjcb.23034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Azqueta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janha, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahindra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mapesa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Char, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriranganadane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancucci, N. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simwela, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millar, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinwale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitcheson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solyakov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nwakanma, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colmenarejo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvaro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranford-Cartwright, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A. B.</span></span> <span> </span><span class="NLM_article-title">Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>365</i></span>, <span class="NLM_elocation-id">eaau1682</span> <span class="refDoi"> DOI: 10.1126/science.aau1682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1126%2Fscience.aau1682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=31467193" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2019&author=M.+M.+Alamauthor=A.+Sanchez-Azquetaauthor=O.+Janhaauthor=E.+L.+Flanneryauthor=A.+Mahindraauthor=K.+Mapesaauthor=A.+B.+Charauthor=D.+Sriranganadaneauthor=N.+M.+B.+Brancucciauthor=Y.+Antonova-Kochauthor=K.+Crouchauthor=N.+V.+Simwelaauthor=S.+B.+Millarauthor=J.+Akinwaleauthor=D.+Mitchesonauthor=L.+Solyakovauthor=K.+Dudekauthor=C.+Jonesauthor=C.+Zapateroauthor=C.+Doerigauthor=D.+C.+Nwakanmaauthor=M.+J.+V%C3%A1zquezauthor=G.+Colmenarejoauthor=M.+J.+Lafuente-Monasterioauthor=M.+L.+Leonauthor=P.+H.+C.+Godoiauthor=J.+M.+Elkinsauthor=A.+P.+Watersauthor=A.+G.+Jamiesonauthor=E.+F.+%C3%81lvaroauthor=L.+C.+Ranford-Cartwrightauthor=M.+Martiauthor=E.+A.+Winzelerauthor=F.+J.+Gamoauthor=A.+B.+Tobin&title=Validation+of+the+protein+kinase+PfCLK3+as+a+multistage+cross-species+malarial+drug+target&doi=10.1126%2Fscience.aau1682"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aau1682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aau1682%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DM.%2BM.%26aulast%3DSanchez-Azqueta%26aufirst%3DA.%26aulast%3DJanha%26aufirst%3DO.%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DMahindra%26aufirst%3DA.%26aulast%3DMapesa%26aufirst%3DK.%26aulast%3DChar%26aufirst%3DA.%2BB.%26aulast%3DSriranganadane%26aufirst%3DD.%26aulast%3DBrancucci%26aufirst%3DN.%2BM.%2BB.%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DCrouch%26aufirst%3DK.%26aulast%3DSimwela%26aufirst%3DN.%2BV.%26aulast%3DMillar%26aufirst%3DS.%2BB.%26aulast%3DAkinwale%26aufirst%3DJ.%26aulast%3DMitcheson%26aufirst%3DD.%26aulast%3DSolyakov%26aufirst%3DL.%26aulast%3DDudek%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DZapatero%26aufirst%3DC.%26aulast%3DDoerig%26aufirst%3DC.%26aulast%3DNwakanma%26aufirst%3DD.%2BC.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DM.%2BJ.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DLeon%26aufirst%3DM.%2BL.%26aulast%3DGodoi%26aufirst%3DP.%2BH.%2BC.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26aulast%3DJamieson%26aufirst%3DA.%2BG.%26aulast%3D%25C3%2581lvaro%26aufirst%3DE.%2BF.%26aulast%3DRanford-Cartwright%26aufirst%3DL.%2BC.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DTobin%26aufirst%3DA.%2BB.%26atitle%3DValidation%2520of%2520the%2520protein%2520kinase%2520PfCLK3%2520as%2520a%2520multistage%2520cross-species%2520malarial%2520drug%2520target%26jtitle%3DScience%26date%3D2019%26volume%3D365%26doi%3D10.1126%2Fscience.aau1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawa, M.</span></span> <span> </span><span class="NLM_article-title">7-Azaindole: A versatile scaffold for developing kinase inhibitors</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1248/cpb.c17-00380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1248%2Fcpb.c17-00380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=29311509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOntr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=29-36&author=T.+Irieauthor=M.+Sawa&title=7-Azaindole%3A+A+versatile+scaffold+for+developing+kinase+inhibitors&doi=10.1248%2Fcpb.c17-00380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">7-Azaindole: a versatile scaffold for developing kinase inhibitors</span></div><div class="casAuthors">Irie, Takayuki; Sawa, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  This review summarized recent examples of 7-azaindole-based kinase inhibitors and discusses their binding interactions with the kinase hinge regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9QuvBOqQ8GrVg90H21EOLACvtfcHk0lhuGdfRpxKeQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOntr%252FK&md5=69a5097cb54f2598d2e02414e74b3e6b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c17-00380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c17-00380%26sid%3Dliteratum%253Aachs%26aulast%3DIrie%26aufirst%3DT.%26aulast%3DSawa%26aufirst%3DM.%26atitle%3D7-Azaindole%253A%2520A%2520versatile%2520scaffold%2520for%2520developing%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2018%26volume%3D66%26spage%3D29%26epage%3D36%26doi%3D10.1248%2Fcpb.c17-00380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallamo, J. P.</span></span> <span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5149</span>– <span class="NLM_lpage">5171</span>, <span class="refDoi"> DOI: 10.1021/jm800475y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery&doi=10.1021%2Fjm800475y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lhuGdfRpxKeQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171%26doi%3D10.1021%2Fjm800475y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, T.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent and selective Pim kinase inhibitors by targeting unique structure of ATP-binding pocket</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00518</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=504-509&author=H.+Nakanoauthor=T.+Hasegawaauthor=H.+Kojimaauthor=T.+Okabeauthor=T.+Nagano&title=Design+and+synthesis+of+potent+and+selective+Pim+kinase+inhibitors+by+targeting+unique+structure+of+ATP-binding+pocket&doi=10.1021%2Facsmedchemlett.6b00518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket</span></div><div class="casAuthors">Nakano, Hirofumi; Hasegawa, Tsukasa; Kojima, Hirotatsu; Okabe, Takayoshi; Nagano, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">504-509</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the development of kinase inhibitors, one of the major concerns is selectivity.  An effective strategy to achieve high selectivity is to utilize structural differences among kinases to inform inhibitor design.  Here, we set out to improve the PIM (proviral integration site for Moloney murine leukemia virus) kinase-inhibitory selectivity of our previously reported 7-azaindole deriv. 2, which has promising ADMET properties, by targeting a unique bulge in the ATP-binding pocket. 6-Substituted 7-azaindoles, esp. the 6-chlorinated derivs., proved to be potent and selective PIM kinase inhibitors and appear to be promising lead compds. for future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBu3SXcZr8bVg90H21EOLACvtfcHk0lhEsQL9NAVuAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVynsro%253D&md5=b4393c5c6f77ddfa140ebf669b552e44</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00518%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DKojima%26aufirst%3DH.%26aulast%3DOkabe%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520and%2520selective%2520Pim%2520kinase%2520inhibitors%2520by%2520targeting%2520unique%2520structure%2520of%2520ATP-binding%2520pocket%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D504%26epage%3D509%26doi%3D10.1021%2Facsmedchemlett.6b00518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">The azaindole framework in the design of kinase inhibitors</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">19935</span>– <span class="NLM_lpage">19979</span>, <span class="refDoi"> DOI: 10.3390/molecules191219935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.3390%2Fmolecules191219935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=25460315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=19935-19979&author=J.-Y.+M%C3%A9rourauthor=F.+Buronauthor=K.+Pl%C3%A9author=P.+Bonnetauthor=S.+Routier&title=The+azaindole+framework+in+the+design+of+kinase+inhibitors&doi=10.3390%2Fmolecules191219935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The azaindole framework in the design of kinase inhibitors</span></div><div class="casAuthors">Merour, Jean-Yves; Buron, Frederic; Ple, Karen; Bonnet, Pascal; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">19935-19979, 45 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This review article illustrates the growing use of azaindole derivs. as kinase inhibitors and their contribution to drug discovery and innovation.  The different protein kinases which have served as targets and the known mols. which have emerged from medicinal chem. and Fragment-Based Drug Discovery (FBDD) programs are presented.  The various synthetic routes used to access these compds. and the chem. pathways leading to their synthesis are also discussed.  An anal. of their mode of binding based on X-ray crystallog. data gives structural insights for the design of more potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLtZrGItBQbVg90H21EOLACvtfcHk0lhEsQL9NAVuAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO&md5=7797450a99abb4a4c8e2492eb8a43dd7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191219935%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DPl%25C3%25A9%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DThe%2520azaindole%2520framework%2520in%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D19935%26epage%3D19979%26doi%3D10.3390%2Fmolecules191219935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurwitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massagué, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/376313a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2F376313a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=7630397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaK2MXnt1Sjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=313-320&author=P.+D.+Jeffreyauthor=A.+A.+Russoauthor=K.+Polyakauthor=E.+Gibbsauthor=J.+Hurwitzauthor=J.+Massagu%C3%A9author=N.+P.+Pavletich&title=Mechanism+of+CDK+activation+revealed+by+the+structure+of+a+cyclinA-CDK2+complex&doi=10.1038%2F376313a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex</span></div><div class="casAuthors">Jeffrey, Philip D.; Russo, Alicia A.; Polyak, Kornelia; Gibbs, Emma; Hurwitz, Jerard; Massague, Joan; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">6538</span>),
    <span class="NLM_cas:pages">313-20</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of the human cyclin A-cyclin-dependent kinase 2 (CDK2)-ATP complex was detd. at 2.3 Å resoln.  Cyclin A was found to bind to one side of the catalytic cleft of CDK2, inducing large conformational changes in its PSTAIRE helix and T-loop.  These changes activate the kinase by realigning active site residues and relieving the steric blockade at the entrance of the catalytic cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj6tVVZjR6SrVg90H21EOLACvtfcHk0lhEsQL9NAVuAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt1Sjsrk%253D&md5=582f0a3741e0417ff650c3172b39249c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F376313a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F376313a0%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPolyak%26aufirst%3DK.%26aulast%3DGibbs%26aufirst%3DE.%26aulast%3DHurwitz%26aufirst%3DJ.%26aulast%3DMassagu%25C3%25A9%26aufirst%3DJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DMechanism%2520of%2520CDK%2520activation%2520revealed%2520by%2520the%2520structure%2520of%2520a%2520cyclinA-CDK2%2520complex%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D313%26epage%3D320%26doi%3D10.1038%2F376313a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horatscheck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basarab, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyermann, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Plasmodial kinase inhibitors: license to cure?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8061</span>– <span class="NLM_lpage">8077</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps12ltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8061-8077&author=D.+G.+Cabreraauthor=A.+Horatscheckauthor=C.+R.+Wilsonauthor=G.+Basarabauthor=C.+J.+Eyermannauthor=K.+Chibale&title=Plasmodial+kinase+inhibitors%3A+license+to+cure%3F&doi=10.1021%2Facs.jmedchem.8b00329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodial Kinase Inhibitors: License to Cure?</span></div><div class="casAuthors">Cabrera, Diego Gonzalez; Horatscheck, Andre; Wilson, Colin R.; Basarab, Greg; Eyermann, Charles J.; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8061-8077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Advances in the genetics, function, and stage-specificity of Plasmodium kinases has driven robust efforts to identify targets for the design of antimalarial therapies.  Reverse genomics following phenotypic screening against Plasmodia or related parasites has uncovered vulnerable kinase targets including PI4K, PKG, and GSK-3, an approach bolstered by access to human disease-directed kinase libraries.  Alternatively, screening compd. libraries against Plasmodium kinases has successfully led to inhibitors with antiplasmodial activity.  As with other therapeutic areas, optimizing compd. ADMET and PK properties in parallel with target inhibitory potency and whole cell activity becomes paramount toward advancing compds. as clin. candidates.  These and other considerations will be discussed in the context of progress achieved toward deriving important, novel mode-of-action kinase-inhibiting antimalarial medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI0bcml4uRWbVg90H21EOLACvtfcHk0ljNJWX_IwegqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps12ltrg%253D&md5=274df0d629d4cf4fcb7a158e9e72aaab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00329%26sid%3Dliteratum%253Aachs%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DHoratscheck%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DC.%2BR.%26aulast%3DBasarab%26aufirst%3DG.%26aulast%3DEyermann%26aufirst%3DC.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DPlasmodial%2520kinase%2520inhibitors%253A%2520license%2520to%2520cure%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8061%26epage%3D8077%26doi%3D10.1021%2Facs.jmedchem.8b00329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwicke, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koretke-Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newlander, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleykowski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrish, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarpong, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3973</span>– <span class="NLM_lpage">4001</span>, <span class="refDoi"> DOI: 10.1021/jm901870q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901870q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3973-4001&author=N.+D.+Adamsauthor=J.+L.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=R.+A.+Copelandauthor=C.+A.+Donatelliauthor=D.+H.+Drewryauthor=K.+E.+Fisherauthor=T.+Hamajimaauthor=M.+A.+Hardwickeauthor=W.+F.+Huffmanauthor=K.+K.+Koretke-Brownauthor=Z.+V.+Laiauthor=O.+B.+McDonaldauthor=H.+Nakamuraauthor=K.+A.+Newlanderauthor=C.+A.+Oleykowskiauthor=C.+A.+Parrishauthor=D.+R.+Patrickauthor=R.+Plantauthor=M.+A.+Sarpongauthor=K.+Sasakiauthor=S.+J.+Schmidtauthor=D.+J.+Silvaauthor=D.+Suttonauthor=J.+Tangauthor=C.+S.+Thompsonauthor=P.+J.+Tumminoauthor=J.+C.+Wangauthor=H.+Xiangauthor=J.+Yangauthor=D.+Dhanak&title=Discovery+of+GSK1070916%2C+a+potent+and+selective+inhibitor+of+Aurora+B%2FC+kinase&doi=10.1021%2Fjm901870q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase</span></div><div class="casAuthors">Adams, Nicholas D.; Adams, Jerry L.; Burgess, Joelle L.; Chaudhari, Amita M.; Copeland, Robert A.; Donatelli, Carla A.; Drewry, David H.; Fisher, Kelly E.; Hamajima, Toshihiro; Hardwicke, Mary Ann; Huffman, William F.; Koretke-Brown, Kristin K.; Lai, Zhihong V.; McDonald, Octerloney B.; Nakamura, Hiroko; Newlander, Ken A.; Oleykowski, Catherine A.; Parrish, Cynthia A.; Patrick, Denis R.; Plant, Ramona; Sarpong, Martha A.; Sasaki, Kosuke; Schmidt, Stanley J.; Silva, Domingos J.; Sutton, David; Tang, Jun; Thompson, Christine S.; Tummino, Peter J.; Wang, Jamin C.; Xiang, Hong; Yang, Jingsong; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3973-4001</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Aurora kinases play crit. roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors.  Selective inhibitors may provide a new therapy for the treatment of tumors with Aurora kinase amplification.  Herein we describe our lead optimization efforts within a 7-azaindole-based series culminating in the identification of GSK1070916 (17k).  Key to the advancement of the series was the introduction of a 2-aryl group contg. a basic amine onto the azaindole leading to significantly improved cellular activity.  Compd. 17k is a potent and selective ATP-competitive inhibitor of Aurora B and C with Ki* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, resp., and is >250-fold selective over Aurora A.  Biochem. characterization revealed that compd. 17k has an extremely slow dissocn. half-life from Aurora B (>480 min), distinguishing it from clin. compds. 1 and 2.  In vitro treatment of A549 human lung cancer cells with compd. 17k results in a potent antiproliferative effect (EC50 = 7 nM).  I.p. administration of 17k in mice bearing human tumor xenografts leads to inhibition of histone H3 phosphorylation at serine 10 in human colon cancer (Colo205) and tumor regression in human leukemia (HL-60).  Compd. 17k is being progressed to human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9vBAsDJpiNrVg90H21EOLACvtfcHk0ljNJWX_IwegqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChtrk%253D&md5=250f76a1ca89afdb94c7cbac4f37d11f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901870q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901870q%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DHamajima%26aufirst%3DT.%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DHuffman%26aufirst%3DW.%2BF.%26aulast%3DKoretke-Brown%26aufirst%3DK.%2BK.%26aulast%3DLai%26aufirst%3DZ.%2BV.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DOleykowski%26aufirst%3DC.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DPlant%26aufirst%3DR.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DSilva%26aufirst%3DD.%2BJ.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DC.%2BS.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26aulast%3DXiang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK1070916%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520Aurora%2520B%252FC%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3973%26epage%3D4001%26doi%3D10.1021%2Fjm901870q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verbiscar, A. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 1-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol as a potential antimalarial agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1021/jm00272a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00272a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaE38XhtlGku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=149-152&author=A.+J.+Verbiscar&title=Synthesis+of+1-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol+as+a+potential+antimalarial+agent&doi=10.1021%2Fjm00272a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1-p-chlorobenzyl-7-azaindole-3-α-piperidylmethanol as a potential antimalarial agent</span></div><div class="casAuthors">Verbiscar, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-52</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">1-P-chlorobenzyl-7-azaindole-3-α-piperidylmethanol (I) [27413-43-0] was prepd. from 7-azaindole-3-carboxaldehyde, obtained by a Duff formylation of 7-azaindole with hexamethylenetetraamine in AcOH.  1-Alkylation gave 1-p-chlorobenzyl-7-azaindole-3-carboxaldehyde which was condensed with 2-pyridyllithium followed by low pressure hydrogenation to give I as mixed diastereoisomers.  A single diastereoisomer of I (obtained by fractional crystn.) has antimalarial activity against Plasmodium berghei in mice; 320 mg/kg increased mean survival time by 3.1 days.  The low activity of the mixed diastereoisomers indicated that one of the isomers was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMU9KtbFO7orVg90H21EOLACvtfcHk0ljNJWX_IwegqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XhtlGku70%253D&md5=d3f42494e964d504643a435765fba2a4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00272a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00272a008%26sid%3Dliteratum%253Aachs%26aulast%3DVerbiscar%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520of%25201-p-chlorobenzyl-7-azaindole-3-.alpha.-piperidylmethanol%2520as%2520a%2520potential%2520antimalarial%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D149%26epage%3D152%26doi%3D10.1021%2Fjm00272a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapozza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, D.</span></span> <span> </span><span class="NLM_article-title">Differences in conformational dynamics between plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2524</span>– <span class="NLM_lpage">2535</span>, <span class="refDoi"> DOI: 10.1021/jm401801t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401801t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlOlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2524-2535&author=T.+Wangauthor=W.+H.+Bissonauthor=P.+M%C3%A4serauthor=L.+Scapozzaauthor=D.+Picard&title=Differences+in+conformational+dynamics+between+plasmodium+falciparum+and+human+Hsp90+orthologues+enable+the+structure-based+discovery+of+pathogen-selective+inhibitors&doi=10.1021%2Fjm401801t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in Conformational Dynamics between Plasmodium falciparum and Human Hsp90 Orthologues Enable the Structure-Based Discovery of Pathogen-Selective Inhibitors</span></div><div class="casAuthors">Wang, Tai; Bisson, William H.; Maser, Pascal; Scapozza, Leonardo; Picard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2524-2535</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The high sequence conservation of druggable pockets of closely related proteins can make it challenging to develop selective inhibitors.  The authors designed a new drug discovery approach that exploits both the static and dynamic differences of two orthologues.  The authors applied it, as a proof of concept, to identify compds. that discriminate between the mol. chaperone Hsp90 of the protozoan pathogen Plasmodium falciparum (Pf) and that of its human host.  The authors found that the ATP-binding pocket has a Pf-specific extension, whose sequence lining is identical in human Hsp90 but which differs by tertiary structure and dynamics.  Using these insights for a structure-based drug screen, the authors discovered novel 7-azaindole compds. that exclusively bind the recombinant N-terminal domain of PfHsp90 but not of human Hsp90 nor of a PfHsp90 mutant with "human-like" dynamics.  Moreover, these compds. preferentially inhibit the growth of yeast complemented by PfHsp90 and block the growth of Pf in culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHtrYEZf7JI7Vg90H21EOLACvtfcHk0ljJzsxt760RYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlOlsb8%253D&md5=748c9874b0d5e0e5beb03c70d16fe981</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm401801t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401801t%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBisson%26aufirst%3DW.%2BH.%26aulast%3DM%25C3%25A4ser%26aufirst%3DP.%26aulast%3DScapozza%26aufirst%3DL.%26aulast%3DPicard%26aufirst%3DD.%26atitle%3DDifferences%2520in%2520conformational%2520dynamics%2520between%2520plasmodium%2520falciparum%2520and%2520human%2520Hsp90%2520orthologues%2520enable%2520the%2520structure-based%2520discovery%2520of%2520pathogen-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2524%26epage%3D2535%26doi%3D10.1021%2Fjm401801t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barberis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorcroft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Mazza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majid, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of N -substituted 7-azaindoles as PIM1 kinase inhibitors - Part I</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4730</span>– <span class="NLM_lpage">4734</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.08.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2Fj.bmcl.2017.08.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=28947155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOisL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4730-4734&author=C.+Barberisauthor=N.+Moorcroftauthor=C.+Arendtauthor=M.+Levitauthor=S.+Moreno-Mazzaauthor=J.+Batchelorauthor=I.+Mechinauthor=T.+Majid&title=Discovery+of+N+-substituted+7-azaindoles+as+PIM1+kinase+inhibitors+-+Part+I&doi=10.1016%2Fj.bmcl.2017.08.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-substituted 7-azaindoles as PIM1 kinase inhibitors - Part I</span></div><div class="casAuthors">Barberis, Claude; Moorcroft, Neil; Arendt, Chris; Levit, Mikhail; Moreno-Mazza, Sandra; Batchelor, Joseph; Mechin, Ingrid; Majid, Tahir</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4730-4734</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel N-substituted azaindoles have been discovered as PIM1 inhibitors.  X-ray structures have played a significant role in orienting the chem. effort in the initial phase of hit confirmation.  Disclosure of an unconventional binding mode for 1 and 2, as demonstrated by X-ray crystallog., is presented and was an important factor in selecting and advancing a lead series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYw_Bc_I4re7Vg90H21EOLACvtfcHk0lgV9m-1dJlykw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOisL%252FI&md5=d24157fcc92dbf59d9e40936816a0467</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.08.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.08.069%26sid%3Dliteratum%253Aachs%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DMoorcroft%26aufirst%3DN.%26aulast%3DArendt%26aufirst%3DC.%26aulast%3DLevit%26aufirst%3DM.%26aulast%3DMoreno-Mazza%26aufirst%3DS.%26aulast%3DBatchelor%26aufirst%3DJ.%26aulast%3DMechin%26aufirst%3DI.%26aulast%3DMajid%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520N%2520-substituted%25207-azaindoles%2520as%2520PIM1%2520kinase%2520inhibitors%2520-%2520Part%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4730%26epage%3D4734%26doi%3D10.1016%2Fj.bmcl.2017.08.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zadjura, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiGiugno Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesenberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggers, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowicka-Sans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dicker, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colonno, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7778</span>– <span class="NLM_lpage">7787</span>, <span class="refDoi"> DOI: 10.1021/jm900843g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900843g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKns7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7778-7787&author=T.+Wangauthor=Z.+Yinauthor=Z.+Zhangauthor=J.+A.+Benderauthor=Z.+Yangauthor=G.+Johnsonauthor=Z.+Yangauthor=L.+M.+Zadjuraauthor=C.+J.+D%E2%80%99Arienzoauthor=D.+DiGiugno+Parkerauthor=C.+Gesenbergauthor=G.+A.+Yamanakaauthor=Y.-F.+Gongauthor=H.-T.+Hoauthor=H.+Fangauthor=N.+Zhouauthor=B.+V.+McAuliffeauthor=B.+J.+Eggersauthor=L.+Fanauthor=B.+Nowicka-Sansauthor=I.+B.+Dickerauthor=Q.+Gaoauthor=R.+J.+Colonnoauthor=P.-F.+Linauthor=N.+A.+Meanwellauthor=J.+F.+Kadow&title=Inhibitors+of+Human+Immunodeficiency+Virus+Type+1+%28HIV-1%29+Attachment.+5.+An+Evolution+from+Indole+to+Azaindoles+Leading+to+the+Discovery+of+1-%284-Benzoylpiperazin-1-yl%29-2-%284%2C7-dimethoxy-1H-pyrrolo%5B2%2C3-c%5Dpyridin-3-yl%29ethane-1%2C2-dione+%28BMS-488043%29%2C+a+Drug+Candidate+That+Demonstrates+Antiviral+Activity+in+HIV-1-Infected+Subjects&doi=10.1021%2Fjm900843g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects</span></div><div class="casAuthors">Wang, Tao; Yin, Zhiwei; Zhang, Zhongxing; Bender, John A.; Yang, Zhong; Johnson, Graham; Yang, Zheng; Zadjura, Lisa M.; D'Arienzo, Celia J.; DiGiugno Parker, Dawn; Gesenberg, Christophe; Yamanaka, Gregory A.; Gong, Yi-Fei; Ho, Hsu-Tso; Fang, Hua; Zhou, Nannan; McAuliffe, Brian V.; Eggers, Betsy J.; Fan, Li; Nowicka-Sans, Beata; Dicker, Ira B.; Gao, Qi; Colonno, Richard J.; Lin, Pin-Fang; Meanwell, Nicholas A.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7778-7787</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Azaindole derivs. derived from the screening lead 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione were prepd. and characterized to assess their potential as inhibitors of HIV-1 attachment.  Systematic replacement of each of the unfused carbon atoms in the Ph ring of the indole moiety by a nitrogen atom provided four different azaindole derivs. that displayed a clear SAR for antiviral activity and all of which displayed marked improvements in pharmaceutical properties.  Optimization of these azaindole leads resulted in the identification of two compds. that were advanced to clin. studies: (R)-1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione I, and 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione, II.  In a preliminary clin. study, II administered as monotherapy for 8 days, reduced viremia in HIV-1-infected subjects, providing proof of concept for this mechanistic class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr84dI0I-kTkrVg90H21EOLACvtfcHk0lgV9m-1dJlykw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKns7zK&md5=c381dc8129dcc2a36547db53aae3a654</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm900843g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900843g%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DJohnson%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZadjura%26aufirst%3DL.%2BM.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DDiGiugno%2BParker%26aufirst%3DD.%26aulast%3DGesenberg%26aufirst%3DC.%26aulast%3DYamanaka%26aufirst%3DG.%2BA.%26aulast%3DGong%26aufirst%3DY.-F.%26aulast%3DHo%26aufirst%3DH.-T.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DMcAuliffe%26aufirst%3DB.%2BV.%26aulast%3DEggers%26aufirst%3DB.%2BJ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DNowicka-Sans%26aufirst%3DB.%26aulast%3DDicker%26aufirst%3DI.%2BB.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DLin%26aufirst%3DP.-F.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DInhibitors%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520%2528HIV-1%2529%2520Attachment.%25205.%2520An%2520Evolution%2520from%2520Indole%2520to%2520Azaindoles%2520Leading%2520to%2520the%2520Discovery%2520of%25201-%25284-Benzoylpiperazin-1-yl%2529-2-%25284%252C7-dimethoxy-1H-pyrrolo%255B2%252C3-c%255Dpyridin-3-yl%2529ethane-1%252C2-dione%2520%2528BMS-488043%2529%252C%2520a%2520Drug%2520Candidate%2520That%2520Demonstrates%2520Antiviral%2520Activity%2520in%2520HIV-1-Infected%2520Subjects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7778%26epage%3D7787%26doi%3D10.1021%2Fjm900843g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span> <span> </span><span class="NLM_article-title">Vemurafenib: the first drug approved for BRAF-mutant cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">886</span>, <span class="refDoi"> DOI: 10.1038/nrd3847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1038%2Fnrd3847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23060265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=873-886&author=G.+Bollagauthor=J.+Tsaiauthor=J.+Zhangauthor=C.+Zhangauthor=P.+Ibrahimauthor=K.+Nolopauthor=P.+Hirth&title=Vemurafenib%3A+the+first+drug+approved+for+BRAF-mutant+cancer&doi=10.1038%2Fnrd3847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Vemurafenib: the first drug approved for BRAF-mutant cancer</span></div><div class="casAuthors">Bollag, Gideon; Tsai, James; Zhang, Jiazhong; Zhang, Chao; Ibrahim, Prabha; Nolop, Keith; Hirth, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">873-886</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The identification of driver oncogenes has provided important targets for drugs that can change the landscape of cancer therapies.  One such example is the BRAF oncogene, which is found in about half of all melanomas as well as several other cancers.  As a druggable kinase, oncogenic BRAF has become a crucial target of small-mol. drug discovery efforts.  Following a rapid clin. development path, vemurafenib (Zelboraf; Plexxikon/Roche) was approved for the treatment of BRAF-mutated metastatic melanoma in the United States in August 2011 and the European Union in Feb. 2012.  This Review describes the underlying biol. of BRAF, the technol. used to identify vemurafenib and its clin. development milestones, along with future prospects based on lessons learned during its development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT6Fbb43oRTbVg90H21EOLACvtfcHk0lgV9m-1dJlykw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rsLjL&md5=b1b38cad542be9b3a30060b77c584bc1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3847%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26atitle%3DVemurafenib%253A%2520the%2520first%2520drug%2520approved%2520for%2520BRAF-mutant%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D873%26epage%3D886%26doi%3D10.1038%2Fnrd3847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carias, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesch, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5689</span>– <span class="NLM_lpage">5694</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219457110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1073%2Fpnas.1219457110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23493555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5689-5694&author=C.+Zhangauthor=P.+N.+Ibrahimauthor=J.+Zhangauthor=E.+A.+Burtonauthor=G.+Habetsauthor=Y.+Zhangauthor=B.+Powellauthor=B.+L.+Westauthor=B.+Matusowauthor=G.+Tsangauthor=R.+Shellooeauthor=H.+Cariasauthor=H.+Nguyenauthor=A.+Marimuthuauthor=K.+Y.+J.+Zhangauthor=A.+Ohauthor=R.+Bremerauthor=C.+R.+Hurtauthor=D.+R.+Artisauthor=G.+Wuauthor=M.+Nespiauthor=W.+Spevakauthor=P.+Linauthor=K.+Nolopauthor=P.+Hirthauthor=G.+H.+Teschauthor=G.+Bollag&title=Design+and+pharmacology+of+a+highly+specific+dual+FMS+and+KIT+kinase+inhibitor&doi=10.1073%2Fpnas.1219457110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span></div><div class="casAuthors">Zhang, Chao; Ibrahim, Prabha N.; Zhang, Jiazhong; Burton, Elizabeth A.; Habets, Gaston; Zhang, Ying; Powell, Ben; West, Brian L.; Matusow, Bernice; Tsang, Garson; Shellooe, Rafe; Carias, Heidi; Nguyen, Hoa; Marimuthu, Adhirai; Zhang, Kam Y. J.; Oh, Angela; Bremer, Ryan; Hurt, Clarence R.; Artis, Dean R.; Wu, Guoxian; Nespi, Marika; Spevak, Wayne; Lin, Paul; Nolop, Keith; Hirth, Peter; Tesch, Greg H.; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5689-5694, S5689/1-S5689/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inflammation and cancer, two therapeutic areas historically addressed by sep. drug discovery efforts, are now coupled in treatment approaches by a growing understanding of the dynamic mol. dialogues between immune and cancer cells.  Agents that target specific compartments of the immune system, therefore, not only bring new disease modifying modalities to inflammatory diseases, but also offer a new avenue to cancer therapy by disrupting immune components of the microenvironment that foster tumor growth, progression, immune evasion, and treatment resistance.  McDonough feline sarcoma viral (v-fms) oncogene homolog (FMS) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) are two hematopoietic cell surface receptors that regulate the development and function of macrophages and mast cells, resp.  The authors disclose a highly specific dual FMS and KIT kinase inhibitor developed from a multifaceted chem. scaffold.  As expected, this inhibitor blocks the activation of macrophages, osteoclasts, and mast cells controlled by these two receptors.  More importantly, the dual FMS and KIT inhibition profile has translated into a combination of benefits in preclin. disease models of inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofECnjzEONuLVg90H21EOLACvtfcHk0lghtryAibkWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D&md5=e4fbca9d41f95718a5119a08a54f5acc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219457110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219457110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCarias%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DHurt%26aufirst%3DC.%2BR.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTesch%26aufirst%3DG.%2BH.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDesign%2520and%2520pharmacology%2520of%2520a%2520highly%2520specific%2520dual%2520FMS%2520and%2520KIT%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D5689%26epage%3D5694%26doi%3D10.1073%2Fpnas.1219457110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crafter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luke, R. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2059</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1021/jm301762v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301762v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2059-2073&author=M.+Addieauthor=P.+Ballardauthor=D.+Buttarauthor=C.+Crafterauthor=G.+Currieauthor=B.+R.+Daviesauthor=J.+Debreczeniauthor=H.+Dryauthor=P.+Dudleyauthor=R.+Greenwoodauthor=P.+D.+Johnsonauthor=J.+G.+Kettleauthor=C.+Laneauthor=G.+Lamontauthor=A.+Leachauthor=R.+W.+A.+Lukeauthor=J.+Morrisauthor=D.+Ogilvieauthor=K.+Pageauthor=M.+Passauthor=S.+Pearsonauthor=L.+Ruston&title=Discovery+of+4-Amino-N-%5B%281S%29-1-%284-chlorophenyl%29-3-hydroxypropyl%5D-1-%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29piperidine-4-carboxamide+%28AZD5363%29%2C+an+Orally+Bioavailable%2C+Potent+Inhibitor+of+Akt+Kinases&doi=10.1021%2Fjm301762v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases</span></div><div class="casAuthors">Addie, Matt; Ballard, Peter; Buttar, David; Crafter, Claire; Currie, Gordon; Davies, Barry R.; Debreczeni, Judit; Dry, Hannah; Dudley, Philippa; Greenwood, Ryan; Johnson, Paul D.; Kettle, Jason G.; Lane, Clare; Lamont, Gillian; Leach, Andrew; Luke, Richard W. A.; Morris, Jeff; Ogilvie, Donald; Page, Ken; Pass, Martin; Pearson, Stuart; Ruston, Linette</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2059-2073</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-aralkyl aminopyrrolopyrimidinylpiperidinecarboxamides such as I (AZD5363) were prepd. as inhibitors of Akt kinases, particularly Akt1, Akt2, and Akt3 kinases, for potential use as antitumor agents based on a collaboratively-identified ATP-competitive pyrrolopyrimidine inhibitor of Akt kinases.  The selectivities of N-aralkyl aminopyrrolopyrimidinylpiperidinecarboxamides for Akt 1, Akt2, and Akt3 over ROCK2 and the hERG ion channel, their octanol-water partition coeffs., and their aq. solubilities were detd.  The oral pharmacokinetics of I in mice, rats, and dogs and the plasma protein binding of I in people, the inhibition of a panel of 75 kinases by I, and the activity of I against human cancer cell lines (particularly breast and prostate cancer) were detd.; I showed pharmacodynamic knockdown of phosphorylation of Akt and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.  The structure of I bound to Akt1 was detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFU3WrUUalYLVg90H21EOLACvtfcHk0lghtryAibkWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsrw%253D&md5=847a03b036460fc14d85c860b0d08f5a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301762v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301762v%26sid%3Dliteratum%253Aachs%26aulast%3DAddie%26aufirst%3DM.%26aulast%3DBallard%26aufirst%3DP.%26aulast%3DButtar%26aufirst%3DD.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DCurrie%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DDry%26aufirst%3DH.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DLane%26aufirst%3DC.%26aulast%3DLamont%26aufirst%3DG.%26aulast%3DLeach%26aufirst%3DA.%26aulast%3DLuke%26aufirst%3DR.%2BW.%2BA.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DOgilvie%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DPearson%26aufirst%3DS.%26aulast%3DRuston%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204-Amino-N-%255B%25281S%2529-1-%25284-chlorophenyl%2529-3-hydroxypropyl%255D-1-%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529piperidine-4-carboxamide%2520%2528AZD5363%2529%252C%2520an%2520Orally%2520Bioavailable%252C%2520Potent%2520Inhibitor%2520of%2520Akt%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2059%26epage%3D2073%26doi%3D10.1021%2Fjm301762v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van
Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeuvray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span> <span> </span><span class="NLM_article-title">Designing the next generation of medicines for malaria control and eradication</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">187</span>, <span class="refDoi"> DOI: 10.1186/1475-2875-12-187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1186%2F1475-2875-12-187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=23742293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=187&author=J.+N.+Burrowsauthor=R.+Hooft+van%0AHuijsduijnenauthor=J.+J.+M%C3%B6hrleauthor=C.+Oeuvrayauthor=T.+N.+Wells&title=Designing+the+next+generation+of+medicines+for+malaria+control+and+eradication&doi=10.1186%2F1475-2875-12-187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Designing the next generation of medicines for malaria control and eradication</span></div><div class="casAuthors">Burrows Jeremy N; van Huijsduijnen Rob Hooft; Mohrle Jorg J; Oeuvray Claude; Wells Timothy N C</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the fight against malaria new medicines are an essential weapon.  For the parts of the world where the current gold standard artemisinin combination therapies are active, significant improvements can still be made: for example combination medicines which allow for single dose regimens, cheaper, safer and more effective medicines, or improved stability under field conditions.  For those parts of the world where the existing combinations show less than optimal activity, the priority is to have activity against emerging resistant strains, and other criteria take a secondary role.  For new medicines to be optimal in malaria control they must also be able to reduce transmission and prevent relapse of dormant forms: additional constraints on a combination medicine.  In the absence of a highly effective vaccine, new medicines are also needed to protect patient populations.  In this paper, an outline definition of the ideal and minimally acceptable characteristics of the types of clinical candidate molecule which are needed (target candidate profiles) is suggested.  In addition, the optimal and minimally acceptable characteristics of combination medicines are outlined (target product profiles).  MMV presents now a suggested framework for combining the new candidates to produce the new medicines.  Sustained investment over the next decade in discovery and development of new molecules is essential to enable the long-term delivery of the medicines needed to combat malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjy7sj0k3cHtFxYDaSSP8XfW6udTcc2ebBFTi7dgIoibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjgsVSisA%253D%253D&md5=c4283af83b04bc217f40528dde196e23</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-187%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DOeuvray%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DDesigning%2520the%2520next%2520generation%2520of%2520medicines%2520for%2520malaria%2520control%2520and%2520eradication%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D187%26doi%3D10.1186%2F1475-2875-12-187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span> <span> </span><span class="NLM_article-title">New developments in anti-malarial target candidate and product profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>, <span class="refDoi"> DOI: 10.1186/s12936-017-1809-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+H.+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+M%C3%B6hrleauthor=T.+N.+Wells&title=New+developments+in+anti-malarial+target+candidate+and+product+profiles&doi=10.1186%2Fs12936-017-1809-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0lj_-VpBaKkAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DNew%2520developments%2520in%2520anti-malarial%2520target%2520candidate%2520and%2520product%2520profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26doi%3D10.1186%2Fs12936-017-1809-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H. C.</span>, <span class="NLM_string-name">Santiago, A. S.</span>, <span class="NLM_string-name">Ramos, P. Z.</span>, <span class="NLM_string-name">Fala, A. M.</span>, <span class="NLM_string-name">Salmazo, A. P. T.</span>, <span class="NLM_string-name">Counago, R. M.</span>, <span class="NLM_string-name">Righetto, G. L.</span>, <span class="NLM_string-name">Silva, P. N. B.</span>, <span class="NLM_string-name">Gileadi, O.</span>, <span class="NLM_string-name">Guimaraes, C. R. W.</span>, <span class="NLM_string-name">Massirer, K. B.</span>, <span class="NLM_string-name">Arruda, P.</span>, <span class="NLM_string-name">Elkins, J. M.</span>, <span class="NLM_string-name">Edwards, A. M.</span></span> <i>Crystal structure of the human PRPF4B in complex with Rebastinib</i>; <span class="NLM_publisher-name">Structural Genomics Consortium (SGC)</span> <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+H.+C.+Godoi&author=A.+S.+Santiago&author=P.+Z.+Ramos&author=A.+M.+Fala&author=A.+P.+T.+Salmazo&author=R.+M.+Counago&author=G.+L.+Righetto&author=P.+N.+B.+Silva&author=O.+Gileadi&author=C.+R.+W.+Guimaraes&author=K.+B.+Massirer&author=P.+Arruda&author=J.+M.+Elkins&author=A.+M.+Edwards&title=Crystal+structure+of+the+human+PRPF4B+in+complex+with+Rebastinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGodoi%26aufirst%3DP.%2BH.%2BC.%26jtitle%3DCrystal%2520structure%2520of%2520the%2520human%2520PRPF4B%2520in%2520complex%2520with%2520Rebastinib%26pub%3DStructural%2520Genomics%2520Consortium%2520%2528SGC%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liddle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamborough, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousins, R. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heathcote, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Molina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumsey, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tape, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicentini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitworth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, R. A.</span></span> <span> </span><span class="NLM_article-title">4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5222</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1016%2Fj.bmcl.2012.06.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22801646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVCjsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5222&author=J.+Liddleauthor=P.+Bamboroughauthor=M.+D.+Barkerauthor=S.+Camposauthor=C.-W.+Chungauthor=R.+P.+C.+Cousinsauthor=P.+Faulderauthor=M.+L.+Heathcoteauthor=H.+Hobbsauthor=D.+S.+Holmesauthor=C.+Ioannouauthor=C.+Ramirez-Molinaauthor=M.+A.+Morseauthor=R.+Osbornauthor=J.+J.+Payneauthor=J.+M.+Pritchardauthor=W.+L.+Rumseyauthor=D.+T.+Tapeauthor=G.+Vicentiniauthor=C.+Whitworthauthor=R.+A.+Williamson&title=4-Phenyl-7-azaindoles+as+potent%2C+selective+and+bioavailable+IKK2+inhibitors+demonstrating+good+in+vivo+efficacy&doi=10.1016%2Fj.bmcl.2012.06.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy</span></div><div class="casAuthors">Liddle, John; Bamborough, Paul; Barker, Michael D.; Campos, Sebastien; Chung, Chun-Wa; Cousins, Rick P. C.; Faulder, Paul; Heathcote, Michelle L.; Hobbs, Heather; Holmes, Duncan S.; Ioannou, Chris; Ramirez-Molina, Cesar; Morse, Mary A.; Osborn, Ruth; Payne, Jeremy J.; Pritchard, John M.; Rumsey, William L.; Tape, Daniel T.; Vicentini, Giorgia; Whitworth, Caroline; Williamson, Rick A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5222-5226</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The lead optimization of a series of potent azaindole IKK2 inhibitors is described.  Optimization of the human whole blood activity and selectivity over IKK1 in parallel led to the discovery of 16, a potent and selective IKK2 inhibitor showing good efficacy in a rat model of neutrophil activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDgiw_Aw0Bc7Vg90H21EOLACvtfcHk0lhaYk0XqK8A0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVCjsbvE&md5=0cf65e328cf53e8ba1f72b1f08ad22bf</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBarker%26aufirst%3DM.%2BD.%26aulast%3DCampos%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCousins%26aufirst%3DR.%2BP.%2BC.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DHeathcote%26aufirst%3DM.%2BL.%26aulast%3DHobbs%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DIoannou%26aufirst%3DC.%26aulast%3DRamirez-Molina%26aufirst%3DC.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOsborn%26aufirst%3DR.%26aulast%3DPayne%26aufirst%3DJ.%2BJ.%26aulast%3DPritchard%26aufirst%3DJ.%2BM.%26aulast%3DRumsey%26aufirst%3DW.%2BL.%26aulast%3DTape%26aufirst%3DD.%2BT.%26aulast%3DVicentini%26aufirst%3DG.%26aulast%3DWhitworth%26aufirst%3DC.%26aulast%3DWilliamson%26aufirst%3DR.%2BA.%26atitle%3D4-Phenyl-7-azaindoles%2520as%2520potent%252C%2520selective%2520and%2520bioavailable%2520IKK2%2520inhibitors%2520demonstrating%2520good%2520in%2520vivo%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5222%26doi%3D10.1016%2Fj.bmcl.2012.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nwakanma, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amambua-Ngwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oriero, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojang, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakeley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacInnis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D. J.</span></span> <span> </span><span class="NLM_article-title">Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>209</i></span>,  <span class="NLM_fpage">1126</span>, <span class="refDoi"> DOI: 10.1093/infdis/jit618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1093%2Finfdis%2Fjit618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=24265439" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2013&pages=1126&author=D.+C.+Nwakanmaauthor=C.+W.+Duffyauthor=A.+Amambua-Ngwaauthor=E.+C.+Orieroauthor=K.+A.+Bojangauthor=M.+Pinderauthor=C.+J.+Drakeleyauthor=C.+J.+Sutherlandauthor=P.+J.+Milliganauthor=B.+MacInnisauthor=D.+P.+Kwiatkowskiauthor=T.+G.+Clarkauthor=B.+M.+Greenwoodauthor=D.+J.+Conway&title=Changes+in+malaria+parasite+drug+resistance+in+an+endemic+population+over+a+25-year+period+with+resulting+genomic+evidence+of+selection&doi=10.1093%2Finfdis%2Fjit618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjit618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjit618%26sid%3Dliteratum%253Aachs%26aulast%3DNwakanma%26aufirst%3DD.%2BC.%26aulast%3DDuffy%26aufirst%3DC.%2BW.%26aulast%3DAmambua-Ngwa%26aufirst%3DA.%26aulast%3DOriero%26aufirst%3DE.%2BC.%26aulast%3DBojang%26aufirst%3DK.%2BA.%26aulast%3DPinder%26aufirst%3DM.%26aulast%3DDrakeley%26aufirst%3DC.%2BJ.%26aulast%3DSutherland%26aufirst%3DC.%2BJ.%26aulast%3DMilligan%26aufirst%3DP.%2BJ.%26aulast%3DMacInnis%26aufirst%3DB.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DClark%26aufirst%3DT.%2BG.%26aulast%3DGreenwood%26aufirst%3DB.%2BM.%26aulast%3DConway%26aufirst%3DD.%2BJ.%26atitle%3DChanges%2520in%2520malaria%2520parasite%2520drug%2520resistance%2520in%2520an%2520endemic%2520population%2520over%2520a%252025-year%2520period%2520with%2520resulting%2520genomic%2520evidence%2520of%2520selection%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D209%26spage%3D1126%26doi%3D10.1093%2Finfdis%2Fjit618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amambua-Ngwa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okebe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceesay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Fatouri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joof, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, O.</span></span> <span> </span><span class="NLM_article-title">Sustained ex vivo susceptibility of plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in The Gambia</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e00759</span> <span class="refDoi"> DOI: 10.1128/aac.00759-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1128%2FAAC.00759-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=28971859" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=A.+Amambua-Ngwaauthor=J.+Okebeauthor=H.+Mbyeauthor=S.+Ceesayauthor=F.+El-Fatouriauthor=F.+Joofauthor=H.+Nyangauthor=R.+Janhaauthor=M.+Affaraauthor=A.+Ahmadauthor=O.+Kolly&title=Sustained+ex+vivo+susceptibility+of+plasmodium+falciparum+to+artemisinin+derivatives+but+increasing+tolerance+to+artemisinin+combination+therapy+partner+quinolines+in+The+Gambia&doi=10.1128%2Faac.00759-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FAAC.00759-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00759-17%26sid%3Dliteratum%253Aachs%26aulast%3DAmambua-Ngwa%26aufirst%3DA.%26aulast%3DOkebe%26aufirst%3DJ.%26aulast%3DMbye%26aufirst%3DH.%26aulast%3DCeesay%26aufirst%3DS.%26aulast%3DEl-Fatouri%26aufirst%3DF.%26aulast%3DJoof%26aufirst%3DF.%26aulast%3DNyang%26aufirst%3DH.%26aulast%3DJanha%26aufirst%3DR.%26aulast%3DAffara%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DKolly%26aufirst%3DO.%26atitle%3DSustained%2520ex%2520vivo%2520susceptibility%2520of%2520plasmodium%2520falciparum%2520to%2520artemisinin%2520derivatives%2520but%2520increasing%2520tolerance%2520to%2520artemisinin%2520combination%2520therapy%2520partner%2520quinolines%2520in%2520The%2520Gambia%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2Faac.00759-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chausset-Boissarie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Àrvai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guénée, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kündig, E. P.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of (+)-vertine and (+)-lythrine</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6473</span>– <span class="NLM_lpage">6479</span>, <span class="refDoi"> DOI: 10.1039/c2ob25880c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1039%2Fc2ob25880c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=22763639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSlsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=6473-6479&author=L.+Chausset-Boissarieauthor=R.+%C3%80rvaiauthor=G.+R.+Cummingauthor=L.+Gu%C3%A9n%C3%A9eauthor=E.+P.+K%C3%BCndig&title=Asymmetric+synthesis+of+%28%2B%29-vertine+and+%28%2B%29-lythrine&doi=10.1039%2Fc2ob25880c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric synthesis of (+)-vertine and (+)-lythrine</span></div><div class="casAuthors">Chausset-Boissarie, Laetitia; Arvai, Roman; Cumming, Graham R.; Guenee, Laure; Kundig, E. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">6473-6479</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The total syntheses of the Lythracea alkaloids (+)-vertine and (+)-lythrine are described.  Enantioenriched pelletierine is used as a chiral building block and engaged into a two step pelletierine condensation leading to two quinolizidin-2-one diastereomers in a 8:1 ratio.  The major product is used in the synthesis of (+)-vertine (I) via aryl-aryl coupling and ring closing metathesis to provide a Z-alkene α to the lactone carbonyl function.  The same procedure was used for (+)-lythrine after base induced epimerization of the main quinolizidin-2-one diastereomer.  Alternative classical ring closure strategies like macrolactonization or aryl-aryl coupling failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7P9wTZFNNLVg90H21EOLACvtfcHk0lhaYk0XqK8A0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSlsLbF&md5=aa9583e5ffae311f2155bda21e52714e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fc2ob25880c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ob25880c%26sid%3Dliteratum%253Aachs%26aulast%3DChausset-Boissarie%26aufirst%3DL.%26aulast%3D%25C3%2580rvai%26aufirst%3DR.%26aulast%3DCumming%26aufirst%3DG.%2BR.%26aulast%3DGu%25C3%25A9n%25C3%25A9e%26aufirst%3DL.%26aulast%3DK%25C3%25BCndig%26aufirst%3DE.%2BP.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%2528%252B%2529-vertine%2520and%2520%2528%252B%2529-lythrine%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2012%26volume%3D10%26spage%3D6473%26epage%3D6479%26doi%3D10.1039%2Fc2ob25880c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dluzewski, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’donnell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withers-Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M. J.</span></span> <span> </span><span class="NLM_article-title">Molecular identification of a malaria merozoite surface sheddase</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e29</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.0010029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1371%2Fjournal.ppat.0010029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&author=P.+K.+Harrisauthor=S.+Yeohauthor=A.+R.+Dluzewskiauthor=R.+A.+O%E2%80%99donnellauthor=C.+Withers-Martinezauthor=F.+Hackettauthor=L.+H.+Bannisterauthor=G.+H.+Mitchellauthor=M.+J.+Blackman&title=Molecular+identification+of+a+malaria+merozoite+surface+sheddase&doi=10.1371%2Fjournal.ppat.0010029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.0010029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.0010029%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BK.%26aulast%3DYeoh%26aufirst%3DS.%26aulast%3DDluzewski%26aufirst%3DA.%2BR.%26aulast%3DO%25E2%2580%2599donnell%26aufirst%3DR.%2BA.%26aulast%3DWithers-Martinez%26aufirst%3DC.%26aulast%3DHackett%26aufirst%3DF.%26aulast%3DBannister%26aufirst%3DL.%2BH.%26aulast%3DMitchell%26aufirst%3DG.%2BH.%26aulast%3DBlackman%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520identification%2520of%2520a%2520malaria%2520merozoite%2520surface%2520sheddase%26jtitle%3DPLoS%2520Pathog.%26date%3D2005%26volume%3D1%26doi%3D10.1371%2Fjournal.ppat.0010029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roncalés, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span> <span> </span><span class="NLM_article-title">In Vitro culture of plasmodium falciparum obtention of synchronous asexual erythrocytic stages</span>. <i>Open J. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>05</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.4236/ojepi.2015.51010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.4236%2Fojepi.2015.51010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=05&publication_year=2015&pages=71-80&author=M.+Roncal%C3%A9sauthor=J.+Vidalauthor=P.+A.+Torresauthor=E.+Herreros&title=In+Vitro+culture+of+plasmodium+falciparum+obtention+of+synchronous+asexual+erythrocytic+stages&doi=10.4236%2Fojepi.2015.51010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.4236%2Fojepi.2015.51010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fojepi.2015.51010%26sid%3Dliteratum%253Aachs%26aulast%3DRoncal%25C3%25A9s%26aufirst%3DM.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DTorres%26aufirst%3DP.%2BA.%26aulast%3DHerreros%26aufirst%3DE.%26atitle%3DIn%2520Vitro%2520culture%2520of%2520plasmodium%2520falciparum%2520obtention%2520of%2520synchronous%2520asexual%2520erythrocytic%2520stages%26jtitle%3DOpen%2520J.%2520Epidemiol.%26date%3D2015%26volume%3D05%26spage%3D71%26epage%3D80%26doi%3D10.4236%2Fojepi.2015.51010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10534321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1350-1359&author=R.+S.+Obach&title=Prediction+of+human+clearance+of+twenty-nine+drugs+from+hepatic+microsomal+intrinsic+clearance+data%3A+an+examination+of+in+vitro+half-life+approach+and+nonspecific+binding+to+microsomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1350-1359</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Twenty-nine drugs of disparate structures and physicochem. properties were used in an examn. of the capability of human liver microsomal lability data ("in vitro T1/2" approach) to be useful in the prediction of human clearance.  Addnl., the potential importance of nonspecific binding to microsomes in the in vitro incubation milieu for the accurate prediction of human clearance was investigated.  The compds. examd. demonstrated a wide range of microsomal metabolic labilities with scaled intrinsic clearance values ranging from less than 0.5 mL/min/kg to 189 mL/min/kg.  Microsomal binding was detd. at microsomal protein concns. used in the lability incubations.  For the 29 compds. studied, unbound fractions in microsomes ranged from 0.11 to 1.0.  Generally, basic compds. demonstrated the greatest extent of binding and neutral and acidic compds. the least extent of binding.  In the projection of human clearance values, basic and neutral compds. were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions.  Including only blood binding yielded very poor projections of human clearance for these two types of compds.  However, for acidic compds., disregarding all binding considerations yielded poor predictions of human clearance.  It was generally most difficult to accurately predict clearance for this class of compds.; however the accuracy was best when all binding considerations were included.  Overall, inclusion of both blood and microsome binding values gave the best agreement between in vivo clearance values and clearance values projected from in vitro intrinsic clearance data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWp2hUTOxyubVg90H21EOLACvtfcHk0lhvBoBVNol-SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSht7c%253D&md5=7804cd4dfb131caac45aff9b7a1df901</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPrediction%2520of%2520human%2520clearance%2520of%2520twenty-nine%2520drugs%2520from%2520hepatic%2520microsomal%2520intrinsic%2520clearance%2520data%253A%2520an%2520examination%2520of%2520in%2520vitro%2520half-life%2520approach%2520and%2520nonspecific%2520binding%2520to%2520microsomes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1350%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valkó, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D.</span></span> <span> </span><span class="NLM_article-title">Chromatographic hydrophobicity index by fast-gradient RP-HPLC: a high-throughput alternative to log P/log D</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2022</span>– <span class="NLM_lpage">2029</span>, <span class="refDoi"> DOI: 10.1021/ac961242d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac961242d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADyaK2sXivVertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=2022-2029&author=K.+Valk%C3%B3author=C.+Bevanauthor=D.+Reynolds&title=Chromatographic+hydrophobicity+index+by+fast-gradient+RP-HPLC%3A+a+high-throughput+alternative+to+log+P%2Flog+D&doi=10.1021%2Fac961242d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to Log P/log D</span></div><div class="casAuthors">Valko, Klara; Bevan, Chris; Reynolds, Derek</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2022-2029</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new chromatog. hydrophobicity index (CHI) is described which can be used as part of a protocol for high-throughput (50-100 compds./day) physicochem. property profiling for rational drug design.  The index is derived from retention times (tR) obsd. in a fast gradient reversed-phase HPLC method.  The isocratic retention factors (log k') were measured for a series of 76 structurally unrelated compds. by using various concns. of acetonitrile in the mobile phase.  By plotting the log k' as a function of the acetonitrile concn., the slope (S) and the intercept (log k'w) values were calcd.  The previously validated index of hydrophobicity φ0 was calcd. as -log k'w/S.  A good linear correlation was obtained between the gradient retention time values, tR and the isocratically detd. φ0 values for the 76 compds.  The consts. of this linear correlation can be used to calc. CHI.  For most compds., CHI is between 0 and 100 and in this range it approximates to the percentage (by vol.) of acetonitrile required to achieve an equal distribution of compd. between the mobile and the stationary phases.  CHI values can be measured using acidic, neutral, or slightly basic eluents.  Values corresponding to the neutral form of mols. could be measured for 52 of the compds. and showed good correlation (r = 0.851) to the calcd. octanol/water partition coeff. (c log P) values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozvQI1B1cnpbVg90H21EOLACvtfcHk0lhvBoBVNol-SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVertLs%253D&md5=fcbb641105c12dc490d4a20db8fc5032</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fac961242d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac961242d%26sid%3Dliteratum%253Aachs%26aulast%3DValk%25C3%25B3%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DChromatographic%2520hydrophobicity%2520index%2520by%2520fast-gradient%2520RP-HPLC%253A%2520a%2520high-throughput%2520alternative%2520to%2520log%2520P%252Flog%2520D%26jtitle%3DAnal.%2520Chem.%26date%3D1997%26volume%3D69%26spage%3D2022%26epage%3D2029%26doi%3D10.1021%2Fac961242d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/bj20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2Fbj20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lgTt0heLsT9kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2Fbj20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CNH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CNH','PDB','6CNH'); return false;">PDB: 6CNH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AWI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AWI','PDB','4AWI'); return false;">PDB: 4AWI</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00451">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27826"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00451?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00451</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures and characterization data for all compounds; copies of <sup>1</sup>H, <sup>13</sup>C, NMR spectra for all compounds; log <i>D</i><sub>7.4</sub> (distribution co-efficient), metabolic stability, and analytical HPLC traces for final compounds; and <i>P. falciparum</i> culture, synchronization, and TR-FRET assay data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_001.pdf">jm0c00451_si_001.pdf (7.57 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00451/suppl_file/jm0c00451_si_002.csv">jm0c00451_si_002.csv (1.15 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00451&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00451%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00451" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a1059f6e3d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
